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Abstract 
Chronic diseases and conditions are the leading causes of death worldwide. In 2005, 
approximately 35 million people died from chronic diseases, making them responsible for 
60% of all mortalities. Despite the popular belief that chronic diseases affect mostly high-
income countries and older people, the reality gives quite a different picture: 80% of 
deaths from chronic diseases occur in low- and middle-income countries, and these are 
mostly concentrated among the poor. Almost half of the deaths occur at an age under 70 
years. The premature mortality and reduced quality of life for chronic patients not only 
results in an epidemiological burden, but also exerts a significant impact on national 
economies. Therefore, chronic disease prevention and management has been a major 
concern for governments and related international organisations.  
This thesis narrows on a particular scope within the greater paradigm of chronic disease 
prevention and management, which is to understand chronic disease progression and 
then predict risk based on this understanding. The motivation for this project comes from 
the fact that a significant proportion of potentially preventable hospital admissions are 
due to chronic disease. In many cases, patients are unaware of their chronic conditions, 
and only when they are admitted to hospital are these chronic conditions discovered as a 
secondary diagnosis. This results in further complications, longer length of stay and an 
increased burden on limited healthcare resources. Had they been diagnosed as chronic 
patients before, all of these complications could have been averted. However, traditional 
methods of clinical diagnosis and regular monitoring of a large population are often 
resource-intensive in terms of available clinical provisions and economic capability. One 
potential alternative comes from a data mining perspective on healthcare information 
systems, more specifically hospital admission data, which carries rich semantic 
information about the patients’ overall health status and diagnosis information in the 
form of standardised codes. This vast amount of systematically generated data can help us 
to understand the disease footprints left by chronic patients. The understanding can then 
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be utilised to evaluate the health status of another population. At present, very limited 
work has been done in realising these particular potentials of this administrative data. 
This thesis, therefore, asks the questions: how administrative data can generate 
knowledge that can help us to understand chronic disease pathways? Is it possible to 
reasonably predict chronic disease risk by leveraging our understanding of disease 
progression? This thesis attempts to answer these questions by presenting a framework. 
The framework has two major parts: (i) to understand and represent the progression of a 
particular chronic disease, and (ii) to develop a model based on that understanding to 
predict chronic disease risk for non-chronic patients. We utilised graph theory and social 
network analysis for both of these parts. For the first part, we propose the concept of a 
‘baseline network’ that can effectively model chronic disease comorbidities and their 
transition patterns, thereby representing the chronic disease progression. We further take 
the attribution effect of the comorbidities into account while generating the baseline 
network; that is, we not only look at the pattern of disease in the chronic disease patients, 
but also compare them with that of non-chronic patients to understand which 
comorbidities are more responsible for leading to the chronic disease pathway. For the 
second part, we used this ‘baseline network’ to compare against the individual health 
trajectories of non-chronic patients. For matching the networks, we proposed several 
graph theory and social network-based methods. These methods look at multiple 
parameters, including the prevalence of the comorbidities, transition patterns and 
frequencies, clustering membership, and demographic and behavioural factors such as 
age, sex and smoking. Individual risk scores against each of these parameters are then 
merged to generate the single prediction score that purports to represent the risk of 
future chronic disease for current non-chronic patients.  
We implemented the framework on administrative data drawn from the Australian 
healthcare context and chose type 2 diabetes as the chronic disease for the model to 
predict. The overall dataset contained approximately 1.4 million admission records from 
.75 million patients, from which we filtered and sampled the records of 2,300 diabetic and 
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2,300 non-diabetic patients. We followed an exploratory approach during the 
implementation to understand the relative contributions of different types of parameters 
in the prediction. We utilised three different predicting modelling methods—regression, 
parameter optimisation and tree classification—all of which gave the highest ranking to 
the graph theory-based ‘comorbidity prevalence’ and ‘transition pattern match’ scores. 
This proves the effectiveness of our proposed network theory-based measures. We also 
explored the effect of using limited and selected comorbidities compared to using fixed-
length International Classification of Diseases (ICD) codes in representing the actors or 
nodes of the baseline network. Fixed-length ICD codes, together with tree classification, 
showed the highest accuracy. Overall, the framework showed prediction accuracy within 
90% to 95% in identifying the future risk of type-2 diabetes. This is a significant 
improvement over the other similar prediction methods. Further, we critically analysed 
the effect of using different predictive models, attribution adjustment and ICD code 
collapse on performance. This provides direction on which specific method settings to use 
based on the specific chronic disease and type of healthcare dataset, thereby making the 
overall framework more generic and versatile.  
The framework proposed in the thesis can potentially be useful for stakeholders including 
governments and health insurers to identify cohorts of patients at high risk of developing 
chronic disease. Adopting a rigorous early intervention and prevention policy targeted at 
those patients can potentially divert them from the chronic disease pathway, and reduce 
healthcare costs from both provider and consumer perspective. 
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Preface 
We started this research with the focus to quantify the longitudinal nature of complex and 
dynamic networks. To do that, we developed a set of measures during the first year. We 
combined them into an analytical framework and started to implement them on 
longitudinal datasets like obesity research data, collaboration network etc. At the same 
time, we were looking for a more robust context to extend the framework that can have a 
practical implication. By the end of 2014, we got the opportunity to collaborate with 
Capital Markets Cooperative Research Centre (CMCRC) who became our industry partner. 
CMCRC provided us the access to a large private health data after all the parties sorted 
out rigorous security, privacy and ethical requirements. Access to this health data opened 
up a vast research scope in front of us. This was the turning point that shaped the overall 
research questions and the way this thesis is presented. 
The target audience of this research are likely to be data and network scientists, 
healthcare related policy makers and analytics as the research lies between the broad 
disciplines of data mining, health informatics, complex systems and network science. 
Keeping this in mind, we tried to present it comprehensibly and avoided technical terms 
as much as possible. Also, before ‘introduction’ we added the most frequent 
terminologies used in the thesis. A comprehensive list of terms, abbreviations and related 
background information are included later in appendix. The total length of the thesis is 
approximately 61,000 words excluding appendices and references. 
This research used de-identified personal health data of patients containing information 
like age, sex, hospital admission summary etc. Required human ethics approval was 
obtained from the Human Research Ethics Committee of University of Sydney under the 
project number 2015/824. A copy of the approval letter is attached in the Appendix D. 
This thesis was first submitted on 31 August, 2016. Revised version was submitted for final 
lodgement on 9 March 2017.  
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Chapter 1: Introduction 
In this chapter, we present a broad-level overview of the whole thesis. We begin by 
stating the primary objective of our research. We then briefly discuss the contextual 
background and the primary motivations that led the research project. Following the 
background and motivation, we list the research questions and approach followed in the 
thesis. Finally, we discuss the major contributions of the research, followed by an 
overview of the thesis that is presented in the subsequent chapters. As our research is 
based on the Australian healthcare system, we try to provide statistics focused on 
Australia and countries dependent on similar policies to make the thesis more 
comprehensible and provide relevant context. 
1.1 Objectives 
This thesis has two broad goals: (1) to understand and represent the progression of 
chronic disease, and (2) to develop a model based on this understanding to predict 
chronic disease risk for non-chronic patients. To achieve them in real-world healthcare 
data as context, this thesis develops a set of methodologies which are mostly based on 
graph theory and social network analysis. Together, these methodologies provide a 
generic and systematic model to understand chronic disease progression and assess 
future risks. Throughout this thesis, the term ‘framework’ is used to collectively refer to 
this set of methodologies. 
Chronic diseases are a broad set of different illnesses and health conditions that are non-
communicable and persist over a long period of time. The four most prevalent chronic 
disease groups are: cardiovascular diseases (e.g., stroke, heart attacks), cancers, chronic 
obstructive pulmonary disease (COPD) and diabetes. These diseases generally do not have 
preventive vaccines or definitive cures once the patient has developed the condition. 
Previous research has shown that chronic diseases often occur together as comorbidities, 
because they share similar underlying causes and risk factors. As a result, the progression 
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towards a particular chronic disease often comes from a complex interplay and transition 
between different diseases or comorbidities. We define these interactions and transitions 
between comorbidities leading to a particular chronic disease as ‘disease progression’. The 
first part of our framework aims at understanding this disease progression—that is, the 
comorbidities and their prevalence and transition patterns over time. We propose a 
networked representation called a ‘baseline network’ for understanding this disease 
progression.  
We use the administrative claim dataset that is routinely generated when patients are 
admitted to hospitals. This dataset contains all disease-related information for admitted 
patients along with timestamps, thus enabling us to obtain a snapshot of their health 
trajectory. This information is used in the first part of the framework to generate a 
baseline network to understand the progression of the chronic disease. For this thesis, the 
chronic disease we focus on is type 2 diabetes. This is a progressive condition in which the 
body becomes resistant to the normal effects of insulin (a hormone) and/or gradually 
loses the capacity to produce enough insulin in the body’s pancreas (Thomas, 2015). 
In the second part of the framework, we make a prediction model by utilising the 
empirical understanding gained from the previous part, i.e., from the baseline network of 
the comorbidities that lead to type 2 diabetes. The goal is to propose a set of graph theory 
and social network-based measures to compare the baseline network with the health 
trajectory of a non-diabetic (i.e., non-chronic) patient. These measures are then used to 
predict the overall risk of diabetes for that patient. 
In addition to the primary goals, the framework adopts an explorative approach to 
developing secondary understanding throughout the research. This is necessary because 
hospital administrative datasets have rarely been used in prior studies that properly align 
with our research goals. Therefore, we want to explore different alternative methods 
within the framework to test their effectiveness. For example, we employ three different 
prediction models in the second part of the thesis to compare their performance and 
discuss individual benefits and pitfalls. Further, we consider several parameters based on 
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demographic and behavioural risk factors. Parameters based on the baseline network and 
disease cluster matching are also considered. The goal is to understand and quantify these 
parameters’ influence in diabetes prediction and discuss why some parameters are better 
predictors than others. It is hoped that the explorative comparison between different 
approaches within the framework will make it more flexible in its applicability to other 
chronic diseases and dataset contexts. 
1.2 Background and Motivation 
 1.2.1 Burden of chronic diseases 
Since antiquity, major causes of human death have been mostly concerned with childhood 
mortality, infectious disease, malnutrition, epidemics and physical injury. Modern 
scientific and medical advancement has drastically reduced deaths due to these causes 
through vaccines, antibiotics, and improved medication and diagnostic techniques. 
Conversely, chronic non-communicable diseases have become the leading causes of death 
in most parts of the world. In 2012,  38 million people died of chronic diseases worldwide, 
representing 68% of all death (World Health Organization, 2012). Similar statistics are also 
observed across countries within last decade. For instance, in United States (US) as of 
2012, 117 million people (about half of all adults) had one or more chronic conditions 
(Ward, et al., 2014), 90% of all deaths in Australia in 2011 were due to chronic disease 
(AIHW, 2014). While it is often assumed that chronic diseases are only prevalent problems 
for richer countries, statistics paint a completely different picture: 80% of deaths from 
chronic diseases occur in low- and middle-income countries, mostly concentrated among 
the poor. One of the reasons for this trend is that many low- and middle-income countries 
are undergoing economic and nutritional transition (Popkin, et al., 2012), resulting in a 
higher prevalence of obesity, which is a common risk factor for many chronic diseases. As 
a result, many developing countries have to deal with infectious diseases and malnutrition 
side by side with the alarmingly increasing prevalence of obesity and chronic diseases.  
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Figure 1.1 shows the evidence that deaths related to chronic disease are leading in most 
regions of the world compared to deaths from non-chronic diseases, according to research 
from the WHO (Cohn, 2007, Mathers, et al., 2003). 
 
Figure 1.1: Comparison of percentage of total death from chronic and selected non-
chronic causes in different regions (Cohn, 2007, Mathers, et al., 2003) 
Another common misconception is that chronic diseases occur mostly in the elderly. In 
reality, almost half of all deaths from chronic diseases occur at an age under 70 years, 
when people are still in their productive years. Premature mortality is, however, not the 
only concern. As has been mentioned above, across the world countries are undergoing 
economic transition. Rising incomes, falling food prices, improved supply chains and 
urbanisation have led to global changes in diet, overweight, obesity and physical inactivity 
across all age groups (Alwan, 2011). As a result, early onset of chronic conditions is ever 
on the rise (Kopelman, 2000). The potential loss of productivity, illness, disability, death 
and healthcare costs thus put a significant strain on the economy. 
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The primary motivation for this thesis has come from the efforts to prevent chronic 
diseases exerted by government, stakeholders, healthcare providers and patients. The 
good news is that many chronic diseases are preventable. For example, 80% of premature 
heart disease, stroke and type 2 diabetes and 40% of cancer cases are preventable (WHO, 
2005). Healthy and careful lifestyle choices can prevent the onset of complications or 
manage them once they are developed. However, the problem is that many chronic 
diseases, especially type 2 diabetes, develop slowly without explicit symptoms; thus the 
patients may remain unaware of their condition until it is too late (Gregg, et al., 2004, 
Rathmann, et al., 2003). Moreover, when patients are admitted to hospitals for 
treatments or surgical procedures, they are often diagnosed with chronic disease such as 
type 2 diabetes (Taubert, et al., 2003) as comorbidity, not the primary reason for 
admission. There is substantial evidence to show that patients with diabetes take longer 
to recover, have higher mortality and contract more secondary infections, and in general 
there is a substantial increase in the cost of care to achieve the desired health outcomes 
(Harris, 1993, Kapur, et al., 1999, Lauruschkat, et al., 2005, MacKenzie, et al., 1989, 
Tenenbaum, et al., 2000, Umpierrez, et al., 2002). 
The growing evidence, therefore, suggests the need for more accurate diagnosis of 
chronic diseases. The intuitive way is to achieve this need is to implement a healthcare 
policy that encourages rigorous and timely screening for chronic diseases. However, mass 
screening is often expensive and difficult to implement, given the scarcity of clinical 
resources and related infrastructure in many countries. Therefore, a cost-effective option 
could be to target only a portion of the population that are at high risk based on their 
previous medical conditions, as many chronic diseases, as we have observed, can 
demonstrate a comorbidity pattern leading up to the disease. There are two challenges: 
first, we need to understand the comorbidity pattern, and, based on that pattern, identify 
the cohort most at risk. Second, if we can achieve this, the at-risk cohort can be further 
screened or advised to take preventive measures, which can be a sustainable and cost-
effective solution from both provider and consumer perspectives. 
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 1.2.2 Modern health system and availability of healthcare data 
Most countries today have well-defined health systems (often referred to as healthcare 
systems) that focus on providing affordable and quality healthcare services for their 
citizens. The WHO defined a health system as follows:  
A health system consists of all organizations, people and actions whose primary intent is 
to promote, restore or maintain health. … It includes, for example, a mother caring for a 
sick child at home; private providers; behaviour change programmes; vector-control 
campaigns; health insurance organisations; occupational health and safety legislation. It 
includes inter-sectoral action by health staff, for example, encouraging the ministry of 
education to promote female education, a well-known determinant of better health. 
(World Health Organization., 2007)  
The broad goals of a health system are to improve health and health equity in ways that 
are responsive, financially fair, and make the best, or most efficient, use of available 
resources (World Health Organization., 2007, 2000). 
Since the modernisation of computers and networking technology, the health systems of 
most countries have evolved and revolutionised the way healthcare services are delivered. 
As a consequence, modern health systems generate large amounts of data as the health 
consumer traverses the system, accessing services. The origin, type and purpose of 
healthcare-related datasets vary widely. Nevertheless, we can broadly categorise 
healthcare datasets into four groups based on the ways in which they are collected. The 
first type of health dataset is ‘survey data’ generated through systematic surveys, mostly 
conducted by researchers or other stakeholders, to understand trends in populations 
through specific tailored questions. Specifically, chronic diseases incur long-term burdens 
on healthcare systems as well as in the individual’s quality of life; therefore, many 
countries maintain an active registry of databases through longitudinal surveys of sections 
of the population. For an example, the organisation Diabetes Australia keeps an active 
registry of diabetes patients under the National Diabetes Services Scheme (NDSS) to 
monitor the prevalence of diabetes across Australia (Diabetes Australia, 2016). Another 
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example is the ‘45 and Up Study’, which regularly surveys a large population of Australians 
aged over 45 (SAX Institute, 2016). 
The second type of health dataset, which is emerging as an important source of data, is 
‘device-generated data’. These data are generated by electronic devices in an automated 
manner. For example, modern medical devices (e.g., ICU devices) may generate periodic 
vital statistics of patients, and these sources of data are often mined. Also, personal 
electronic devices (e.g., smart watches, wristbands, smartphone apps) may generate and 
share real-time health statistics.  
The third type of health dataset is ‘medical records’. This type of dataset contains 
information related to a patient’s medical condition, including diagnosis and treatment. A 
medical record is created for each patient in most primary and tertiary healthcare settings 
and is mainly used by the providers. Typically, patients are assigned a unique identifier 
(e.g., Medical Record Number [MRN]) to link records created during subsequent 
consultations. As information technology has substantially improved globally, more 
countries have begun to implement the concepts of electronic healthcare, commonly 
known as e-health. As a result, individual medical records are shared, unified and often 
stored centrally. This has become a valuable resource for managing continuity of care, so 
that the various providers and emergency departments can have unified, up-to-date and 
consistent access to patients’ health records. The patient, in turn, can also have access to 
their complete medical history.  
The last of the four datasets is the ‘administrative dataset’, which is collected for billing, 
quality assurance, auditing and other administrative purposes. Unlike the ‘medical 
records’ set, which is mostly maintained by healthcare providers to understand individual 
health conditions, administrative datasets contain more service-level information, such as 
fees and charges and summaries of provided services. These datasets are often shared 
across policy makers, funders, government agencies and other stakeholders, and can 
serve as rich sources of information. Figure 1.2 shows a snapshot of the four different 
types of healthcare datasets and their potential use by different stakeholders. 
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Figure 1.2: Organisation of healthcare data 
This research utilises the fourth type of dataset, i.e., ‘administrative dataset. Therefore, in 
this chapter and in the subsequent ones, we make particular effort to discuss the potential 
for knowledge discovery from the administrative dataset.  
In Australia, as in several other countries, an important portion of administrative data 
consists of hospital admission and discharge details. Several applications that are 
illustrated in the following sections are based on data stored in such administrative 
records, which are kept in both public and private health sectors in Australia. The 
administrative record of a hospital-admitted patient contains: patient demographics; 
patient’s medical condition, represented as principal and secondary diagnosis ICD codes 
(Rizzo, et al., 2015); procedures performed, represented as MBS (AIHW, 2014) and 
International Classification of Diseases (ICD) procedure codes; and length of service 
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provided (including accommodation and prosthetics). The billing information is of 
particular interest for private and public funders such as Medicare (Department of Human 
Services, 2016). As the records also contain information about patient demographics, time 
and duration of stay, diagnoses and treatment, they can be used to understand disease 
progression at a population level. Further, the billing information in the administrative 
data also contains the provider information (i.e., physicians and hospitals who have 
provided the treatment). When this data is viewed from the perspective of a specific 
treatment or procedure, the group of physicians who were involved in providing a 
particular type of treatment can be discovered. This information can then be used to 
understand the collaboration pattern among the physicians within and across hospitals. 
The preceding discussion on the potential of the administrative dataset has primarily 
motivated us to pursue this research in order to explore how much we can learn about 
disease progression from a given dataset. For the scope and practicalities of the research, 
we have only focused on one particular chronic disease (i.e., type 2 diabetes), and have 
excluded from consideration some of the available information in the dataset, such as 
billing details and provider information. One feature of these datasets that inspired their 
use in this research is their untapped potential: there has been very little research done 
on disease risk prediction using administrative data to date. This is partly because such 
datasets have not been accessible to researchers before. Even though the administrative 
datasets were generated by individual providers, policy and related issues have created 
barriers to mining these data. A brief discussion of these issues is presented in the 
following section.  
 1.2.3 Policy-level changes in the healthcare industry 
In the last two decades, several policy-level changes and their subsequent 
implementations have changed the ways in which administrative health data are 
recorded, formatted, stored and transmitted. With the aid of modern computer and 
network technology, these policy-level implementations enabled the data to reach the 
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research community and made them suitable for mining. This is also one of the reasons 
why it recently became possible to do this research in the Australian health context. 
Two of the major issues in health data analytics have been standardisation and the 
availability of the data itself. Especially if the population of the dataset represents people 
from different geographical locations and socioeconomic conditions, it is important to be 
aware of the most relevant variables to be able to conduct a proper analysis. To 
understand the health status of the population, and patterns such as disease progression, 
it is crucial that all healthcare facilities (e.g., hospitals) record and report the data using a 
common format. This is a significant challenge even for most developed countries, as it 
demands multi-disciplinary effort, technical and medical expertise, resource allocation and 
training. Further, on an international level, countries follow different protocols and coding 
standards, making it difficult to utilise or merge datasets from different countries. 
Fortunately, the research community and international organisations have been working 
on solutions to this problem of standardisation. In the last decade, several milestones 
were achieved in standardising disease codes: for example, the ICD codes have been 
proposed and adopted by many countries, creating a common platform for analysing data 
from a wide range of sources. At present, for the Australian context, hospitals now follow 
the implementation of the ICD-10-AM coding format (see Section 3.3.1 for details) to 
record the health conditions and diseases of the patient throughout the country. Also, 
there are now established protocols on how healthcare data should be transmitted to 
governments, as well as to the research community. Further, policies have been 
implemented to ensure the privacy and security of the data as it is transferred across 
different bodies. All of these policies that have been formulated and implemented in 
recent years have motivated and allowed us to undertake this research. 
Another factor that contributed to the research plan is the modernisation of the 
healthcare industry, especially of private health insurance companies. In fact, our research 
data comes from a group of private health funds i.e., organisation providing private health 
insurance. The complex process of recording, transmitting and obtaining this large amount 
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of health data would not have been possible if the government-established policy e.g., 
2008 and 2010 health reform (Australian Department of Health and Ageing, 2011) had not 
recently been formulated and implemented. Newer policy has also opened up new 
frontiers of economic prospects for private health funds to provide added cover to citizens 
by providing quality healthcare. The economic incentive, policy and market competition in 
turn has boosted their efforts to minimise their costs. As discussed previously, a significant 
part of the healthcare burden, both economically and medically, comes from chronic 
diseases. So, naturally, the health industry is focusing more on identifying the high-risk 
chronic disease patients to adopt a suitable policy for them to minimise cost and improve 
quality of service. These policies have encouraged the industry to open up to researchers 
by sharing their vast stores of administrative data for investigation from data mining and 
analytical perspectives. This research is the direct outcome of such efforts, and is one of 
the earliest projects of its kind in this respect. 
1.3 Key Research Questions 
This thesis explores the use of administrative health data in understanding chronic disease 
progression, and subsequently goes on to develop a predictive model for identifying high-
risk patients. In the process, we utilise several network-based methods and socio-
behavioural parameters. The research questions that we aim to answer throughout the 
thesis can be stated as follows: 
1. How can we utilise administrative data to understand chronic disease 
pathways?  
a. How can we best organise and filter administrative data for effective 
knowledge discovery, especially when the data is gathered from 
heterogeneous sources over a long period time? 
b. Do chronic and non-chronic patients follow different health 
trajectories? 
c. If they follow different trajectories, then what significant differences do 
they normally have? 
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d. Can we interpret the differences in health trajectories of chronic and 
non-chronic patients in terms of a baseline network? 
2. Is it possible to make reasonable predictions of chronic disease risk from the 
understanding gained from the previous research question? 
a. Can we utilise graph theory and social network measures to compare 
the health trajectory of test (i.e., as yet non-chronic) patients with that 
of chronic disease patients (i.e., as represented by a baseline network)?  
b. To what extent do behavioural (e.g., smoking etc.) and demographic 
(e.g., age, sex etc.) risk factors contribute to chronic diseases?  
c. Overall, how can we construct a generic and adaptive predictive 
framework to assess any chronic disease risk based on the 
administrative data? 
1.4 Approach 
The research presented in this thesis is largely explorative, aiming to explore the 
potentials of the administrative dataset to answer the research questions stated above. 
Considering the context and features of the healthcare dataset, we selected type 2 
diabetes as the chronic disease that would be the focus of the investigation. Overall, the 
research is presented in terms of a generic framework that can be implemented for other 
chronic diseases. In the thesis, the framework takes a longitudinal view of a diabetic 
patient’s health data, and analyses the pattern of the health trajectory to understand the 
influencers and inhibitors that contribute to health outcomes (i.e., whether or not the 
patient becomes diabetic). The differences between diabetic and non-diabetic patients’ 
admission histories are used to develop a baseline network. We consider the diagnosis 
codes that are present in the individual admission histories and formatted in ICD-10-AM 
as the main data elements of the research. We also use dates of admission as longitudinal 
information to represent the heath trajectory of the patient. 
In relation to the second set of research questions, we formulated several methods 
derived from graph theory and social network measures to compare the baseline network 
13 
 
against the test patients’ health trajectories. These methods give scores against several 
graph matching scores. We also derive several other scores from behavioural and 
demographic risk factors. Finally, the framework utilises several data mining methods to 
develop predictive models based on these risk factors. As mentioned previously, the 
present research and data analysis is explorative; we do not have prior information on 
which combination of methods and risk factors yields the most accurate prediction of 
diabetes risk. Therefore, we implement different combinations of methods and, based on 
the empirical result, decide on the optimum methods. This discussion, including why the 
optimum methods outperform the others, is presented in Chapter 5. 
1.5 Contribution of the Study 
This thesis explores a research problem that covers different fields, primarily - data 
science, network science and healthcare. To address the research problem, we develop a 
framework that has a theoretical and methodological contribution towards its related 
fields. Also, the outcome of the research can be potentially implemented into a predictive 
tool that can be used by different stakeholders in the healthcare industry. Considering 
these, we describe below the possible contribution of this thesis in three different 
contexts. 
 1.5.1 Theoretical contribution 
This thesis proposes a framework that utilises graph theory and social network measures 
to predict the likelihood of chronic diseases developing in a patient. The type of 
healthcare data that we are using in this research is administrative data, which has rarely 
been used in previous research on chronic disease risk prediction. Therefore, this research 
is likely to contribute to the scientific community by showing the potential for the use of 
administrative data in chronic risk prediction.  
The theoretical contribution of the research is likely to come from the methods and 
network based measures that we have proposed in the framework. These methods and 
measures can give insights about chronic disease risk and progression from health data. 
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For example, in the first part of the framework—‘understanding the progression of 
chronic disease using administrative data’—we have proposed a network formulation to 
representation of chronic disease progression. The framework shows that the diseases 
that occur as comorbidities of chronic disease (i.e., diabetes) have a networked relation 
that differs from the network of diseases of non-chronic patients. In the second part of 
the framework, we have proposed mathematical formulation of several new scoring 
measures (i.e., risk factors) derived from network theory and social network analysis 
(SNA). These new measures quantify the risk of chronic disease by looking at network-
based similarities between a test patient’s health trajectory and the baseline network of 
the chronic disease. The implementation of the framework in the type 2 diabetes context 
has shown that some of these network-based measures are significant in predicting the 
risk for test patients. Therefore, the framework as a whole uniquely shows the networked 
structure of chronic disease comorbidities and the potential to use this structure for 
prediction using graph theory. These sets of concepts that the research has revealed are 
the primary theoretical contributions from the research.  
 1.5.2 Methodological contribution 
The present research framework is more inclined to exploratory and analytical methods 
than to generating theories. Therefore, the significant contribution of this research will be 
its methodological contribution. The full methodological framework is divided into two 
steps, each of which introduces new methods required for analysis. For some parts, the 
framework proposes alternate methods (i.e., more than one), which are run in turns as 
part of the exploratory analysis. Later on, the prediction performances of these different 
combinations of methods are compared to understand which framework workflow, in 
terms of choice of methods, yields the maximum accuracy. This design is adopted to keep 
the framework as flexible and generic as possible, because administrative datasets may 
differ significantly in their properties based on the source organisation and country. Also, 
the context relevant to the chronic disease under investigation may vary. Therefore, the 
framework and underlying components should be adaptable to different contexts. 
15 
 
 1.5.3 Knowledge translation for the health policy maker 
The outcomes of this research should be of interest to several stakeholder groups 
connected to the healthcare industry. The research likely will offer little to physicians in 
terms of clinical diagnosis, as the input data for this research are generated once the 
physicians have completed the diagnostic procedures and evaluated the health condition. 
Rather, the contribution of this research is more targeted at policy makers working in 
government health organisations such as the AIHW, international organisations such as 
the WHO, or in public or private health funds.  
The outcomes of the research and the knowledge generated from them can be directly 
translated into creating suitable risk assessment tools for the healthcare industries. One of 
the major aims of stakeholders and policy makers in these industries is to formulate 
health policies that can deliver the best possible health outcomes in addressing the 
burden of chronic disease and an ageing population. This aim is aligned with our research 
aim of understanding chronic disease progression. Accordingly, the network analysis 
methods presented in this research for analysing and visualising administrative health 
data have the potential to facilitate evidence-based decision making for stakeholders in 
the healthcare sector. The analytics can reveal trends among various comorbidities 
associated with a particular chronic disease for a targeted population (e.g., members of a 
health fund); for example, they can show which diseases occur more commonly with type 
2 diabetes and their relative prevalence, and they can reveal patterns of disease 
progression that can help the analyst to forecast the burden of diseases that may ensue in 
the near future. These insights should help tremendously in formulating policies for 
resource allocation and budget planning. The first part of our research framework—
‘understanding the health trajectory of chronic disease patients’—is focused on revealing 
these insights. 
The most important and directly translatable contribution for policy makers should come 
from the second part of our research framework. This part of the framework is aimed at 
predicting the likelihood of chronic disease for a given patient. As per our direct 
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discussions with the private and public health funds and other interest groups before 
undertaking the research and receiving administrative data, it is evident that policy 
makers always face challenges in tailoring effective policy to different populations based 
on age, vulnerability, demographic condition, health status and other factors. As they 
formulate policies for the delivery of cost-effective and high quality care, they face several 
conflicting goals that need to be balanced. For example, to deliver high quality healthcare 
to consumers, they must allocate sufficient financial, medical and human resources and 
services. These resources and services are also scarce and exhaustive as the development 
and supply of health workforce and resources takes a lot of time, budget and pre-
planning. Thus, it is a big challenge to plan, supply and distribute limited health resources 
in a comprehensive, efficient and transparent manner (Armstrong, et al., 2007). Further, 
market competition and financial models play a role in minimising resource allocation 
while achieving a balance between ensuring maximum turn-over for the stakeholders and 
providing sufficient quality of care to the consumers. One potential way to ensure this is 
to identify high-risk chronic disease patients in advance and plan preventive health 
management strategies for those high-risk groups. These can potentially reduce the future 
cost of accessing providers and improve quality of life for the patients, thus achieving a 
win-win situation for all. This is exactly the aim of the second part of our research. 
1.6 Thesis Structure 
This thesis is presented in six chapters, including this introduction chapter. In the 
following chapter, i.e., in Chapter 2, we review the existing literature to discuss theories 
and methods that are being used in understanding chronic disease progression and 
prediction of the disease risks. Because of the multi-disciplinary nature of this research, 
we begin with a brief introduction to prediction methods and evolution in healthcare, and 
discuss how computer technology has permeated the field, giving rise to the concept of 
electronic healthcare. We then discuss different groups of methods and their 
implementations in disease-related predictions, along with example models or systems 
built upon those methods. Following the review of existing literature, we discuss the 
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limitations of current methods and approaches. We then discuss the opportunities of 
improvements and applicability of newer methods in this area, followed by an overview of 
important social network theories that might be used in deriving the framework. 
Therefore, by the end of this chapter, the reader should have a clear idea of the 
theoretical and methodological background on which the thesis is constructed.  
Chapter 3 then introduces the context and conceptual background of the research. As we 
implement our framework on a real-world health dataset, it is essential to understand the 
dataflow and the different components of the data that are used during the 
implementation and analysis. Health datasets, particularly administrative datasets, vary 
significantly based on their location and the legislation, policy and technology that are 
used throughout the data flow process. As mentioned earlier, our context is that of the 
Australian health system, and our administrative data were received from private health 
funds. Chapter 3 discusses the specific features of our health dataset that are relevant for 
the implementation of the framework. This chapter also gives conceptual background on 
the core topics related to the framework.  
Next, in Chapter 4 we introduce our methodology and framework in detail, including its 
different methods and components. We begin by providing an overview of the framework 
as a whole. After that, we introduce several conceptual definitions that form the basis of 
the framework. Then we explain the methods involved with each of the components, as 
well as the relations between them. We introduce the related mathematics, equations 
and algorithms involved in the methods when necessary. 
In the following chapter, i.e., in Chapter 5, we present the results and discussion. We 
describe the implementation of the proposed framework on an administrative dataset 
generated within the Australian healthcare context. As mentioned, type 2 diabetes was 
chosen as the chronic disease in focus. The results and findings of the implementation are 
presented, along with discussions alongside the relevant results. It is worthwhile to note 
that we intended to present the discussion of all results as a separate chapter. However, 
the methods involved in the framework are quite complex and the corresponding results 
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require lengthy descriptions. Therefore, separating the discussions of different framework 
components from their empirical result would make the discussions more difficult to 
comprehend. Hence, we present the discussion alongside the results and findings in an 
interleaved fashion that is easier to understand. This has made the chapter a bit lengthier. 
At the end of the chapter, we provide the summary and key findings from the 
implementation. 
Finally, in Chapter 6, we present the conclusion. We provide an overall summary of the 
thesis followed by the implications of this research in terms of future research and 
practical applications. Following that, we discuss in more detail some directions for future 
research that are aligned with the current research topic. We conclude the chapter by 
discussing the limitations that were present in the implementation of the research 
framework. 
After the chapters, we include a detailed Appendix section that might be of interest to 
readers. We have planned and presented this research with the aim that anyone with a 
moderate knowledge in healthcare and computer science should be able to replicate our 
research framework. Therefore, there are many topics that are not directly relevant to our 
analysis, but important to note for understanding the implementation. The Appendix 
section provides supplementary illustrations of this nature, including code snippets, 
definitions, data structures, software interface snapshots, mathematical notations etc. 
When necessary, we have included references to the Appendix within the main thesis. 
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Chapter 2: Background and Related Research 
‘It appears to me a most excellent thing for the physician to cultivate Prognosis; for by 
foreseeing and foretelling, in the presence of the sick, the present, the past, and the 
future, and explaining the omissions which patients have been guilty of, he will be the 
more readily believed to be acquainted with the circumstances of the sick; so that men 
will have confidence to intrust themselves to such a physician. And he will manage the 
cure best who has foreseen what is to happen from the present state of matters…’ 
Hippocrates, The Book of Prognostics, 400 B.C.E. 
 
In this chapter, we review the literature and discuss the theories and methods that are 
aligned with the research. Our research has a multi-disciplinary scope, as it involves topics 
from two broad domains: computer science and healthcare. The underlying theory and 
methods used in this research largely come from graph theory and network analysis, 
whose logics are strongly embedded in computer science. Another part of the research 
methods is derived from SNA. Although the theory of SNA originated in the social 
sciences, it has been adapted and used extensively within the computer science domain in 
recent years. For the present research context, we have further applied these methods in 
the healthcare domain—specifically on hospital admission data collected for 
administrative purposes. Therefore, our research utilises methods grounded in computer 
science, applying them in healthcare context; in a broad sense, this work can be 
categorised as belonging to the field of healthcare informatics.  
The healthcare industry involves work from diverse fields and disciplines. Today, almost all 
of its subdomains have adopted some forms of information technology. From the 
management of resources to clinical decision making, healthcare informatics has a wide 
array of applications, each backed by large amounts of research. Since the scope of the 
present research falls within the sub-speciality of disease risk prediction using healthcare 
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data, in this chapter, we identify this scope within the broad discipline of healthcare 
informatics and review the major work done to date related to our method of predicting 
the risk of chronic disease.  
 
Figure 2.1: Organisation of literature review concepts 
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2.1 Evolution of Healthcare Informatics 
Since ancient times, illness, diseases and epidemics have shaped the course of human 
civilisation, including its politics, commerce and culture. Smallpox likely disfigured and 
killed Rameses V (the fourth Pharaoh) in 1157 BCE (Nelson and Williams, 2013, Ruffer and 
Ferguson, 1911). Bubonic plague and its coinfections contributed to the collapse of the 
Han empire in 160 CE and its subsequent hit halved the northern Chinese population 
during the third and fourth centuries (McMichael, 2001). Meanwhile, the Antonine Plague 
of 165–180 CE contributed to the fall of the Roman Empire (Fears, 2004) by devastating it 
on the western side of Eurasia. Until medical science developed to understand the 
underlying pathophysiology of these diseases, waves of epidemics continued to devastate 
various empires and parts of the world until the twentieth century.  
Living at this current point in history, we are now facing tremendous opportunity and new 
health challenges. In terms of opportunities, we have modern medicine capable of 
treating or preventing various fatal diseases. We have highly developed computer, 
information and database technology aiding all subdomains of healthcare. People no 
longer die in significant proportions from smallpox, polio, measles and cholera-like 
epidemics. Conversely, we have different sets of diseases on the rise: chronic diseases in 
particular are greatly affecting the quality of life of our ageing population. We have huge 
amounts of structured data automatically generated within the healthcare system that is 
not mined, yet has the potential to yield deeper understanding of quality of care matrices. 
To illuminate the scope of the present research of utilising healthcare data to predict risk 
of chronic diseases, it is worthwhile to review briefly the evolution of healthcare 
informatics to understand how the field has reached its present state. 
 2.1.1 Prognosis: from ancient times to Greek medicine 
Primitive medicine was essentially dominated by soothsayers, priests, oracles and various 
magico-religious authorities (Venot, et al., 2013, p. 142). It was the Greeks who 
established the foundation of modern medicine, with the notable works of Hippocrates, 
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Aristotle and Galen appearing within an approximate span of 800 years (600 BCE–200 CE) 
(Singer and Underwood, 1962, p. 1). Hippocrates is credited as the first person to consider 
medicine as a science, believing that diseases neither come down by God’s wrath nor by 
evil magic. Rather, he held the more rational view that they are caused by various 
environmental and lifestyle factors (Hippocrates, 400 BCE). Hippocratic medicine and 
philosophy tried to understand patient health and mental wellbeing, favouring passive or 
more natural methods of treatment (Kleisiaris, et al., 2014), reflected in the ethics of the 
Hippocratic oath (Edelstein, 2000). Related to our research scope, a key area of 
Hippocratic philosophy was ‘prognosis’ (Schiefsky, 2005, p. 17), which emphasises 
predicting the future state (progression) of the disease based on the present condition 
and clinical evidence. The Aphorisms, one of the most famous books in the Hippocratic 
Corpus (Hippocrates, 400 BCE), lists a series of brief generalisations on prognosis and 
clinical knowledge. Some notable extracts are:  
• ‘When sleep puts an end to delirium, it is a good sign.’ 
• ‘Weariness without cause indicates disease.’ 
• ‘The old have fewer illnesses than the young, but if any become chronic with them 
they generally carry it with them to the grave.’ 
• ‘Those naturally very fat are more liable to sudden death than the thin.’ 
• ‘Convulsion supervening on a wound is deadly.’ (This is referring to tetanus.) 
• ‘Those attacked by tetanus either die within four days or if they get through these 
they recover.’ 
• ‘It is fatal for a woman in pregnancy to be attacked by one of the acute diseases.’  
Critical examination of the few examples above, as well as many others in the original 
corpus, demonstrates the clinical achievement of Hippocratic medicine in establishing 
sound guidelines for case description, clinical reasoning and observation, risk assessment, 
patient care and confidentiality, unparalleled in an age shrouded in medical follies, 
animism and superstitions. 
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To make a sound clinical decision involving risk assessment and disease prediction, one 
has to identify clearly the underlying factors and their interrelationships with potential to 
affect the progression of the disease. Although Greek medicine was arguably ahead of its 
time in establishing guidelines for finding those underlying factors for diagnosis and 
prognosis, it is not surprising that it lacked understanding in numerous areas on the 
pathophysiology of diseases. Different schools of thought existed within Greek medicine 
(e.g., the Koan and Knidian), often giving contradictory views. Knowledge of human 
anatomy was limited, as human dissection was taboo (Klaver, 2012). Many Greek medical 
beliefs were propagated through later civilisations and ultimately dismissed by modern 
medicine, such as the association of humoral pathology, involving four ‘humours’ in the 
body, with personality traits. 
To sum up, the field of risk prediction of diseases, which forms the focus of the present 
thesis, can be traced back to Greek medicine, beginning with the concept of prognosis and 
establishing the bases of modern healthcare in principle. However, the accuracy and 
correctness of Greek practices are arguably weak compared to modern healthcare. From 
the time of the Greeks up until the present, history has seen the reign of several empires, 
through which and medical knowledge has flourished and been transmitted. Some 
notable periods were marked by the undivided Roman Empire, its division, the rise of 
Islam in the Arab Peninsula, Arabic medicine and the subsequent medieval awakening of 
Europe. An interesting thing to notice here is the lack of uniformity and access to 
healthcare knowledge during transitions between empires. A significant barrier in the 
dissemination of knowledge was perhaps language. For example, the Greek medicinal 
works known as the Hippocratic Corpus were written in Greek, while the Roman Empire 
mostly used Latin and the works of Islamic medicine were in Arabic. The lack of translation 
may have hindered the progress of knowledge.  
 2.1.2 Romans, Arabs and medieval Europe 
After the Greeks, the Roman Empire contributed to medicine notably in the fields of public 
health, sanitation and hygiene (Singer and Underwood, 1962, p. 77). Hospital systems 
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were greatly organised and advanced by the Romans. Some areas that were improved are 
public hospital systems (Singer and Underwood, 1962, p. 46), resource management and 
codes of conduct. The western part of Roman Empire collapsed around 476 CE. However, 
the Eastern Roman Empire, which existed until it fell to the Ottoman Turks in 1453, 
preserved much of the Greek medical works (Singer and Underwood, 1962, p. 66). In fact, 
much of the original Greek corpus was translated by Romans into the Syriac language.  
One striking argument for the importance of maintaining a universal language (Venot, et 
al., 2013, p. 11) for defining diseases (e.g., ICD) and protocols can be understood from the 
fact that different civilisations used different languages. Therefore, to properly 
understand the works of previous generations, one must be capable of reading their 
books or manuscripts without significant loss in translation. Assimilating knowledge from 
texts written hundreds of years previously in a language not known to many 
contemporary people seems extremely challenging, if not impossible. Still, this feat was 
achieved by the wonderful people belonging to the Roman or Arab empires or to the 
Spanish peninsula. As stated earlier, a number of Greek works were translated into Syriac 
by Romans. During the Islamic Empire in the Arab Peninsula, many of the original and 
translated works of the Romans were further translated into and studied in Arabic. Arabic 
science also progressed significantly in terms of its fundamental contributions in medicine, 
mathematics (e.g., algebra, Arabic numerals) and astrophysics (Rashed, 2013). In fact, 
many modern mathematical and prediction models are indebted to Arabic arithmetic and 
algebra. As the Spanish peninsula was inundated by the Arabs as early as the eighth 
century, a bilingual generation began to appear. They were able to further translate the 
Arabic texts into Latin. Christian Europe, or the West, finally obtained access to this body 
of knowledge via the Arabic-Latino literature. From the thirteenth century onwards, a 
large number of universities were established across Europe (Singer and Underwood, 
1962, pp. 70–72), and the practice of medical science and related topics became much 
more oriented around them.  
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 2.1.3 Renaissance and the industrial revolution 
The Renaissance in Europe spanned between the fourteenth and seventeenth centuries. 
Having begun as a cultural movement in Florence, it soon revolutionised the fields of 
science and medicine. Several notable events took place to assist this revolution: the 
printing press was invented, making available printed copies of improved translations of 
Greek works. The invention of the microscope made it possible to look into the minute 
structures of animal bodies. Knowledge of human anatomy and physiology were greatly 
enhanced, rendering many previous medical beliefs outdated or invalid. This indeed 
helped the greater scientific community to understand the origins and prognosis of 
diseases better than ever.  
Following this period, the industrial revolution (approximately 1760–1840) in Europe 
came, which resulted in rapid urbanisation, economic growth and lifestyle changes. The 
improved living standards, especially in urban or industrial areas, along with the 
contemporary agricultural revolution, brought positive changes in public health and 
nutrition. For example, hospitals had more hygienic guidelines, the prevalence of various 
diseases (e.g., malaria, rickets, scurvy) declined rapidly (Singer and Underwood, 1962, p. 
181), and life expectancy increased. One of the biggest contributions in medicine, the 
germ theory of diseases, matured during and immediately after this period. The germ 
theory scientifically explained the pathophysiology of different communicable diseases 
such as smallpox, plague, puerperal fever, cholera and anthrax. 
The decline of the plague and improved life expectancy brought attention to non-
communicable chronic diseases. Factors like industrial and agricultural revolution, 
urbanisation and changed lifestyle contributed to the higher prevalence of obesity, which 
is the common risk factor for multiple chronic diseases.  
A significant part of public health, clinical decision making and medical prediction relies on 
basic statistics. During the industrial revolution, a substantial amount of novel work was 
done in this field. In particular among the probability theories, Bayesian statistics (Bayes 
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and Price, 1763) was proposed by Thomas Bayes and presented posthumously. Others 
notable work included that of Laplace, who, apart from contributing to mathematics, 
astrophysics and statistics, popularised the notion of Bayesian probability (Stigler, 1986, 
pp. 97–98, 131). However, the true potential of Bayesian probability or statistical 
inference (Venot, et al., 2013, p. 6) went unexplored in the medical literature until the 
twentieth century, when the medical domains matured, and particularly began to 
integrate digital computers into their research.  
 2.1.4 Introduction of computer and medical informatics 
The invention of computers has fundamentally influenced medical science and all of its 
subdomains. Although the idea of the modern programmable computer can be traced 
back to the early nineteenth century (Halacy, 1970), working versions of digital computers 
began to be developed from the 1940s. At that time, these were not yet practical to use in 
the medical sector for record keeping or diagnosis purposes, yet several advancements 
were made subsequently in computer technology that finally overcame the usability issue 
in the medical domain. We could mention five such breakthroughs of particular relevance. 
The first was the invention of the transistor in 1947 (for which the inventors John 
Bardeen, Walter Brattain, and William Shockley were awarded Nobel Prize). Transistors 
quickly replaced bulky vacuum tubes and made computers smaller, cheaper and more 
energy-efficient. The second was the invention of the microprocessor. First becoming 
available commercially around 1971, microprocessors paved the way for general purpose 
personal computers. Third, the development of application software, both customised and 
generic (word processing, spreadsheet), greatly helped to replace paperwork with 
computer-based records. Fourth, databases helped to popularise the idea of analysing 
healthcare data, as they facilitate saving and organising data and offer efficient retrieval 
methods. Last but not least was the advent of the internet around the late 1990s; local 
networking, database systems and client–server software architecture all synergistically 
contributed in shifting paper-based medical records onto computer-based systems. 
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Similarly, the internet made it possible to share and gather knowledge over large 
distances quickly and conveniently.  
 
Figure 2.2: Evolution of healthcare informatics and related fields with computer 
technology 
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These five key developments allowed medical informatics to evolve gradually into a 
scientific discipline (Venot, et al., 2013, p. 2). In fact, it is possible to trace this 
development by making a crude comparison of the frequency of appearance of the terms 
‘medical informatics’, ‘health informatics’, ‘biomedical informatics’ and ‘healthcare 
informatics’ in the literature over time (Michel, et al., 2011). This evolution is shown in the 
Figure 2.2. Interestingly, we can see how the frequencies of these terms leapt soon after 
breakthroughs in computer technology, thus aligning the developing science with the 
shifting paradigms of technological advancement. 
 2.1.5 Electronic health records and administrative data 
As part of social security measures by governments, national health insurance systems 
started to become common after the 1950s. For example, in the US, Medicare was 
founded in 1956 (Robinson, 1957), while Australia’s Medibank was initiated in 1975, later 
reformed as Medicare in 1984 (Kewley, 1973). Eventually, in order to formulate better 
policy to ensure optimum value for money in healthcare, there was an increased need to 
understand the healthcare inputs for different stakeholders. These healthcare 
stakeholders related to policy formulation and research can include: 
1. Government organisations (e.g., health department, bureau of statistics etc.); 
2. State or local area government bodies (e.g., state health departments, when 
applicable); 
3. Private health insurance providers; 
4. Healthcare providers (e.g., hospitals); 
5. Independent research institutions (e.g., universities). 
Healthcare providers routinely collect data for their internal records, as well as for 
reporting to different governing bodies. These records are commonly known as 
administrative data, as they are used for administrative purposes, not for any clinical 
reasons. Initially, these records were completely paper-based. When personal computing 
became sufficiently affordable and powerful, healthcare providers began to shift to 
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electronic means of keeping records. However, in most cases, data was still collected in 
paper format, as it was more convenient, and policy makers did not yet see the potential 
use of electronic data stores. Concurrently with the popularisation of technologies such as 
the World Wide Web, email and database systems after the 1990s, this potential for 
keeping electronic administrative records began to be realised. The concept of e-health 
records also became more widely recognised, where the complete medical information of 
the patient is to be stored in a central database. This data can be accessed by patients, 
general physicians or emergency medical teams with convenience to provide faster and 
more accurate treatment.  
After the 2000s, the concepts of big data and data mining also gained widespread 
recognition and, accordingly, administrative data was recognised for its research 
potential. Unlike data from clinical trials, which are run on smaller populations, 
administrative data offer a representation of the health conditions of the larger 
population that can be made easily accessible to researchers. This offers ample 
opportunity to understand the prevalence of diseases by doing epidemiological research 
(Warren, et al., 2002). Further, healthcare data contains time information, making it 
suitable for longitudinal studies and understanding patterns of disease occurrence. This 
has the potential to offer ways of predicting future stages of health conditions of an 
individual or a particular cohort (e.g., the ageing population). The focus of this thesis lies in 
this field—to develop a predictive framework for identifying chronic disease risk for 
patients.  
2.2 Statistical Methods of Disease Risk Prediction 
Different statistical methods are used extensively in clinical decision making. For any 
disease risk prediction, whether by a computer or by a physician, one has to (1) 
understand the factors or variables that are responsible for the disease, and (2) based on 
the presence or absence of the factor, assess the patient’s risk of disease. A similar 
process is used in clinical diagnosis. Now, to make these clinical decisions of diagnosis and 
risk prediction, one has to apply logic or deductive reasoning (Ledley and Lusted, 1959). 
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This natural reasoning process in medical research essentially is to examine a sufficiently 
large number of patients having the same disease (cohort) to check the common variables 
within the cohort. Then, if these variables are absent from another cohort of patients who 
do not have the disease, the variables are held to be connected with the disease. The 
variables could be symptoms (e.g., diagnostic test results, clinical observations) or physical 
characteristics (e.g., age, sex). However, in most cases, a set of responsible underlying 
variables cannot be considered as exclusively belonging to the diseased patients. For 
example, imagine a scenario where a cohort of obese people is found to have more heart 
disease prevalence than a non-obese cohort. Now, in most real study data, there should 
be some degree of exception. Not all obese people will have heart disease, and similarly, 
some non-obese people will have heart disease. Therefore, the variables will not be 
assigned a categorical risk status (i.e., either they are responsible or they are not); rather, 
they are assigned a contributing probability of risk. Based on the found likelihood of heart 
disease being associated with obese people, one should carefully examine whether or not 
the association is significant. This scenario is very common in medical research, and 
statistical analysis is particularly suitable for this type of study. Statistical methods are 
often used as an integral part of other methods as well as to present the result 
numerically (e.g., p-values) or graphically (e.g., histogram). 
In different branches of epidemiology, comparison studies and other clinical trials 
statistical methods are widely used. For example, descriptive statistics are used to 
understand the relevant variables and their distribution: hypothesis tests, t-tests and 
analysis of variance (ANOVA) or significance tests are widely used to compare two 
different cohorts; risk statistics particularly focus on assessing the odds of contracting a 
disease by people exposed to certain factors compared to others; and correlation 
statistics deal with describing how closely two variables are related (Barton and Peat, 
2014).  
Regression models are often used in predicting the future state of a variable (outcome 
variable) given one or more variables (explanatory variable). The outcome variable can 
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denote the risk of disease when applicable. Regression models are often used in predictive 
modelling (Barton and Peat, 2014, p. 205): for example, age and gender (explanatory 
variables) can be used to predict normal values in Body Mass Index (BMI). Regression 
models can also be used for hypothesis testing by examining the effect of an explanatory 
variable on an outcome variable after adjusting for other important explanatory factors. 
For example, the model can use age and gender to predict BMI, and in turn be used to test 
the hypothesis that groups with different exercise regimes have different BMI values. 
Statistical methods have several limitations; it is sometimes said satirically that ‘statistics 
can prove anything’. The advantage and accuracy of any risk prediction model highly 
depends on its methods and design, including the identification and choice of variables, 
appropriate statistical methods and research questions. Correlation tests can lead 
researchers in the wrong direction if not handled properly. Two variables can be shown to 
be related, but this does not readily prove that one is causing the other; that is, 
correlation is not causation. A well-designed statistical method should investigate the 
underlying cause of the correlation once it is shown by the test. In some cases, correlation 
can show false negative results, as in the case of non-linear relationships. Also, if there are 
any missing variables in the experiment, statistical methods can give erroneous results, 
although this is a limitation for other methods as well. 
2.3 Data Mining-Based Disease Prediction 
Traditionally, clinical decisions—including diagnosis, treatment and disease prediction—
are made by doctors’ intuition, knowledge and experience with the aid of various clinical 
and diagnostic tests. This practice often leads to unwanted biases, errors and excessive 
medical costs (Palaniappan and Awang, 2008). Clinical decision-making processes can be 
supported by computer-based patient records, and this has been shown to improve 
several performance matrices, such as improving patient safety and outcome, and 
reducing medical errors and unwanted practice variation (Wu, et al., 2001). Computer-
based information management, including, for instance, patient record keeping and 
database management, prove to be cost-effective and superior in performance compared 
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to traditional record keeping. Computer-based information management has been 
popularised as an idea and begun to be integrated; in the process, computerised data 
keeping systems have generated huge amounts of data. This not only includes patient 
health records, but also includes information on patient–doctor interactions, insurance 
claim data, medical history and referral information. However, this wealth of data often 
goes untapped. Recently, data mining methods have been devised in search of ways to 
utilise these data. 
 2.3.1 Score-based models 
Scoring-based methods are perhaps one of the earliest and most intuitive methods of 
disease prediction. In traditional medicine, before the aid of computerised systems, 
doctors were obliged to observe the symptoms and medical history of patients and to 
evaluate them based on a combination of experience and well-established case studies to 
predict the risk of disease or comorbidity. This idea of symptoms-based prognosis has led 
to the development of many scoring-based methods to ease and standardise the 
assessment of disease and related risk in various healthcare settings. In these methods, 
scores are assigned to various factors such as physiologically observable conditions, 
demographic information or family history. Once a patient’s score is calculated, it is then 
normally evaluated against an interpretation table that describes the probable range of 
scores and their corresponding meanings. The ‘risk score’ thresholds are established 
based on clinical studies of different cohorts, often employing multivariate regression 
analysis methods. Risk score-based methods are simple to use, take less time to assess 
and are often deployed in web-based health assessment calculators for consumer use. 
The following Table 2.1 shows some sample factors that are considered while assigning 
scores. 
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Table 2.1: Sample parameters to score against in score-based system 
Category Example of risk factors for scoring 
Demographic factors Age, sex 
Population subgroups based on age (e.g., children, 
adult, elderly), ethnicity (e.g., Asian, African) 
Behavioural factors Smoking, drinking, duration of physical activity, sun 
exposure time, etc.  
Genetic Family history of diseases 
Biomedical factors Physical traits: weight, height 
Diagnostics: blood pressure, cholesterol, blood glucose 
level, etc. 
Various score-based systems are currently in use. For example, the Charlson Comorbidity 
Index (Charlson, et al., 1987) was proposed as early as 1987, and predicts the 10-year 
mortality for a patient by ranking a range (total 22) of demographic factors (e.g., age) and 
comorbid conditions (e.g., heart disease, cancer, AIDS). A higher overall score means a 
higher chance of mortality of the patient within next 10 years. The Charlson Comorbidity 
Index has been extended and adapted into different variants, such as Charlson/Deyo, 
Charlson/Romano, Charlson/Manitoba, Charlson/D’Hoores, Charlson/Ghali or 
Charlson/Dartmouth. Some of these methods have migrated to newer coding schemes 
such as ICD-9. The Elixhauser index (Elixhauser, et al., 1998) is another similar index for 
finding mortality rates (discussed in details in the next chapter). It has slightly better 
prediction performance (Sharabiani, et al., 2012), especially when predicting mortality 
beyond 30 days. Another widely used scoring system is APACHE-II (Wong and Knaus, 
1991) (versions I–IV are available, version IV is only used in the US). It scores against 12 
variables with a range of 0–71 to assess the condition of ICU patients in the first 24 hours 
of admission (higher values indicate greater severity). Other similar ICU scoring methods 
include SAPS (Simplified Acute Physiology Score, version 1-3) and MPM (Mortality 
Prediction Model, version 1, 2). Later versions of these systems usually incorporate larger 
datasets, calibrated against different hospital settings, and can give predictions of 
different phases of ICU admission (Breslow and Badawi, 2012). These models provide a 
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good way for physicians to assess patient condition, often without the help of 
sophisticated software. They usually work well in a specific healthcare setting like ICU, 
where it is important to determine quickly the required aggressiveness of treatment 
based on the patient’s chance of mortality. However, these score-based systems are 
mostly unsuitable for predicting a patient’s long-term chance of contracting a chronic 
disease where a huge volume of admission and related medical history data is available. 
Scoring-based methods are also used to group diseases into several types according to 
their complexity. This is often done to estimate the hospital resources needed to ensure 
quality of care and facilitate reimbursement. The Diagnosis-Related Group (DRG) (Fetter, 
et al., 1980) is one set of disease codes, implemented in the US in the early 1990s and 
later adopted internationally with local modifications in different countries. The original 
motivation of the DRG was to develop a classification system that could identify the 
‘products’ received by the patient to aid in medical financing. However, as the healthcare 
industry has evolved since its initial introduction, the DRG codes have been modified and 
extended to support different objectives with a higher level of sophistication and precision 
(Baker, 2001). Modifications were also made by governments to meet national policies. A 
grouper software based on ICD codes scores the medical conditions of the patient, 
including diagnosis codes, comorbidities, discharge status and demographic information, 
and determines the DRG grouping, on which medical financing and reimbursement are 
planned. While this grouper software is useful for hospital resource management and cost 
planning, it does not predict future disease risk, but rather gives an estimation of the 
current condition. Overall, these scoring-based methods are limited to a smaller scope 
within the healthcare setting, and mostly cannot capture the interrelations or 
comorbidities of different disease codes. Table 2.2 shows some example of different 
scoring systems in practice. 
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Table 2.2: Example of different scoring systems 
Score Name Predicts Prediction Range 
Framingham Risk Score Different cardiovascular 
diseases, type-2 diabetes 
10 years (for most 
cardiovascular diseases) 
30 years (one variant for CVD) 
8 years (diabetes) 
Reynolds Risk Score Cardiovascular disease  10 years 
SCORE Cardiovascular disease 10 years 
QRISK Cardiovascular disease 10 years (QRisk, QRisk-2) 
Lifetime (QRisk-lifetime) 
QDiabetes (QDScore) Type-2 diabetes 1–10 years 
Diabetes Risk Calculator Type-2 diabetes 8 years 
ARIC Diabetes Risk 
Calculator 
Type-2 diabetes 9 years 
Gargano Mortality Risk 
Score 
Mortality of type-2 diabetes 
pre-diagnosed patients 
2 years 
Charlson Comorbidity Index Mortality 10 years 
APACHE-II ICU mortality 24 hours of admission 
SAPS II ICU mortality 24 hours of admission 
 
 2.3.2 Collaborative filtering 
Collaborative filtering is a set of data mining techniques generally used to filter or 
understand the collaboration or behaviour of users and to understand the pattern of the 
collaboration (Terveen and Hill, 2001). This broad idea has been scaled down to find 
application in many different fields of science. In our present research, collaborative 
filtering is related to predicting a user’s choice by analysing the choices (or collaboration) 
of similar users. It is often used as a recommender system by learning users’ past choices 
of items (Adomavicius and Tuzhilin, 2005). The basic proposition behind this is that, if a 
certain user group habitually chooses a set of items and another user chooses an item 
from that set, it is likely that the user will also like the other items of the set. The 
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preference information might be explicit (e.g., user ratings, likes on posts) or implicit (e.g., 
browsing history, bounce rate). As part of the recommender system, collaborative filtering 
is used extensively to track a user’s activity or choices in various online sites and to 
provide a more personalised experience, including suggestions and advertisements based 
on the choice profile. For example, a collaborative filtering-based recommender system is 
used to suggest items in e-commerce sites like Amazon (Linden, et al., 2003), movies in 
Netflix (Bell and Koren, 2007, Bennett and Lanning, 2007) or news (Billsus, et al., 2002), 
and even to find compatible matches in online dating services (Brozovsky and Petricek, 
2007). 
The methods of implementing collaborative filtering vary widely in the literature. The 
method of finding similarity can be loosely categorised as memory-based or model-based, 
or a hybrid of the two (Das, et al., 2007). In memory-based collaborative filtering, all user 
preferences for items are loaded or mapped into memory, and then similarities with a test 
user’s preferences are computed using certain methods. The test user’s preferences are 
predicted based on the items that have the highest weight of similarity. Alternatively, in 
many cases, a limited number of user preferences from ‘nearest neighbours’ are 
calculated (Davis, et al., 2010) by finding the similarity between two users and iterating 
the process over all users. The two most common similarity calculation methods are 
Pearson correlation (Resnick, et al., 1994) and vector similarity (Breese, et al., 1998). 
Memory-based collaborative filtering is relatively straightforward, intuitive and normally 
performs well. However, loading entire user preference databases for similarity 
calculation is often resource-intensive, especially if the data is sparse, which is true for 
most online items. Besides, as the item database or vector space is tightly structured, 
introducing new items is often difficult, as it requires reorganisation of the structure.  
Model-based collaborative filtering methods generally utilise machine learning and data 
mining algorithms. There is an extensive variety of algorithms for implementing model-
based filtering, which vary considerably in terms of performance and prediction accuracy 
(Si and Jin, 2003). Different clustering algorithms are often used in model-based 
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collaborative filtering. Here, users are clustered into different classes using the training 
dataset of user-item preference. The active user is then classified using the same 
algorithm to discover to which cluster it belongs, and choices are predicted from that 
cluster. Bayesian clustering and Bayesian network models (Breese, et al., 1998, Dempster, 
et al., 1977) are often used as the clustering algorithm. Another model-based 
collaborative filtering method is k-means clustering (Xue, et al., 2005). Here, the users are 
grouped into k clusters or classes by vector quantisation, where the users of the same 
clusters have the minimum mean. However, finding clusters with the minimum mean 
property is an iterative process and computationally expensive (NP-hard). Therefore, 
approximations using heuristic algorithms (Kanungo, et al., 2002) are often utilised to 
work around. Besides these, Markov decision process (Su and Khoshgoftaar, 2009), an 
extension of state-based Markov chain modelling, is also implemented in some 
collaborative filtering methods. 
Unlike memory-based methods, model-based algorithms are usually scalable and faster, 
as they can efficiently handle the sparsity of the data when the dataset is too large. 
However, constructing the model is often expensive, and can make it difficult to introduce 
new data into the training dataset. Several algorithms have been proposed to increase 
performance by reducing complexity. For example, principal component analysis (Kim and 
Yum, 2005) is used to reduce the number of parameters; fuzzy clustering (Honda, et al., 
2001) has been used to approximate the clustering process and missing values; and 
singular value decomposition has been used to reduce dimensionality (Sarwar, et al., 
2000). Again, this introduces a trade-off between prediction performance and scalability. 
As the complexity of the model or data is reduced, scalability and performance increase, 
at the cost of prediction accuracy. 
Collaborative filtering methods have great potential in predicting diseases because of their 
comorbid nature in patients; that is, many diseases or symptoms tend to occur 
simultaneously. However, only limited research has been done in this particular field 
(Hassan and Syed, 2010). Davis et al. presented ICARE (Davis, et al., 2008, Davis, et al., 
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2010), a method based on clustering and collaborative filtering to predict risk for 
individual patients based on their own medical history and that of other similar patients. 
The ICARE system uses vector similarity as a collaborative filtering method, where ‘users’ 
are patients and ‘items’ are diseases. This method is extended by using the inverse 
frequency of diseases to capture the effect that having rare diseases in common has more 
impact than having a trivial disease in common. While this method incorporates several 
features, it still does not consider the sequence or timing of diseases, which is very 
important in disease behaviour. For example, the risk of disease C might be higher if the 
patient has disease A and then disease B in sequence. However, if the patient develops 
disease B before A, the chances of getting C might be low. Vector similarity does not 
capture this sequence. Further, gaps in time between occurrences of diseases are also 
important. These longitudinal aspects of disease occurrence are not captured in the ICARE 
system. While our research method does not directly employ collaborative filtering, our 
approach implicitly captures the essence of it. Further, we have taken into account the 
effects of sequence and time gaps between occurrences of diseases. 
2.4 Networked Approach in Healthcare 
In generic use, network means a group of people, objects or any other entities connected 
by some sort of relation, such as a road network connecting places, a friendship network 
connecting people, or a citation network connecting scholars with the relation ‘who-cites-
whom’. In mathematics or computer science, a network holds a similar meaning, and can 
be represented as a graph. A graph has a set of nodes (also known as vertices or actors) 
and a set of edges (also known as ties). Nodes symbolise any entity and edges symbolise 
relations between entities. Problems from different scientific domains can be modelled as 
networks and visualised as a graph, and range of graph-theoretic methods and algorithms 
are found in the literature for analysing or solving problems. 
In the context of disease prediction from healthcare data, many statistical and data mining 
methods do not take the relationship between diseases and symptoms into account 
explicitly. However, in reality, diseases—especially chronic or non-communicable 
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diseases—do not occur in isolation (Barabási, 2007). They often share a common risk 
factor, which can be genetic, environmental or behavioural. These risk factors have a 
synergistic effect (Burton, et al., 2007, Loscalzo, et al., 2007) on the health outcome that is 
often hard to predict if considered in isolation. For example, obesity is a common risk 
factor for many chronic diseases (Must, et al., 1999), including type 2 diabetes and heart 
disease. Simultaneously, obesity itself is the product of other risk factors related to 
lifestyle and behaviour. Also, the relations are not one-directional, and can often be part 
of a feedback loop. Thus the risk factors have a synergistic effect on one another. These 
relations are explicitly considered, studied and visualised in a networked approach.  
A significant portion of network-based analysis is done on genetic associations of diseases. 
The human body has 23 pairs of chromosomes responsible for transferring genetic 
information as a blueprint from one generation to another. Chromosomes are made of 
DNA (deoxyribonucleic acid), which controls the production as well as production time of 
proteins, which in turn play a major role in determining the function and structure of cells, 
tissues and organs (World health Organization, 2014). Overall, a set of genes (i.e., 
genotype) in our DNA is responsible for a particular trait (e.g., eye colour). Further, the 
interaction between genotypes and the environment results in the physical expressions or 
characteristics of that trait commonly known as phenotypes. The overall relations 
between genotypes, environment and phenotypes are complicated. 
Dysfunctional gene behaviour is commonly termed a mutation (World health 
Organization, 2014). These mutations are often responsible for causing illnesses. 
Moreover, if the gene mutations exist in the egg or sperm cells, children can inherit 
defective genes from their parents. As a consequence, researchers are trying to 
understand disease pathogenesis by mapping gene expression and the associated proteins 
that act on the same pathway (Hidalgo, et al., 2009). The networked approach is perhaps 
the most suitable and natural way to understand these relations, as it explicitly considers 
different micro- (e.g., DNA) and macro- (e.g., organ) level actors as nodes. These nodes are 
related in multiple ways; that is, they have ‘many-to-many’ relations from a network 
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perspective. Numerous studies, especially in the biomedical domain, have employed a 
networked approach in understanding gene behaviour (Ideker and Sharan, 2008). Linkage 
analysis and association studies (Botstein and Risch, 2003) have been shown to be 
successful in identifying causative genes for many Mendelian or single-gene disorders 
(Chial, 2008). According to the Online Mendelian Inheritance in Man (Hamosh, et al., 
2005), an extensive online database focused on inherited genetic diseases in humans, 
there are 3,5522 human genes of known sequence with a known phenotype-causing 
mutation, and 5,733 human phenotypes with a known molecular basis (OMIM, 1985).  
In contrast to the Mendelian disorders, for diseases that are more complex (e.g., autism) 
or chronic (e.g., inflammatory bowel disease, diabetes, coronary heart diseases), a larger 
genomic region must be analysed to understand the genetic association. This can include 
tens or hundreds of candidate genes within the research scope, making the analysis a 
more difficult task. However, studies have suggested that genetic diseases are caused by 
functionally related genes (Oti and Brunner, 2007). Further network-based studies have 
shown that these causative genes for the same or similar diseases will generally reside in 
the same biological module, either a protein complex (Lage, et al., 2007), a pathway 
(Wood, et al., 2007) or a sub-network of protein interactions (Lim, et al., 2006).  
Different statistical methods are also incorporated in network-based gene-network 
analysis. For example, Wu et al. (2008) proposed a regression-based generic tool called 
CIPHER to predict disease genes by prioritising candidate genes from the whole genome 
instead of genetic loci. This can perform genome-wide scans of causative genes for most 
of the recorded human phenotypes. Letrovsky and Kasif (2003) proposed a probabilistic 
binomial model combined with a Markov random field propagation algorithm. The model 
aimed at finding node neighbours in a protein–protein interaction network to predict 
which proteins are more likely to interact. Again, this model is based on an assumption 
similar to that discussed previously: network neighbours (i.e., proteins) are more likely to 
share functions than nodes that are distant. Other notable methods involve protein 
                                                            
2 As of 11 May, 2016. 
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function prediction using (a) logistic regression models (Lee, et al., 2006), (b) sequence 
similarity and interaction databases (Espadaler, et al., 2005), (c) message-passing 
algorithms or belief propagation (Leone and Pagnani, 2005) and (d) annotation of protein 
function across species by network comparison (Bandyopadhyay, et al., 2006). The 
following Figure 2.3 shows some examples of the network-based approach in disease or 
associated biomarker prediction. 
 
Figure 2.3: Sample network-based approach in disease or associated biomarker 
prediction 
2.5 Social Network Analysis in Medical Informatics 
Social Network Analysis, commonly known as SNA, is based on network and graph 
theories. However, it stands out as its own domain because of its breadth of theoretical 
focus, encompassing the dynamics and structure of real-world networks with application 
in different domains, many of which have only recently begun to receive attention. As the 
name suggests, SNA is particularly aimed at understanding the formation and evolution of 
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social ties (e.g., friendship, collaboration) between actors (e.g., people). In real-world 
scenarios, social ties between people do not form randomly and at the same time. For 
example, given a classroom, students who are unknown to each other do not readily 
befriend others. There are specific extrinsic and intrinsic factors that dynamically affect 
friendship choices, such as personality, friendliness, presence of mutual friends or 
academic performance. SNA methods and theories are particularly focused on addressing 
questions such as how social ties are formed between individuals, how they evolve over 
time, which actors have a more central role, which patterns of ties will yield better 
performance and which tie will form next (Wasserman, 1994).  
The origin of the idea of ‘social networks’ can be traced back to the late 1800s, when 
Émile Durkheim and Ferdinand Tönnies did their research on social groups forming as a 
result of interaction between individuals (Aldous, et al., 1972). Subsequently, some 
notable research on social networks was conducted in the 1930s by different researchers 
from the fields of psychology, anthropology and mathematics. Some of the earliest 
experimental studies on SNA were done by Bavelas and Levitt (1950, 1949), Milgram 
(Small-world experiment, 1967) and Sampson (1968). The last of these, Sampson’s 
monastery experiment, can be credited as the first longitudinal social network experiment 
to systematically analyse change in the structure of a social network (e.g., friendship 
network) over time. Subsequent longitudinal studies on social networks can be credited to 
Newcomb (1961), Sanil et al. (1995), Snijders et al. (1990, 2010), Huisman and Snijders 
(2003) and McCulloh and Carley (2008). Doreian and Stokman (1997) produced a seminal 
text on the evolution of social networks. In their book they identified a minimum of 47 
articles published on social networks that included some use of time, as of 1994. 
Although SNA was originally intended for the social science domain, it has quickly spread 
to other domains, including medicine and public health. Because SNA is based on a solid 
theoretical background derived from graph theory, along with the advantages of its own 
theories, SNA is inherently strong in understanding collaboration patterns and subsequent 
network performance. As a result, it is widely used to understand collaboration between 
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physicians, physicians and patients, or across a hospital network. For example, Uddin et al. 
(2011, 2015) proposed an SNA framework for understanding the performance of 
collaboration (between physicians) and coordination (between hospitals). Using network 
centrality theories, they explored structures yielding optimal performance among 
different networks: the patient-centric care coordination network (PCCN), hospital-rehab 
coordination network (HRCN) and physician collaboration network (PCN). SNA is also used 
to understand research trends and map knowledge structures in the healthcare domain, 
for instance, in obesity research (Khan, et al., 2016, Uddin, et al., 2015).  
Recent technological advancement has enabled hospitals to electronically collect and 
report healthcare data commonly known as administrative data (e.g., hospital admission, 
discharge reports). Along with concepts like ‘big data mining’, SNA-based approaches in 
administrative data mining have gained much attention among researchers (Baglioni, et 
al., 2013), as these datasets are inherently linked. For example, administrative data 
contains information about which patients are treated in which hospitals and whether 
they have been transferred between healthcare centres—for example, between public 
and private hospitals, between hospitals and rehabilitation centres, or towards a more 
specialised unit. Effective coordination for patient transfers between hospitals or related 
entities has been studied using administrative data and SNA (Anderson, 2002); some of 
these studies were mentioned earlier (Uddin, 2011, Uddin, et al., 2015). Apart from 
hospital information, administrative data contains a summary of diagnosis information. 
This has great potential for analysis on a large population level to understand the nature 
of comorbidities (i.e., which diseases occur together). SNA has been used previously in 
understanding the progression of chronic comorbidities (Luijks, et al., 2012) and predicting 
diseases (Folino, et al., 2010, Khan, et al., 2016, Khan, et al., 2017). However, the actual 
contexts in terms of healthcare settings, approaches and entities considered in SNA vary 
widely (Baglioni, et al., 2013, Chambers, et al., 2012). 
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2.6 Limitations of Existing Theories 
The theories and methods of prediction in contemporary literature both have some 
limitations in the analysis of complex networks. These limitations vary across the different 
approaches, but in general, they tend to relate to the limited perspective of dynamic 
networks. Most of the theories focus on the underlying social phenomenon, such as 
interpersonal liking, information diffusion in certain communities, profit maximisation or 
ethnographic study, and make attempts to discuss and explain the underlying causes and 
their effect on the overall social structure. In most cases, the network under examination 
has little or no temporal components and the dataset is quite small—generally confined to 
a fixed community. In contrast, the healthcare datasets are quite big, having large 
numbers of different actors who often may have temporal and spatial attributes. On top 
of that, these networks are, in most cases, continuously evolving. To analyse the dynamics 
of such networks, we argue that present theories should be extended to address these 
issues.  
Similarly, existing methods have attempted to explore the dynamics of longitudinal social 
networks. While they all have considerable strength in analysing certain aspects of 
healthcare data, they also have some assumptions and limitations regarding network size, 
structure and social theory. For example, Markovian models have the assumption of the 
memoryless property and do not consider exogenous changes in the network. Multi-agent 
simulation models are also bound to the underlying social theories. Some methods focus 
on analysing different properties of dynamics (e.g., Sampson’s approach on group 
formation) or trying to explain how different properties have changed (e.g., statistical 
methods) by correlating various factors from the observed network at different points in 
time. In cases where the networks are still changing, and the future goal is uncertain, 
present models cannot be applied efficiently to discover the underlying dynamics. In 
addition, in the case of a large healthcare network, it is often not possible to observe all 
the fine-grained changes for all the actors, as this would be computationally expensive. 
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Further, these models are quite impractical for the task of comparing and contrasting 
longitudinal healthcare networks under some benchmarks of centrality rankings.  
Generic prediction models have their strength, in most cases, when the relation is simple 
and does not depend on many variables. Regression analysis, for example, might not work 
as well when we want to model complex phenomena, which rarely have simple 
explanations. For instance, in a healthcare dataset there may be multiple actors, including 
patients, physicians, specialists, hospitals and service providers. Each pair of actors has 
different links between them, resulting in a complex web of interaction that is difficult to 
model solely by regression analysis into dependent and independent variables. 
Like regression analysis, time series analysis is disadvantaged in performance when the 
relations are not well defined, or data is collected irregularly. This can often be the case 
for healthcare data, where the relations between the patient, doctors, hospitals and 
syndromes are not straightforward, but rather complex. The patient does not report to 
the doctor or become ill at regular intervals, and the available data is not observed in a 
sequential manner, but rather it is reported when patients report to a service provider. 
Therefore, the complex and irregular interactions between multiple attributes in 
healthcare data are often unsuitable for analysis by time series analysis alone. 
Network-based prediction models are mostly designed to capture the interrelations of 
different attributes in complex networks. In the context of healthcare data, they often 
focus on predicting missing links that were not observed during the transition of the 
networks. In most cases, these methods focus on a single type of node and a single 
relation (e.g., authors and their collaboration, or people and their friendship). Compared 
to the simplicity of this single-attribute network, healthcare networks are vastly complex, 
having scores of attributes. In addition, traditional network models do not have 
longitudinal or spatial aspects. Conversely, prediction of disease intuitively depends on the 
frequency and duration of the patient’s disease history and the corresponding treatment 
provided, which requires longitudinal timestamps. Similarly, disease prediction depends 
on spatial aspects of the data. For example, people from different regions and different 
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socioeconomic backgrounds have different rates of susceptibility to diseases. Also, the 
spread of disease, especially contagious diseases, is highly dependent on proximity, and 
follows paths of international and domestic transportation. Traditional network-based 
approaches often fail to capture these features of healthcare data. Table 2.3 summarises 
the key properties of different prediction models discussed here. 
Table 2.3: Comparison between different disease prediction models 
Criteria Score-Based Model Collaborative 
Filtering 
SNA-Based Prediction 
Strength  Works well in limited 
and specific 
conditions such as 
ICU or cost grouping 
Can predict risk 
when diseases 
have strong 
comorbidity 
Can reveal the complex 
relationships between 
diseases, patients and 
physicians 
Dynamic 
approach 
No, benchmarks are 
defined on strict 
historical data 
Partly Yes 
Emphasis on 
chronic disease 
No Partly Yes 
Utilises electronic 
and modern 
healthcare data 
Partly Only few 
methods have 
used claim data 
for prediction 
(i.e., ICARE 
system) 
Partly: mainly focused on 
effective collaboration of 
physician and patients; in 
some cases worked on the 
social aspects of disease 
propagation from healthcare 
data 
Considers 
longitudinal 
nature of disease 
occurrence 
No No Partly: the branch of 
longitudinal SNA considers the 
temporal component, but has 
rarely been applied on 
healthcare data 
Dataset size Relatively smaller Large Large 
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2.7 Opportunities for SNA and Graph Theory-Based Methods 
The current literature on predicting chronic diseases varies widely in terms of 
implementation and methods. We grouped the existing research into three broad genres 
and discussed their limitations and fields of strength. This review created opportunities to 
propose new approaches by extending the concepts of current ones in utilising healthcare 
data. First, we want to exploit the potential of the electronic healthcare dataset that is 
gathered by private healthcare organisations. The dataset originates from a group of 
healthcare insurance providers who came forward as a consortium with the similar goal 
and unified reporting scheme. This relatively accurate and vast dataset, covering a large 
proportion of the Australian population, is suitable for analysing relations between 
diseases and their comorbidity patterns. The dataset is reported electronically and 
contains quality of service, hospital resource consumption, complexity and comorbidity 
conditions. 
Second, the dataset has timestamp information that can be analysed using the theories of 
longitudinal social network analysis. This type of analysis can effectively capture the time-
situated nature of disease occurrence, which is necessary because the sequence of 
occurrence of comorbid conditions is important for the prediction of chronic disease. Also, 
this timestamp data is vital for understanding how diseases occur after certain durations 
of time, and how these gaps in time affect the overall health trajectory of the patient. This 
can reveal how, for some patients, taking certain diagnostic tests and preventive 
measures can lengthen the time after which the same condition will occur again. We can 
conclude that such preventive measures are vital for promoting remission of chronic 
diseases over longer periods. 
Third, exploring the complex relationship between demography and physicians’ 
collaboration on the quality of service is another potential for our research. The 
healthcare system is essentially a complex interaction between different healthcare 
facilities, physicians and patients with their comorbid conditions. Treatment patterns and 
collaboration have an effect on patient outcomes and management of chronic disease in 
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the long run. Traditional methods of analysis often ignore these complex relationships by 
focusing only on certain aspects of the data, such as comorbidity. Demographic 
information such as race, sex and geographic location can also have a profound effect on 
patient outcomes. Incorporating these parameters into our approach can potentially lead 
to a better prediction method. 
A fourth opportunity is to take advantage of advanced coding systems followed 
throughout the dataset. The earlier methods often had to rely on limited datasets over 
different formats. The coding system was also not standard, and availability of data from 
people of diverse geographical locations and socioeconomic conditions created many 
difficulties, rendering different methods incompatible with one another. At present, to 
maintain uniformity between various public and private providers, policy makers and 
government organisations, most governments and healthcare organisations have adopted 
uniform coding schemes for recording and reporting the available healthcare data. 
Especially in the last decade, several milestones were achieved in standardising disease 
codes. For example, ICD has been proposed and adopted by many countries, which has 
created a common platform for analysing data from a wide range of sources. In addition, 
with the introduction of database systems, the field of healthcare informatics gained 
recognition, as analysing large relational networks become possible to do more efficiently. 
These developments have created opportunities to extend and propose newer methods 
that can take advantage of these standardised codes and scoring systems. 
In this section, we have discussed how improve clinical coding and electronic healthcare 
data have paved the way to explore the networked property of comorbidity and other 
healthcare entities. We have mentioned how social network theories (SNA) can potentially 
be utilised in this context. Now, SNA is a big field and there are different theories that 
have been proposed and applied to different scientific fields. Before incorporating some 
of these theories into the context of our framework, we should briefly discuss these 
theories. Therefore, we do it in the following section. 
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2.8 Social network theories 
Theories in the Social Network Analysis (SNA) are focused on understanding the formation 
and evolution of social ties (e.g., friendship, collaboration etc.) between actors (e.g., 
people) in the network. These theories suggest that the influence of entities in a social 
network is affected by the structural properties such as whom they are connected to, how 
they communicate etc. Also, these theories try to explain how social networks form, which 
are the likely entities to form ties in future, which set of entities are forming a social group 
etc. In this thesis, we focus on the chronic disease progression or network of diseases. 
Therefore, we need to understand how diseases co-occur (i.e., disease comorbidity) and 
how their interrelation can be analysed to understand the overall nature of the 
progression. This can help us to predict the likelihood of a patient’s progression towards 
chronic disease such as type 2 diabetes. Therefore, we discuss below some of the 
fundamental SNA theories that will form the basis of the predictive framework. 
 2.8.1 Effect of network pattern on performance 
The performance of the actors within a social network depends on the effective flow of 
communication (communication pattern) between them. Some communication patterns 
can be informal (e.g., student network, friendship network) and can emerge, stabilise and 
evolve organically over time. Conversely, other patterns can be formal or fixed (e.g., 
organisational chain of command, defence network) where patterns are well defined and 
imposed. While different kinds of patterns can all yield satisfactory goals (e.g., completion 
of work, innovation, adaptation), some patterns are more effective than others. How 
different communication patterns affect overall performance and personal satisfaction 
(morale) has been a research question since long ago. Harold Leavitt (1949) and Sidney 
Smith (1950) did some exploratory experiments on this question at MIT, and Bavelas 
(1950) subsequently reported and analysed their results concerning success rate, network 
stability, leadership and morale for different communication patterns. The experiment 
was set up as follows: five persons are placed in five uniquely coloured cubicles (Borgatti, 
1997), one in each cubicle. The only way they can communicate with one another is by 
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passing any number of written messages through a tube that connects two cubicles. The 
messages are written on stationary of the same colour as the cubicle, so the receiver can 
differentiate between the senders. The inter-cubicle connections can be changed, 
therefore creating different possible communication patterns. Four separate patterns are 
tested: the star (wheel), the Y, the chain (line), and the circle, as shown in Figure 2.4. 
 
Figure 2.4: Different types of communication pattern 
At the beginning, each person is given five symbols from a set of six, thus keeping at least 
one symbol in common. The objective is to discover which symbol they all have in 
common. Each cubicle has six switches on the wall, labelled by each of the possible 
symbols. By passing messages, the players try to figure out the common symbol and flip 
the corresponding switch, with the freedom to change decisions until the game is halted. 
When all five persons flip a switch (i.e., guessing answers), the experiment is halted, 
answers are checked to decide whether it is right or wrong and the elapsed time is 
measured. Leadership evolution and morale (job satisfaction) are also identified by asking 
questions at the end of the experiments. Network stability is measured as the time taken 
to reach the goal. 
The findings from the experiment showed that the success rate was highest in the Y-
pattern, then in the line pattern and lowest in the circle pattern. In the original 
experiment, the star pattern’s success rate was regarded as erroneous due to the 
confusion of the group members. Results of a survey of participants also strengthened the 
hypothesis that the probability of leadership emergence is highest at the position of 
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highest centrality. The middle positions of the line, star and Y structures had the highest 
occurrences of recognised leaders, whereas the positions of the circle pattern had 
relatively less deviation of frequency or leadership occurrence. The findings also suggest a 
direct relationship of morale with the individual’s position within the communication 
pattern: the more isolated one individual is, the lower their morale. An average morale 
rating of the Y, star and line patterns given by the most centrally positioned actors was 
greater than that of peripherally situated actors. Finally, in terms of stabilisation, the star 
pattern was stabilised earliest, followed by the Y-pattern. The line pattern was less stable 
than the star, and the Y-pattern and circle pattern were mostly unstable.  
In addition to the above findings on the effect of structural pattern on social 
communication parameters such as leadership emergence, morale, success rate and 
stability, Bavelas (1950) also hinted that another parameter—innovation—is affected by 
patterns. Bavelas showed that, as the participants had liberty over the content of the 
communication, there was an easier and elegant way to solve the problem other than the 
trivial one. This is to say that the participants could communicate the symbol they did not 
have rather than communicating the symbols they had. Although following this method 
was not trivial at first thought, it occurred in all the patterns, and the frequency was fairly 
even. However, its adaptation occurred mostly in the circle pattern and then in the line 
pattern. Bavelas concluded that this result may suggest that occurrence of innovation 
decreases when centrality is highly localised in a communication pattern. 
Apart from the human communication network, actor centrality has also been observed 
to affect performance in different networks, such as road networks or friendship networks 
(Wang, et al., 2011). Similarly, in a disease network, the disease in the most central 
position—having connection to many other diseases—can indicate the higher prevalence 
and significance of the disease. The amount of significance is quantifiable; that is, 
mathematical formulations of centrality measures exist. Some of these measures are 
discussed in later sections, but first there is another social network theory that is worth 
noting in the understanding of disease networks.  
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 2.8.2 Strength of weak ties 
One of the earliest studies on how micro-level interaction affects the macro-level 
structure of a social network was done by Granovetter (1973). He argued that the 
processes within interpersonal networks translate small-scale interactions into large-scale 
patterns. He analysed various macro-level phenomena, such as diffusion, social mobility, 
political organisation and social cohesion, as investigated by different researchers and 
discussed their results. He emphasised weak ties, and argued that they play a greater role 
in social phenomena like innovation and diffusion than strong ties. 
Many interpersonal ties indeed form large social networks. On the most macro level, if 
two persons form a strong tie between them, then it is more likely that if a third person 
forms a tie with either of the two, he will also form a tie with the other one. Further, as 
time passes, these bonds are likely to become stronger and to form a close triad (Heider, 
2013, Newcomb, 1961). Thus people with similar personalities bond together over time, 
and the strongly-connected triads merge to form a larger group. However, for a social 
network, this strongly-connected group cannot scale up infinitely, because persons cannot 
maintain strong ties with an infinite number of people, and also they have certain 
differences of choice. In this way, a large social network is likely to be formed by different 
strongly-knitted smaller groups. Now, the groups might not be fully isolated; persons from 
different groups can also form ties with each other. Granovetter (1973) argued that these 
inter-group bonds are more likely to be weak ties; this is because, if a strong tie is formed 
between groups, then the other friends in the groups are also likely to befriend each 
other, and the partition will eventually collapse. This suggests that if one person wants to 
communicate with others from the different group, it should be through one of the weak 
ties. Thus the persons connected by the weak tie act as a local bridge.  
Now if a rumour or novel information is to be diffused in the network, then it is through 
the weak ties by which it spreads further. Using a similar explanation, Granovetter (1973) 
argued that marginal figures are ‘early adopters’, able to spread the innovation 
successfully because they might be rich in weak ties. He further explained his weak tie 
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argument using the results of two experiments. The first one was the ‘small world’ 
experiment done by Milgram and his associates. In the experiment, Milgram gave packets 
or booklets to random persons in several United States cities. The task for them was to 
send the booklet to the person’s address as given in the packet. And, because they did not 
know the recipients, they needed to send them to some of their friends whom they think 
could know the recipient or can forward to other correspondences to keep the process 
running. The experiment was done in several modified way but the overall principal was 
the same – to send a booklet to unknown recipient through correspondence and check 
how many hops it takes to reach. Granovetter pointed out that when the first transfer of 
the booklet is from a White to a Negro ‘acquaintance’ (considered a weak tie), then the 
success rate of reaching the destination is 50% (Korte, 1967, Korte and Milgram, 1970). In 
contrast, that rate falls to 26% when the first transfer is from a White to a Negro ‘friend’ 
(considered a strong tie). This can indicate that weaker interracial ties are more effective 
in bridging social distance. The second experiment Granovetter used to explain his results 
was by Rapoport and Horvath (1961). Some (N = 851) students were asked to write to 
eight of their best friends in order. Networks were traced by considering two consecutive 
choices of best friends. It was observed that the most students were found in a network 
when only the last two choices were considered, and the least were found when the first 
two choices were considered. Granovetter argued that this indicates that strong ties result 
in overlapped networks.  
Finally, Granovetter (1973) elaborated on the implications of his weak tie argument and 
the findings of the above described experiments on both micro and macro levels of a 
social network, citing some empirical results to illustrate these implications. On the micro 
level, Granovetter’s theory implies that the fewer indirect contacts one has, the more 
encapsulated he will be in terms of knowledge of the world beyond his own friendship 
circle. Granovetter developed this point empirically by citing some results from a labour 
market study where he investigated how workers find new jobs through personal contacts 
as opposed to any other methods. He found that, in most cases, the workers (55.6%) 
found their jobs through contacts whom they saw occasionally. Also, the path length of 
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the information flow (i.e., number of intermediaries) in most cases (45.3%) was 1, thus 
strengthening his weak tie claim. 
On the macro level, Granovetter (1973) discussed why some communities organise for 
common goals effectively, whereas others seem unable to adapt to doing so. As an 
example, he cited the Italian community of Boston’s West End, who were unable to fight 
against urban renewal and were ultimately destroyed. He argued that the West End 
community might have been partitioned into isolated cliques, resulting in a lack of 
significant communication paths due to the absence of weak ties between the groups. 
Thus trust relationships between leaders and citizens were hampered, rendering 
unsuccessful the campaign against the urban renewal. 
 2.8.3 Freeman’s concept of centrality 
Researchers have long been trying to discover how to quantify the level of performance of 
actors in a social network in terms of characteristics like innovation, efficiency and 
leadership. The most intuitive approach to this investigation has been via the concept of 
centrality, which captures the sense that some actors of the network are more central 
than others, and hence they differ in measures of performance. Although the precise 
effect of centrality on one’s performance and how to quantify that centrality measure is 
still an open research question, the idea of it was first introduced as early as the 1950s. A 
number of experiments done on centrality (Bavelas, 1950, Burgess, 1969, Cohn and 
Marriott, 1958, Czepiel, 1974, Pitts, 1965) suggested that centrality is relevant to group 
performance. However, results were confusing and contradictory (Burgess, 1969) in terms 
of the definition and quantification of centrality. 
Freeman (1979) wrote a seminal paper clarifying the concept of centrality in social 
networks and its applicability and limitation in group performance. He reviewed old 
centrality measures, fixed some gaps and expressed the measures in terms of a common 
set of symbols and graph theory. He divided the measures into two contexts: one from the 
perspective of a particular actor of the network, known as point centrality, and the other 
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from the whole network level, or graph centrality. Point centrality deals with the 
structural importance of a particular actor within the network, while graph centrality 
expresses the overall compactness of the whole network or graph.  
Regarding point centrality, the measure of importance of a particular node depends on 
the context of the experiment. The measure can be how much communication the actor is 
doing with neighbours, how close it is to others or how strategically it is positioned among 
others. Based on these criteria, three centrality measures have been proposed for actors: 
degree, closeness and betweenness. Degree centrality is measured by how many direct 
neighbours an actor has, closeness is defined by how closely it lies to all other actors in the 
network, and betweenness is measured by the extent to which an actor lies on the 
shortest path to all others in the network. These centrality measures indicate the varying 
structural importance of an actor within the network: degree centrality represents the 
activeness of an actor, betweenness indicates the potential of control and closeness 
specifies independence or efficiency. 
Freeman proposed two versions of each of these three point centrality measures. The first 
version is dependent on the network size, while the second version is normalised in the 
range of 0 to 1 so that actors of different network sizes can be measured and compared 
on a uniform scale.  
Freeman also measured similar forms of centrality on the network level. The network-
level measures are based on aggregations of the same measures on the actor level, and 
finding averages. For inter-network comparison, there is a normalised version of each of 
the three measures. 
Freeman finally applied his centrality measures on all possible graphs comprised of five 
points and compared them. He showed that all three measures give maximum scores to 
star or wheel networks, and minimum scores to circle and complete graph networks. 
Measures on all other possible networks lie somewhere between these archetypes, 
except for disconnected networks, which cannot be measured. However, these 
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intermediate measures are distorted in their relative ranking. The distortion gives rise to 
another question on how these variations of centrality interpret when an actor changes its 
structural position within the network. 
 2.8.4 Structural holes theory 
Burt (1992) introduced the concept of a structural hole in explanation for how, in a 
competitive social network, an individual’s performance and entrepreneurship 
opportunity greatly depends on access to non-redundant information. He emphasised 
structural positions rather than network structure and relational ties. Earlier studies often 
assumed that the strength of interpersonal ties does not change over time. For example, 
Coleman et al. (1966) stated that strong ties in a full closure network, i.e., strongly 
connected network, foster social control of deviant behaviour. Here it is assumed that 
each tie is a provider of unique information or communication. However, these 
assumptions often led to contradictory empirical results that in some extremely dense 
networks with strong ties, individuals failed to perform better. 
Burt (1992) gave an explanation as to why some individuals can perform better than 
others with a network model of competition. He further elaborated Coleman et al.’s 
(1966) study and assumptions on information diffusion within a network from a structural 
point of view, rather than one of interpersonal relations. The key element of his theory is 
structural holes, which are the mechanism underlying Granovetter’s (1973) claim that 
weak ties are more useful because they give actors access to novel information. As 
discussed previously, a large social network is composed of several closely knitted groups. 
Between the structural holes of the groups, actors who work as brokers for passing 
information are structurally in a better position in terms of access to novel information.  
Burt argued that there are several reasons that made the brokerage position structurally 
advantageous, as opposed to a position within a closely knitted network. First, in a social 
network a person cannot maintain interpersonal ties consistently over an extended period 
of time. Keeping a tie incurs some maintenance cost, and thus a large number of 
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interpersonal ties are not feasible for an individual (Gurevitch, 1961). Second, as a dense 
network grows, the information becomes more redundant. The number of retellings of 
the same information creates a damping effect. Therefore, in practice, a social network is 
structurally divided into several clusters or cliques. Burt introduced his ‘structural hole’ 
concept to describe the absence of strong ties or gaps between these groups. These holes 
create social capital via brokerage opportunities. He argued that the actor who sits in 
between these clusters, thus bridging up the gaps between the structural holes, gains 
competitive advantages in several ways in terms of brokerage position, economic gain or 
controlling capability. 
 2.8.5 Homophily and cluster 
Most real-world networks do not generate or evolve in a random manner. Given a set of 
students previously known to each other, who join a new course, they will eventually form 
a friendship network among themselves. The ‘who chooses whom’ preferences will not 
arise randomly. Several factors can affect the choices: for example, friendliness or 
academic performance can have an impact on the friendship. The tendency to form 
interactions based on similarity in a social network is called homophily (McPherson, et al., 
2001). In disease networks, as we discussed earlier (see Section 2.4, ‘Networked Approach 
in Healthcare’), different diseases may share common biomarkers or environmental 
factors. Those diseases are likely to occur together: that is, they follow the homophily 
concept. For example, hypertension and T2D are related: insulin resistance and diabetes 
can precipitate hypertension by stimulating the sympathetic nervous system and the 
renin–angiotensin system, and promoting sodium retention (Lago, et al., 2007). Therefore, 
if a person has hypertension, they are at risk of being diagnosed with T2D. Thus, we 
observe preferential attachments between related diseases in the disease network. 
Now, if the network follows preferential attachment rather than random formation, it 
may form a cluster. A cluster within a social network is a group of similar actors that have 
a great deal of interaction with each other and fewer interactions with the actors outside 
of the cluster. In this thesis, we form a disease progression network where we also look at 
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the clusters of diseases that frequently occur together. We then try to investigate whether 
a patient has diseases that overlap with the clusters. Different mathematical functions and 
algorithms exist for detecting clusters or communities in a social network; we use the one 
proposed by Blondel et al. (2008), as it is suitable and reasonably accurate for large 
networks. The detailed methodology for that is discussed in the later chapter. 
2.9 Summary 
In this chapter, we have reviewed the existing literature and set up a clear background on 
which the framework is introduced. We have discussed related theories and methods that 
are being used in understanding chronic disease progression and prediction of disease 
risk. We began with a brief introduction to prediction methods and evolution in 
healthcare and discussed how computer technology has disseminated in this field, giving 
rise to the concept of electronic healthcare or e-health. We then discussed different 
groups of methods and their implementations in disease prediction. This was followed by 
a discussion of the limitations and opportunities found in the existing literature. Finally, 
we presented some fundamental social network theories that will form the basis of our 
disease prediction framework. 
In the next chapter, we introduce the context of the research. As we implement our 
framework on a real-world health dataset, it is essential to understand the data flow 
process and the different components of the data that are used during the 
implementation and analysis. These can vary considerably across geographical locations 
employing different legislation, policy and technology. Therefore, before going over the 
methodology in detail, it is essential to properly define the context from which the data 
comes. For our research, this is the Australian health system, specifically administrative 
data received from private health funds. The context-specific features, as well as the basic 
structure of the framework, are discussed in the next chapter.  
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Chapter 3: Contextual Background of the Administrative Dataset 
and the Framework 
In this chapter, we introduce some context of the dataset and the framework in a 
comprehensive manner. We begin with a brief introduction to the Australian health 
system, followed by a detailed description of the data collection process and data 
propagation within the Australian health system. Next, we discuss different practical 
issues with the healthcare dataset that we need to take care of during the data curation 
and filtering process. Following this, we addressed the data security and privacy issues. 
Next, we discuss the organisation of the dataset. Then we introduce some core concepts 
that form the basis of the framework. Finally, we give an overview of the basic structure of 
our predictive framework. 
3.1 Australian Health System 
The Australian health system is complex and multifaceted. It can be described roughly as a 
complex web of components interconnected by multiple service relations. A broad-level 
categorisation of these healthcare components would give us three major entities, namely 
(a) consumers, (b) providers and (c) policy makers and funders. 
Consumers are the recipients of healthcare services and remain the focal point of the 
overall system. The term ‘consumer’ is not restricted to Australian citizens, but rather 
encompasses overseas visitors, temporary and permanent visa holders and asylum 
seekers (AIHW, 2014). Consumers finance their healthcare services through a combination 
of three major types of funding, namely (a) Medicare, (b) private health cover and (c) out-
of-pocket pay. Medicare is the universal government-funded healthcare scheme provided 
to all Australian residents and certain categories of visitors. All eligible consumers receive 
free or subsidised (as per the Medicare Benefits Schedule or MBS) treatments under 
Medicare cover. Medicare Australia also administers the Pharmaceutical Benefits Scheme 
(PBS), which partially covers the cost of certain prescription medicines. Consumers can opt 
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from a range of private health insurance funds to cover the cost of services that are not 
covered or partially covered by public funding. Private health cover owners also have 
greater freedom to choose doctors and schedule non-emergency surgeries. Often, public 
and private funding cannot cover the full cost of the service. In these cases, the remaining 
‘gap’ is paid by the consumers as an out-of-pocket fee. According to the AIHW, in 2013–14 
total health expenditure in Australia was $154.6 billion, which translates to $6,639 per 
person (AIHW, 2015). Figure 3.1 shows the different funding sources that met this 
expenditure.  
 
Figure 3.1: Different funding sources for total health expenditure during 2013–14 
Providers are the trained workforce or service settings responsible for delivering 
healthcare to consumers. The category includes medical practitioners, nurses, allied and 
other health professionals, hospitals, clinics and government and non-government 
agencies (AIHW, 2014). Providers can work in the public or the private sector. Policy 
makers and funders are the people or institutions in charge of administration, healthcare 
policy making and overall funding. They include but are not limited to the Commonwealth, 
local, state and territorial governments and health authorities, and private health insurers. 
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Consumers, providers, policy makers and funders are strongly embedded in the health 
system through a plethora of relations. Patients may choose to visit different specialists, 
general practitioners (GPs), hospitals or other providers during their lifetime for different 
health conditions. Providers within a region need to communicate together to deliver 
better service to the community. Policy makers and funders need to monitor the overall 
performance of the system in terms of quality of care, value for money and budget. They 
also track the health status of the community as well as the whole population on a broad 
level. The overall picture of the healthcare entities and their interrelations is complex. We 
present a simplified version of the health system in Figure 3.2. 
 
Figure 3.2: Organisation of Australian health system 
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3.2 Hospital Casemix Protocol Dataflow and Structure 
The Hospital Casemix Protocol (HCP) is the data specification that is maintained 
throughout the pipeline of data transmission, starting with data generation and ending as 
a research dataset, through different stakeholders and agencies. At its origin, providers 
regularly collect data from patients when they access healthcare services. These data are 
used for record keeping and performance monitoring. They may also be shared among 
other providers in the network or reported to stakeholders for auditing, management or 
research. Types of healthcare data vary widely depending on the kinds of service, 
providers and consumers involved. For our research context, we focus on administrative 
data from hospital admissions. This type of data is generated to classify admitted patients 
into different groups based on their diagnoses, associated procedures, complications and 
other healthcare matrices (e.g., length of stay, overall cost). Patients of the same group 
have similar footprints in terms of health status and resources required; in other words, 
they form clinically homogeneous groups that are expected to consume similar amounts 
of resources. This process is described by three related terms: 
1. The concept of grouping the patients into clinically homogenous groups is 
termed as Casemix (Department of Health, 2013). 
2.  The data specifications in which the Casemix should be recorded and 
transmitted to stakeholders is called the Hospital Casemix Protocol 
(Department of Health, 2016), commonly known as HCP. The dataset that we 
use in this research essentially originates from HCP data. 
3. After applying Casemix classification on the patient record, the patient is 
grouped into a single AR-DRG (ACCD, 2016) code, which stands for Australian 
Refined Diagnosis-Related Group. Details of AR-DRG are discussed later in this 
chapter. 
In our research context, the HCP dataset includes clinical, demographic and financial 
information for patients who are members of private health funds. HCP data collection for 
privately insured patients officially began in 1996–97 (Department of Health, 2016), and 
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the specification updates periodically. The data originates in hospitals and is transmitted 
to respective private health insurance funds, who then send the data to the Department 
of Health. Therefore, HCP has two major specifications: one for the hospitals to submit to 
the insurers, and the other for insurers when they send the data to the government (i.e., 
the Department of Health). The specifications are extensive and take into consideration all 
possible services and circumstances that may occur between admission and separation. 
The full HCP specification goes beyond the scope of our research, and therefore we only 
introduce the data items that are relevant later on in the Section 3.5. Up-to-date HCP 
specifications are usually available from the Department of Health website.  
3.3 Factors Affecting Coding Quality in the Dataset 
Healthcare datasets are collected over a span of several years in different healthcare 
facilities. In most cases, the data undergoes several layers of processing, including 
recording, formatting, linking and transferring between various agencies before it finally 
reaches the researchers. Moreover, during the data collection period, the policy and 
specification related to the overall handling process of the data may change multiple 
times. This may introduce heterogeneity into the data, and can introduce different types 
of errors and inconsistencies. In formulating the research method, we should adequately 
consider these issues and ensure consistency in the data for the best possible outcome. 
We briefly discuss the major issues that contribute to the overall coding quality of a 
dataset in the following subsections.  
 3.3.1 Expertise of the coder 
In most healthcare settings, trained healthcare professionals collect the administrative 
data. These professionals are often designated as ‘clinical coders’, whose job is to 
translate information from a patient’s medical record, which in most cases consists of 
written clinical documentation, into an agreed healthcare data classification system (WA 
Health, 2016). In Australia, the ICD-10-AM/ACHI/ACS coding scheme is used to classify 
healthcare data (AIHW, 2016). The three components of the coding scheme are 
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abbreviated as follows: the International Classification of Diseases 10th Revision 
Australian Modification (ICD-10-AM), the Australian Classification of Health Interventions 
(ACHI) and the Australian Coding Standards (ACS). A clinical coder can also be assisted by a 
software tool (e.g., DRG Grouper) to record or transmit the data.  
The overall quality of coding depends on several factors related to the coder. The coder’s 
expertise in the form of training and experience, as well as work environment within the 
healthcare facility, may affect the coding quality. For example, ICD codes vary in length: 
adding a suffix to the core part of the code can provide further information about the 
diseases, such as their aetiology, anatomical site and severity (Centers for Medicare and 
Medicaid Services, 2016). If a person has type-2 diabetes with ketoacidosis, the coder 
should record E11.1 for that condition. However, if the coder simply records E11, which 
only indicates type 2 diabetes, they are providing impoverished information: there will be 
no way for researchers to tell which specific type of diabetes mellitus the patient had. To 
give another example, assume that the patient has gestational diabetes mellitus and the 
onset arose during pregnancy, not pre-existing. The ICD core code for this condition would 
be O24.4. There may be a chance of miscoding this condition as E11.x, the generic code 
for type-2 diabetes, in which case it would not be a correct coding. Such coding 
discrepancies can also occur due to lack of availability or access to the reference manual, 
which may be a medical dictionary, codebooks or software. Further, several other factors, 
such as the version of any coding software used, motivation or time constraints, can also 
play a role in the level of coding. 
 3.3.2 Policy 
Healthcare rules and regulations encounter frequent updates. As healthcare data is 
collected over several years, any midterm policy changes can incur visible pattern changes 
in the trends and may cause significant inconsistencies within the dataset. 
As a real-world example, we can mention the policy changes for the coding practice of 
type-2 diabetes in New South Wales (NSW), Australia (NSW Health, 2016). In July 2008, 
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the Australian health policy for hospital data concerning the coding of additional 
diagnoses for diabetes was revised. The revision was made in response to the increased 
relevance of diabetes to the treatment for the principal diagnosis and the length of the 
hospital stay. This resulted in a requirement that coders include diabetes as a comorbidity 
only if a substantial alteration to the clinical treatment regime took place during the 
hospitalisation due to diabetes. This policy change had a significant impact on the 
numbers and rates of diabetes as a comorbidity only (not as a principal diagnosis). For 
example, in the NSW hospital statistics, a 54% reduction in rates of disease involving T2D 
as comorbidity is observed between 2007–08 and 2008–09. 
The Australian Coding Standard for diabetes was revised again in July 2010. This resulted 
in a major change, mainly affecting the coding of diabetes as a principal diagnosis and, to 
a lesser degree, the coding of diabetes as an additional diagnosis or comorbidity. 
According to the new policy, the coding of the principal diagnosis was to take place first 
(without reference to the fact that a patient may have diabetes), and additional diagnoses 
were then to be coded according to the guideline of relevance and the impact of diabetes 
on the clinical management and treatment of the principal diagnosis. For example, an 
admission for the treatment of a cataract or ulcer in a patient with diabetes before 2009–
10 would have been coded as diabetes with the specific complication of an cataract or 
ulcer (NSW Health, 2016). However, after July 2010, a cataract or ulcer was coded as the 
principal diagnosis, with diabetes only appearing as an additional diagnosis if it made an 
impact on the hospital’s management or treatment of the cataract or ulcer. This particular 
change caused a dramatic 60% drop in the number and rate of hospitalisation for diabetes 
as a principal diagnosis in NSW between 2009–10 and 2010–11. It also contributed to the 
existing trend of decreasing comorbidity rates incurred from the previous policy change.  
A further health policy change took place in July 2012. According to this new rule, all 
health conditions that a patient has at the time of hospitalisation should be recorded as 
additional diagnoses, regardless of their impact on the main cause of hospitalisation. This 
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change partially contributed to a rise of 4.7 times (or by 370%) in terms of admission with 
diabetes as comorbidity, between 2011–12 and 2012–13; this trend has since stabilised.  
It is evident from the above examples that policy changes can introduce consistency issues 
within a dataset. While formulating the research method and framework, we should be 
careful about taking the policy change issue into consideration. 
 3.3.3 Funding 
Funding may also affect the quality of coding. Better funding structure for the medical 
documentation, reporting and coding system will translate into better training, policy 
implementation and facilities like software and IT equipment. This, in turn, will result in 
better quality of coding. 
 3.3.4 Coding standards 
Coding schemes like the Commonwealth Medical Benefits Scheme (CMBS), ICD, and DRG 
change over time. Older coding standards often lack precision or may not precisely specify 
a disease. Coding standards are also frequently updated to keep up with recent 
advancements in diagnosis or pricing areas. However, the implementation of newer 
coding standards requires sufficient policy revisions, funding, training and updating of 
software and equipment, which takes time. As a result, several coding versions may be 
present in the same dataset concurrently over the years. Such inconsistency needs to be 
taken care of during the data preparation process. 
3.4 Healthcare Data Security and Implementation 
Healthcare data contains personal information and medical history of patients. This makes 
it highly sensitive and raises the issues of privacy and confidentiality. Therefore, governing 
bodies in charge of collecting, organising and transmitting the data impose different levels 
of cautionary and security measures to ensure that the privacy is protected under all 
circumstances. While the full spectrum of privacy and security measure is extensive, we 
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briefly identify the major issues among them which are particularly related to our research 
context. We discussed them in the following sections. 
 3.4.1 De-identification 
Data fields like patient name, postcode, contact number, address and identifiers (e.g., 
Medicare, social security number) can potentially identify a patient when they are present 
in the dataset, either individually or in combination. While these fields are often necessary 
for service providers, governments and insurance companies, for research purposes they 
are not usually required. Therefore, personal information is often deleted before 
transmitting the data to another party (i.e., researchers or data scientists). In some cases, 
de-identification is done partially to keep some information intact while minimising the 
risk of security breach: for example, the exact date of birth is omitted and the only birth 
year is mentioned. Similarly, sometimes adjacent postcodes are merged to identify greater 
geographical areas to minimise the risk of identification. In other cases, data is 
aggregated. 
De-identification can have limitations. If the researchers have another dataset for the 
same or somewhat overlapping cohorts, they may need to link the two datasets to form a 
complete cohort. For example, if the researchers have GP data and receive hospital 
admission data for the same cohort, they may want to match the records to see the 
primary and tertiary care matrices for the patients. This would not be possible if the 
received data were de-identified in a manner that is not re-identifiable. To mitigate the 
problem, the original provider can replace the personal identifiers with randomly 
generated unique IDs and send the de-identified data to researchers. At the same time, 
the provider can keep a translation table of personal identifiers against the unique IDs 
that were given to researchers, so that, if needed, the provider can re-link the result from 
the researcher’s end with their original data. Also, if the policy permits, the translation 
table may be used to link up with other data sources that have the same or overlapping 
cohorts. The following Figure 3.3 shows an overview of the data de-identification process. 
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Figure 3.3: Overview of data de-identification process 
 3.4.2 Scrambling and encryption 
Data scrambling refers to the process of obfuscating or removing sensitive or personal 
data (ORACLE, 2014). This is a part of the de-identification process, and is irreversible so 
that the original data cannot be derived from the scrambled version. Encrypted data, in 
contrast, is reversible in the sense that with the proper decryption key, the original data 
can be retrieved. Encryption is usually done in order to protect the data from 
unauthorised access, so that in the event of a breach, the actual data cannot be derived by 
unsolicited users. Only intended users will have access to the decryption key or software 
that can retrieve the actual research data. 
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 3.4.3 Data access control 
Healthcare data that is not an aggregated derivation of individual patient records is not 
normally made accessible to the general public over the internet. Even if the patient 
records are de-identified, there is still a chance of re-identification. For example, if there is 
a very small population of a certain age group or having particular disease within a 
geolocation, it might be possible to identify a few patients based on their age, postcode or 
disease code if present in the dataset, without the help of specific personal identifiers. For 
these reasons, healthcare data is generally hosted in a secure software and hardware 
environment. Hardware implementation of data access control includes a dedicated, 
secure server system inside a closed research facility. Software implementation may 
include firewall, VPN (for remote access), encryption and antivirus programs, and most 
importantly, password protection allowing only specific users to access the system. 
Further, access may be restricted to dedicated workstations to reduce the risk of security 
compromise by unsolicited users or software.  
3.5 Dataset Entities 
As discussed, healthcare data can be stored, represented or transmitted in different 
formats in terms of database structure, naming, level of detail and security. One of the 
main focuses of this thesis is to present its framework a uniform way so that it can be 
transformed and implemented in different healthcare settings and on different datasets. 
Nevertheless, the underlying organisation of the dataset should follow standard relational 
database design best practices for efficiency and consistency during analysis. Therefore, 
regardless of the initial organisation of the dataset, we should reorganise the dataset into 
a suitable relational database format. The primary entities of the dataset as used in our 
present analysis are described in following subsections. The database organisation is 
shown in the form of an Entity-Relationship (E-R) diagram in Figure 3.4. A more technically 
detailed version of the E-R diagram is included in the Appendix E for reference.  
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Figure 3.4: Simplified version of Entity-Relationship (E-R) diagram 
 3.5.1 Patient 
In the originally received dataset, this entity was named ‘Members’. The reasoning behind 
this naming is that the data was received from the private health funds, and from their 
perspective, consumers need to purchase membership to have access to private health 
insurance. Different types of membership exist; for example, one can buy a single cover 
for oneself, or a family cover for all family members. The cover can also be ‘basic’ or 
contain insurance for ancillary or other services. To reflect these variations in membership 
type, the original dataset had two records: ‘membership_ID’ and ‘member_ID’. Everyone 
under the same family cover had the same ‘membership_ID’, but each had a different 
‘member_ID’. Therefore, to point uniquely to a patient, we needed to combine these two 
IDs together.  
In the data preparation phase of the analysis, we simplified the member and membership 
IDs into one unique ID as a primary key, as we do not need to know whether an individual 
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has family cover or single cover. This ID was named ‘pntID’. Other mentionable fields 
storing patient information in the table include year of birth (‘pntYoB’), membership date 
(‘pntMembershipDate’) and sex (‘pntIsMale’: if the value of ‘pntIsMale’ is 1 the sex is male 
and otherwise female). The dataset does not contain any personally identifiable 
information such as name. Two other fields that are used to store calculated information 
later on are ‘pntCohort’ and ‘pntFirstDiagDate’. The ‘pntCohort’ field contains the 
information about which cohort the patient belongs to; the use of cohort number is 
discussed in the ‘Methods’ chapter. The ‘pntFirstDiagDate’ field contains information on 
the earliest date when the patient is diagnosed with the particular chronic disease, if any. 
The value is kept null if the patient is non-chronic. 
 3.5.2 Providers 
This entity contains the information about the healthcare service providers. A provider 
can either be a health professional (e.g., specialist doctor, nurse or anaesthetist) or entity 
(e.g., hospital). Most traditional service providers are identified by a unique code provided 
by the Australian Medical Association (AMA), but for non-standard health services (e.g., 
acupuncture or homoeopathic medicine) the ID may not be standard. In our analysis, we 
do not require any particular provider to be tracked or linked by their AMA code. 
Therefore, we only made sure that the provider ID (‘pvdID’) is unique. Also in the originally 
received dataset, there was a field for each provider named as ‘provider group’. In 
Australian healthcare, some hospital or clinical facilities belong to large conglomerates, so 
providers were identified as belonging to a hospital group. We removed these fields from 
our dataset. Another field is connected to the provider entity is provider type (‘pvdType’). 
This field contains categorical values that indicate whether the provider is a physician or a 
hospital: For example, if the field has value 1, it indicates that the service is provided by a 
physician; if the field has value 2, it indicates that the service is provided in a hospital, and 
so on. 
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 3.5.3 Admission 
Admission is an important entity for our framework. Before describing this entity, we 
should delineate between the related terms of ‘admission’, ‘separation’ and ‘episode of 
care’, as in the Australian healthcare context their definitions are slightly complicated 
based on whether they are used for formal or statistical purposes. An admission is the 
event in which a patient is admitted to the hospital. This can happen in several ways: the 
patient can be admitted for a pre-planned treatment or procedure; the admission can be 
unplanned (e.g., visit to the ER department); or the patient can be transferred from 
another healthcare facility. In contrast, a separation occurs when the patient is discharged 
to go home, is transferred to another healthcare facility (e.g., hospital, rehabilitation, 
nursing home) or dies. Now, for statistical purposes (e.g., administration, audit, billing), 
the full duration of continuous stay in the same facility can be divided into several 
admissions and separations in turns based on the type of care provided. In other words, if 
a patient’s care type changes during a hospital stay (e.g., shifted from the ER department 
to general departments for secondary treatments), it is preferable to keep the duration of 
each care type statistically separated. The summary information generated within this 
period is saved in the admission entity. Therefore, each time the type of care changes, a 
separation and then another admission event occurs. The duration between admission 
and separation events is called an episode of care, which is formally defined as the period 
between admission and separation that a person spends in one hospital including leave 
periods not exceeding seven days. Each episode is recorded in the dataset as a row in the 
admission entity. Because in most cases, there is no important difference between the 
terms ‘admission’ and ‘episode of care’, for simplicity, we will use the term ‘admission’ to 
refer to an episode of care. 
An admission entity has a unique ID (‘admID’) to identify that admission. It also has a 
foreign key (‘admPntID’) pointing to the patient ID field in the patient table. This keeps 
record of which patient an admission belongs to. To record the time-related information, 
the admission entity has two fields denoting time of admission (‘admDoAdm’) and time of 
73 
 
discharge (‘admDoSep’); the gap between these two times is saved into another field 
called length of stay (‘admLoS’), expressed in whole days. Each admission is associated 
with exactly one DRG code (see Section 3.5.4). For design purposes, the dictionary of DRG 
codes is saved as another entity and a field in the admission entity (‘admDRG’) acts as a 
foreign key pointing to the associated DRG code in the DRG entity. 
 3.5.4 Diagnosis-Related Group (DRG) 
The DRG is a coding system designed to classify hospital cases into different groups that 
are expected to use similar amounts of hospital resources in terms of length of stay, cost, 
treatment complexity and care. Admitted patients with the same DRG grouping are 
expected to be clinically homogenous; that is, they exhibit similar resource usage and 
incur similar costs on the health system. For example, elderly osteoarthritis patients 
admitted for knee replacement are expected to incur similar footprints on hospital 
resources and, therefore, they may fall under the same DRG group. The grouping is not, 
however, done on the basis of mere speculation or assumptions. There is a ‘grouper 
software’ that takes into consideration different parameters and classifies the DRG based 
on predefined rules. The parameters include the patient’s demographics (e.g., age, sex), 
diagnoses (e.g., ICD codes) and procedure codes present in the admission. The whole 
process of supervised by a trained clinical coder. 
The DRG version used in our dataset is AR-DRG. Only one DRG is associated with each of 
the admissions. To ensure performance and conformity to database design best practice, 
we put all the unique DRGs into a separate DRG table, thereby creating a dictionary of 
DRG codes. A foreign key from the admission table then points to the DRG record in the 
DRG table that is associated with the admission. The table has a unique primary key called 
‘drgID’ and the main text (‘drgText’), denoting the actual DRG code. It also has a computed 
field called ‘drgFreq’; this field essentially keeps track of the number of admissions that 
have this particular DRG code.  
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 3.5.5 Treatment codes 
Depending on the nature of the admission, a patient can undergo different types of 
treatments. For example, if the admission is due to a simple condition, the record may 
only contain diagnosis codes in the form of ICD-10 codes. If the patient needs procedures 
to be performed (e.g., knee surgery), then the performed procedure will be recorded 
using its own ACHI code. Further, all related fees are charged against different CMBS item 
codes; the Commonwealth government subsequently schedules payment and benefit 
against each CMBS items code. All of these different types of codes may be present in the 
patient’s HCP data, and these are represented in the Treatment codes table. It has two 
important fields: the first, named ‘treatCode’, contains the exact code. The second field, 
‘treatCodeType’, indicates the type of code (e.g., ACHI, CMBS or ICD) in terms of 
categorical values. 
Another relational table, named ‘relAdmTreatPvd’, is used to record which treatment 
codes in the HCP data are associated with which admissions, as well as the provider of the 
service. This table has three relational columns. The first one (‘relAdm’) points to the 
associated admission record in the Admission table. The second field (‘relTreat’) points to 
the associated treatment code record in the Treatment table. Finally, the third field 
(‘relPvd’) refers to the appropriate provider’s ID in the Provider table. 
 3.5.6 Additional derived  entities 
Apart from the primary dataset entities discussed above, we also have two important 
entities required for the networked representation of the disease progression. These two 
entities are derived from the main database through calculation. We now briefly discuss 
these two entities. Also, the following Figure 3.5 shows the graphical representation of the 
additional entities. 
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Figure 3.5: Additional entities derived from the database 
 
3.5.6.1 Node 
This represents an additional node entity that is used to save comorbidity information 
about the baseline networks (discussed in detail later in this chapter, section 3.6.4). Node 
entity has no direct linkage in the forms of ‘primary key’–‘foreign key’ with the main part 
of the dataset, as this is primarily used for analysis as well as storing the output in the 
later stage of analysis in the framework. The entity has three major fields: id, label and 
weight. The ‘id’ field is the primary key of the table; ‘label’ contains the name of the 
disease or disease group for analysis; and ‘weight’ indicates the prevalence of the disease 
or disease group. 
3.5.6.2 Edge 
Like the node entity above, this is also an additional entity. It supplements the node 
entity, and together they store the information regarding the comorbidity or baseline 
network (discussed in detail later in this chapter, section 3.6.4). As the name suggests, the 
edge entity contains the link information about the baseline network. Each row contains 
information on a single link. There are five fields: id, source, target, frequency (‘freq’), 
time gap (‘time_gap’) and standard deviation (‘stnDv’). Source and target fields are foreign 
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keys that point to the ‘id’ field of the node entity which represents the nodes that are 
connected by this particular edge. ‘id’ is the primary key of the edge entity. The rest of the 
fields hold the information about the edge attributes of the baseline network.  
3.6 Core Concepts of The Framework 
The goal of this thesis is to develop a framework for predicting chronic disease risk using 
administrative data that can perform better than the existing methods. In developing this 
framework, we incorporate methods from graph theory and social network methods. 
From the discussion of the literature above, we can observe that a broad spectrum of 
network-based methods is at work in predicting disease risk or understanding disease 
associations with underlying biomolecular factors. However, we also mentioned that 
these existing methods often have limited precision or application over the type of 
administrative data that we are working with. Therefore, to formulate a framework that 
can overcome these limitations, we must first examine the features of the dataset being 
used, and understand the potentials as well as the pitfalls.  
Administrative datasets are usually maintained by providers or stakeholders such as 
government and health insurance companies. The predictive framework, therefore, must 
focus on the benefit that these stakeholders stand to gain from it. One potential 
contribution is that identifying high-risk patients using the framework could help the 
stakeholders tremendously in formulating policy and encouraging those patients to take 
preventive measures, thus saving cost in the long run. The framework can indeed provide 
better and more efficient solutions compared to the ways in which those goals are 
currently approached.  
However, while formulating the framework, we should be cautious not to be 
overconfident in reporting the output. Chronic diseases are extremely complex, and no 
framework can predict perfectly whether an individual will develop the disease in future 
or not. So, rather than aiming for a prediction model that will give a categorical ‘yes/no’ 
answer for the question of future diagnosis, we focus on finding the probability or risk of 
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chronic disease for a group of non-chronic patients. In this way, the framework can make 
a more realistic assumption and prediction performance on risk. The stakeholders, then, in 
turn, can use it to rank their patients in order from high risk to low risk.  
In the following sections, we discuss some discrete features that will make up different 
components of the framework. 
 3.6.1 Determining research scope: chronic diseases and comorbidity 
Administrative data contains information about diagnosis and treatment of patients 
during hospital admission. Our focus in this thesis is to understand disease progression 
and develop a predictive framework for that disease. As a first step, we pose the 
questions: which set of diseases should we focus on? First, the intuitive direction should 
be to focus on the diseases whose risks can be predicted. Some diseases or diagnoses can 
occur by mere chance. For example, physical injuries can occur at random, while the 
pathogenesis of many idiopathic diseases is not understood properly; therefore, we 
should not focus on these conditions. Besides, we are not interested in prediction based 
on a spatial analysis; therefore, communicable diseases are not of interest. Second, as 
stakeholders provide the administrative data, we should be focused on diseases that have 
central importance in their policy, and the outcome (e.g., the framework) of the research 
should be translated into knowledge that can help ensure better policy and service by the 
providers. Third, the focus should be on diseases that are more prevalent within the 
healthcare system and impede the quality of life of patients. Finally, we should focus on a 
disease that is properly recorded in the dataset, often a concern for administrative data. 
Considering these directions, we choose to explore chronic diseases, and more particularly 
type 2 diabetes (T2D). 
Chronic diseases (e.g., diabetes, COPD, cancer) are the group of diseases that tend to be 
long-lasting and have persistent effects (AIHW, 2016), either over the lifetime or through 
recurrent episodes of relapse and remission (e.g., Crohn’s disease). In the Australian 
context, chronic diseases exert a significant social, economic and health burden, and thus 
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demand a great deal of research attention. In planning research on chronic diseases, we 
need to determine whether it is indeed worthwhile to predict risk for these diseases. In 
favour, we bring up the topic of comorbidity, which refers to any two or more diseases 
that occur in one person at the same time (AIHW, 2016). Research literature and empirical 
statistics have shown that chronic diseases have a comorbid nature (Schellevis, et al., 
1993). This is because these diseases either share similar pathobiology, or are connected 
to similar environmental or behavioural factors (e.g., smoking), or both. For this reason, 
chronic diseases are often analysed using the networked approach discussed in the earlier 
chapter (Section 2.4). Administrative data records the comorbid conditions of a patient (if 
any) during admission. For predictive modelling, these characteristics make chronic 
diseases a suitable focus of our research.  
 3.6.2 Elixhauser index as comorbidity measure 
As discussed in the previous chapter (Section 2.3.1: Score-based models), diagnoses and 
comorbidities are recorded using ICD codes. The version of ICD used may vary depending 
on country and policy codes; in the Australian healthcare context, administrative data is 
recorded using the ICD-10-AM version. One of the challenges associated with this method 
of coding is that many ICD codes present in the data are unrelated to the researcher’s 
task. For example, the ICD code Y92.01 indicates that the medical condition occurred in 
outdoor areas; this information is not relevant to include in our analysis. Similarly, there 
are many ICD codes indicating conditions that are not useful for our task of prediction 
(e.g., W10.9: Fall on and from other and unspecified stairs and steps). As a result, in 
developing a framework, we should exclude these unrelated ICD codes, which would 
create noise within the comorbidity network and affect its precision.  
To filter out irrelevant codes, we examined the literature for comorbidity measures (see 
Section 2.3.1 for details) because they list the important associated conditions that are 
present during hospital admission. Not all comorbidity measures factor in the same 
number of comorbidities. Some are more extensive than others; in addition, the measures 
differ on the quality and number of hospital record sets that were empirically analysed to 
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develop them. After studying these factors, we chose the comorbidities defined by the 
Elixhauser index, as it is better empirically validated, shows better performance in risk-
based scoring (Sharabiani, et al., 2012) and does not automatically aggregate individual 
comorbidities, as other measures do. The Elixhauser index comorbidities were originally 
designed to assess risk of hospitalisation, not exactly to predict the risk of a particular 
chronic condition. Therefore, using the index as a basis, we further reviewed the literature 
to find other significant comorbidities and added to the list as necessary. A detailed 
description of the comorbidities used is introduced in the Chapter 4:.  
 3.6.3 Appropriate coding criteria 
The fundamental unit of data for this research is the disease code. In our chosen 
administrative dataset, these codes are recorded at the time of hospital admission, when 
physicians diagnose a health condition. Disease codes represented in the dataset can vary 
widely for various reasons. The data is normally collected from different healthcare 
facilities over a span of several years. In most cases, the data undergoes several layers of 
processing, including recording, formatting, linking and transferring between various 
agencies, before it finally reaches the researchers. Also, during the data collection period, 
policies and specifications related to the overall handling process may change multiple 
times. This may result in heterogeneity in the data, and can introduce different types of 
errors and inconsistencies. For the most part, the disease codes in our dataset are 
recorded in ICD format. However, there are different versions of ICD coding standards 
based on the time recorded and the country-specific adaptation of the coding format, and 
national or local policies may also include the presence of other supplementary disease 
code formats in the dataset. To derive the framework, we must identify an appropriate 
coding scheme and any inconsistencies or errors within the dataset. Sometimes it may be 
necessary to translate the codes to ensure uniformity. The overall choice of coding 
scheme will largely depend on context and implementation. However, regardless of 
context, any disease code-related filtering should be included in the framework during the 
data preparation step. 
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 3.6.4 Representing the health trajectory of particular chronic disease patients 
We have already discussed the networked nature of administrative healthcare data. An 
individual patient can be admitted to hospitals several times during his or her lifetime. 
Each time the main reason for the admission is documented as the principal diagnosis. At 
the same time, the patient can also have other complications that may act as underlying 
causes of the principal diagnosis. Similarly, the patient may have pre-existing medical 
conditions that are worth noting down for both coding and treatment purposes. To give 
an example, if a person is hospitalised for COPD, the clinician may write J44 as the 
principal diagnosis, because COPD is the main reason for hospitalisation. Now, the patient 
may also have asthma, a related disease of the respiratory system. In that situation, J45 
(the ICD or disease code for asthma) is also noted down as a secondary complication in 
the diagnoses list. Similarly, the patient may have a history of tobacco use that may be of 
interest for doctors and may also be a requirement for clinical coding, so the appropriate 
ICD code – Z87 is recorded to represent the patient’s history of tobacco use. Now, these 
diagnosis codes represent the health status of the individual patient at that time of 
admission. Assume that the patient is treated well and is discharged after few days; 
however, after a few months, he has cardiovascular problems and is admitted for angina 
or chest pain. As a principal diagnosis, I20 is recorded. Upon further medical testing, he is 
also diagnosed with type-2 diabetes, so ICD code E11 is registered into his medical history 
for that admission. The earlier history of COPD (because it is chronic) and the person’s 
history of tobacco use may also be recorded during this admission as well. Thus, we can 
see that during the admissions, the patient’s comorbidities are recorded along with other 
important information. These leave a trace of their medical conditions over time like a 
trail of breadcrumbs. If we connect these dots of information left over time, we obtain a 
picture of how the individual’s health progressed. This set of connected pieces of 
information functions as a fundamental basis of an individual’s health trajectory. The 
trajectory can be conceptualised as a network where nodes represent a disease or 
condition, and edges between two nodes indicate that those two diseases have occurred 
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in subsequent hospital admissions. Figure 3.6 illustrates the concept of an individual’s 
health trajectory. 
 
Figure 3.6: Health trajectory of an individual chronic disease patient 
An individual chronic disease patient’s health trajectory should not necessarily represent 
all comorbidities of that chronic disease. However, on a large population level, if we 
merge individual chronic patients’ trajectories by adding up edges between same disease 
pairs, we obtain an aggregated version of the health trajectory network. This summarised 
version of the network, termed the baseline network in our thesis, should represent the 
overall health trajectory for chronic disease patients. While developing the method for 
baseline network creation, we should focus on the following characteristics:  
1. The baseline network should represent the overall health trajectory of patients 
having a particular chronic disease.  
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2. Nodes should have attributes that will represent the overall prevalence of 
diseases. 
3. The transition between diseases in subsequent admissions should be reflected 
by the edges connecting the nodes. Edges should also denote the number of 
times one disease progressed into another. 
4. The time duration for progression from one disease to another will be explored 
in our predictive model, so time information should be recorded in the baseline 
network.  
 3.6.5 Risk assessment through network similarity 
Chronic diseases are of comorbid nature. In many cases, chronic disease patients are not 
aware of their condition because of irregular medical check-ups or lack of specific 
symptoms. This applies in particular to our context of T2D. Patients may have T2D for 
years without being aware of it. However, as chronic diseases (including T2D) have other 
comorbidities, these should be reflected in the records taken during hospital admissions 
before the admission when the first T2D diagnosis is made. By looking at the traces of 
comorbidities in records taken during admissions, we can observe the trajectory that the 
patients are on. Therefore, our assumption is that if we can match the trajectory of a 
group of non-chronic patients with that of the baseline network, we might be able to 
predict that group’s risk of developing the chronic disease (i.e., T2D). If a patient is at high 
risk, it is likely they will stay on the same pathway in the baseline network. The match 
score or the risk output can be an effective way to identify and rank high-risk patients 
without any active medical surveillance over large-scale populations. Subsequently, the 
high-risk cohort can be advised to take the appropriate preventive measures or offered 
further clinical diagnosis to minimise risk. 
The task of risk assessment by comparing two networks (baseline and health trajectory of 
a non-chronic patient) is an important focus and contribution of our framework. Because 
this task requires comparing two networks for similarity, we use the social network and 
graph theory measures. The disease network that we are discussing has properties of a 
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social network, as well as time-related features. Therefore, we should focus on the 
following characteristics while comparing networks: 
1. If the patient has a history of diseases that have a high prevalence in the 
baseline network, they receive a higher risk score. 
2. If the patient meets particular demographic criteria (e.g., age) that are at high 
risk of chronic disease, they receive a higher risk score. 
3. If the patient has diseases that are also present and possibly occur together in 
the baseline network, they receive a higher risk score. 
4. If the patient’s transition time between diseases largely coincides with the 
transition time of the same diseases in baseline network, they receive a higher 
risk score. 
 3.6.6 Adjusting for attribution effect 
Disease diagnosis is essentially a logical reasoning process conducted by physicians. In 
general, it is done by matching or associating symptoms and physiological conditions with 
known diseases. It is often undertaken as a top-down approach, so when multiple 
diseases match the presenting symptoms, physicians looks for other symptoms or 
prescribe various tests that eventually cross out the possibilities of alternate diseases and 
lead to the correct one. Therefore, it is essential to understand which symptoms are 
associated with which diseases. Logically, this can be thought as a many-to-many 
relationship between the two sets of symptoms and diseases. In a generic sense, one 
disease may have one or more symptoms, and one symptom can be associated with 
multiple diseases. To uniquely diagnose a disease, physicians need to find symptoms that 
are exclusive to the particular disease in question. This overall concept can be termed 
attribution.  
The original attribution theory is credited to psychologist Fritz Heider (Sanderson, 2009, p. 
112) after his phenomenal work in social psychology (Heider, 1944, Heider and Simmel, 
1944) in the early twentieth century. The concept had been adopted in different fields of 
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sciences, including finance and medicine (Kessler, et al., 1999, Shiller, 2003). In general, 
attribution theory focuses on understanding the factors that are responsible for a 
particular event. When the factors are properly understood, they are used to predict 
future occurrences of that particular event. In medicine, especially in medical diagnostics, 
attribution tries to make inferences about the factors responsible for a particular medical 
condition (i.e., behaviour or behavioural outcome). The factors can be both internal (e.g., 
pathophysiological) or external (e.g., environmental). In our framework, we will consider 
the attribution effects of different comorbidities (i.e., diseases that occur together) that 
lead to a particular chronic disease. With the aid of network theories, the proposed 
methods in the framework will give more weight to the diseases that have higher 
attribution towards the particular chronic disease. The detailed methods of calculating the 
attribution effect within our predictive framework are discussed in the next chapter 
(Section 4.8). We further note that, in our empirical analysis of the framework, we also 
experimented with the advantages of the attribution effect. That is to say, we ran the 
analysis twice, with and without considering the attribution effect, and compared the 
performance of both variations.  
3.7 Functional Components of the Framework 
In the preceding sections, we have discussed the major theoretical concepts that form the 
basis of our framework. We now discuss the functional components of the framework 
that are derived from the aforementioned concepts and how they fit together in our 
research. This discussion is brief, as further details of the methodological components of 
the framework are discussed in the next chapter. 
The input to the research framework is an administrative health dataset. It is assumed 
that for each patient this should at least contain disease codes representing the health 
condition of the patient at a point of time (e.g., during hospital admission), along with vital 
demographic information like age, sex and smoking status. The output of the framework 
takes two forms: first, it creates a baseline network, which represents an aggregated 
health trajectory for all chronic disease patients. Second, based on the baseline network, 
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the framework should provide an interface for predicting the likelihood of chronic disease 
development for a new test patient who is as yet non-chronic. The interpretation and 
utility of the baseline network and its predictive capability will depend on the dataset, 
context and interests of the stakeholders. To illustrate this capability, we implement the 
framework empirically on an administrative dataset in Chapter 5 and provide the 
interpretation based on the context. 
 
Figure 3.7: Functional components of the framework 
Figure 3.7 shows the functional components of the framework. The overall framework has 
two major parts, each of which offers an output, as described in the previous paragraph. 
These two outputs are discussed below. 
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 3.7.1 Part 1: Generating a baseline network 
The first part of the framework focuses on generating the baseline network (concept 
introduced in Section 3.6.4). This network should represent the health trajectory of 
particular chronic disease (i.e., type 2 diabetes or T2D) patients. Administrative dataset 
containing medical histories of patients serve as the input for this part. Initially, this 
dataset goes through the stages of performing an integrity check, code translation and 
organisation of the data. This, in combination, can be treated as data filtering. The 
resultant dataset is then ready for analysis. We then need to partition the data into 
chronic and non-chronic cohorts. Depending on the context and requirements, one 
chronic disease is selected—for example, T2D—before implementing the framework. 
Then, if a patient in the research dataset has T2D, he is placed in the chronic cohort; 
otherwise, he is moved to the non-chronic cohort. Further, each of the cohorts should be 
partitioned into two groups: the baseline and training partitions. As the names suggest, 
the baseline partition is used to construct the baseline network, and the other partition is 
reserved for training the predictive model later.  
All medical histories of patients up until they are first diagnosed with the chronic disease 
(i.e., T2D) in the baseline partition are iteratively aggregated to form the first baseline 
network, named the ‘positive baseline network’. This network represents the disease 
progression (i.e., patterns, prevalence) that lead to the particular chronic disease. 
Similarly, a ‘negative baseline network’ is derived from the baseline partition of the non-
chronic patients. The process of generating a baseline network from multiple patients’ 
medical histories is done through Statistical Aggregation, discussed in detail in the next 
chapter (Section 4.7). Finally, the two baseline networks are merged into one network by 
adjusting for the attribution effect, as discussed earlier (see Section 3.6.6). In this process, 
different properties of the baseline network—for example, prevalence of disease and 
transitions—are given higher scores if they are more exclusive in the ‘positive baseline 
network’ and are given lower (negative) scores if they are more exclusive in the ‘negative 
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baseline network’. The resultant output is the simply called the baseline network and 
represents the final output from the first part of the framework. 
 3.7.2 Part 2: Generating predictive model 
The second part of the framework focuses on generating a predictive model for the 
chronic disease of interest. Similar to any generic predictive model, this part is divided into 
training and test phases. In general, the predictive model compares the baseline network 
with the medical history of a patient who is not yet diagnosed with the particular chronic 
disease, and calculates this patient’s risk of developing the chronic disease in future. The 
comparison method used here is called Longitudinal Distance Matching, which calculates 
how similar the test patient’s network is, compared to the baseline network. The similarity 
is scored against three risk factors based on the graph and social network theories. Detail 
formulation of these scores is given in the next chapter – “Methodology and Framework”.  
Along with these scores, which are calculated by comparing with the baseline network, 
the framework should also consider demographic and behavioural risk factors of the test 
patients, such as age, sex or smoking history. Therefore, there are multiple risk scores for 
one test patient and the overall risk of chronic disease is calculated by developing a linear 
prediction model from these scores. In this process, weighting factors (i.e., parameters) 
are associated with each of the risk factors. The optimal values of the weighting factors 
are calculated through standard binary logistic regression, or a parameter estimation 
model. Optimal values for these parameters should be determined using the training 
partitions from each cohort (established in the previous step). The framework can now be 
able to predict a test patient’s likelihood of developing chronic disease by comparing their 
medical history with the baseline network and calculating the risk scores, as the weighting 
parameters are known and optimised from the previous training phase. We should also 
consider data mining approach for prediction. For example, binary classification method 
can be used. The choice of predictive model can differ based on the context and 
performance. It should also be interesting to see which predictive modelling gives better 
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performance. Therefore, in our implementation of the framework, we follow an 
exploratory approach, running different models and discussing their relative performance. 
3.8 Summary 
In this chapter, we have introduced the dataset and functional concepts of the framework 
in the context of Australian health system. After Chapter 2 established the methodological 
background in an abstract way in relation to the current literature on disease prediction, it 
was necessary for this chapter to discuss the specific characteristics of a real-world 
dataset and other contextual information. This included a detailed description of how the 
data is generated and transmitted, enabling a closer look at common inconsistencies that 
we should be aware of. We then discussed associated security and privacy issues. Then we 
introduced the database structure that is suitable to support our methodological 
framework. Finally, we discussed some key concepts related to the framework and then 
discussed how these concepts fit together to make up the key components of the 
framework. 
Having introduced the contextual background of the administrative dataset and the 
framework, we now focus on the methodological and mathematical details of the 
framework. We will discuss these in the next chapter. 
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Chapter 4: Methodology and Framework 
In this chapter, we introduce our methodology and framework in detail. We also focus on 
the formulation of methods using mathematical notations and algorithms when possible. 
We begin by providing an overview of the whole framework. After that, we formalise the 
conceptual definitions used in the framework. Then we explain the methods involved with 
each of the components as well as the relations between them. We also discuss the 
process for measuring performance and validate the framework. 
4.1 Overview 
We divide our research framework into two major steps. In the first step, we generate the 
baseline network. This network will represent the health trajectory of patients who have a 
certain chronic disease in common; for our research context, this will be type 2 diabetes 
(T2D). The baseline network is derived by analysing all the T2D and non-T2D patients’ 
medical histories over the full period. The process starts with taking the patients’ medical 
histories from the healthcare database and ends by generating the baseline network. Two 
major intermediary steps, namely Patient Filtering and Statistical Aggregation, are 
involved in generating the baseline network; each of these is discussed in detail later on. 
The second step compares the baseline network with the medical history of a patient who 
is not yet diagnosed with the chronic disease and calculates that patient’s risk of 
developing the chronic disease in the future. The comparison method used here is called 
Longitudinal Distance Matching, which calculates how similar the patient’s network is in 
relation to the baseline network. The calculated similarity score will indicate the risk of 
developing the chronic disease. Figure 4.1 shows the summarised framework with all the 
major intermediate steps. 
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Figure 4.1: Summary of the framework 
Before going into the details of the framework, we should clarify some of the social 
network and graph theory-based definitions used in the framework. These conceptual 
definitions will act as a basis of some of the methods employed. In the next section, we 
introduce these measures and their definitions, and provide mathematical 
representations to quantify them. 
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4.2 Graph Theory-Based Definitions Used in the Framework 
We use several theories and concepts from graph theory in order to formalise the 
research goal and framework. These definitions will constitute the building blocks of our 
framework, and will also be used later on as a tool for visualisation. In the following 
subsections, we introduce the graph theory-based definitions. 
 4.2.1 Individual disease network 
A disease network for an individual patient represents the health trajectory of that 
patient. The health trajectory shows the patient’s transition from one disease to another 
during subsequent admissions in a healthcare environment. It also indicates the transition 
of the patient from one point of time to another. We already discussed in the previous 
chapter (section 3.6.4) about the concept of health trajectory. We also described how to 
represent an individual’s health trajectory by constructing a disease network. We now 
define it in terms of mathematical notation. 
The nodes of the individual disease network consist of diseases that are present in any of 
the admissions for that patient. The relation between any two nodes indicates that the 
patient has progressed from the one disease to another in two subsequent admissions. 
The relation is directional: that is, the disease that the patient has in the former admission 
is the source node, and the disease that he has progressed into in latter admission is 
considered the target node. If there are multiple diseases in any admission, then we 
consider all possible disease pairs. Also, when the patient has multiple diseases recorded 
in the same admission, the relations are shown as bi-directional edges between possible 
disease pairs of the same admission. 
To formalise the notations for the above described concepts, suppose we want to 
construct the disease network for a patient 𝑃 given the following properties: 
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• 𝑃 has total 𝑛 hospital admissions denoted as 𝑎1,𝑎2, … , 𝑎𝑛. The subscripts increase 
in chronological order in terms of the date of admission. Therefore, 
𝑑𝑎𝑑𝑑 𝑜𝑜 𝑎𝑑𝑎𝑎𝑎𝑎𝑎𝑜𝑛𝑎𝑖 >  𝑑𝑎𝑑𝑑 𝑜𝑜 𝑎𝑑𝑎𝑎𝑎𝑎𝑎𝑜𝑛𝑎𝑗 , when 𝑎 > 𝑗.  
• 𝑎 is the total number of possible diseases. 
• 𝐷 = {𝑑1,𝑑2, … ,𝑑𝑚} is the overall set of diseases that are being considered.  
• 𝐷𝑎𝑖 is the set of diseases or comorbidities that are recorded during admission 𝑎𝑖 
such that 1 ≤ 𝑎 ≤ 𝑛. 
• ∀𝑎 (𝐷𝑎𝑖 ⊂ 𝐷), i.e., for all admissions, recorded comorbidity set 𝐷𝑎𝑖  is a subset of 
overall comorbidity list 𝐷. In other words, each disease or comorbidity in 𝐷𝑎𝑖 must 
be present in 𝐷.. 
Therefore, the disease network for patient 𝑃 is 𝑁𝑃(𝑉,𝐸), where 𝑉 is the set of nodes or 
vertices and 𝐸 is the set of edges between any two nodes, such that: 
• 𝑉 = {𝑣|𝑣 ∈ 𝐷𝑎𝑖 , 𝑣 ∈ 𝐷, 1 ≤ 𝑎 ≤ 𝑛), i.e., every node 𝑣 of the disease network 𝑁𝑃 
must be present in any of the admissions’ comorbidity lists for that patient. 
• 𝐸 = {(𝑣1, 𝑣2)|𝑣1 ∈ 𝐷𝑎𝑖 , 𝑣2 ∈ 𝐷𝑎𝑗 , 1 ≤ 𝑎 ≤ 𝑗, 𝑣1 ≠ 𝑣2 𝑤ℎ𝑑𝑛 𝑎 = 𝑗}, i.e., an edge is 
an ordered set of two nodes that are present in the same or subsequent 
admissions where the source node is present in the former and the target node is 
in the latter. In cases when source and target nodes are the same in consecutive 
admissions, the edge will essentially be a self-loop. It should be noted that there 
will be edges between all possible disease pairs (except in self-looping cases) that 
are recorded in the same admission.  
• Bounds for 𝑉 are 1 ≤ |𝑉| ≤ 𝑎, as 𝑎 is the overall number of possible diseases. In 
practice, a patient may not have any admission information, and therefore may 
not have any recorded diseases. However, we do not include such patients in our 
calculations, as they do not contribute sufficient information to the framework. 
Accordingly, the lower bound of the node count is 1: that is, a patient may have 
only one admission with single recorded disease. 
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• Bounds for 𝐸 are 0 ≤ |𝐸| ≤ 𝑎2. If only one admission is present, no edge can be 
formed. There is theoretically no restriction on how many admissions a patient can 
have; however, as there can be maximum 𝑎 diseases in the nodes, therefore, 
these 𝑎 nodes can form 𝑎2 edges among themselves. Allowing for the provision 
of the self-loop, the maximum possible edges in a directed graph of 𝑎 nodes is 𝑎2, 
which is the upper bound for this case. 
 4.2.2 Attributes of individual disease networks 
Following up with the earlier section, which discusses formalising individual disease 
networks, we now discuss some of the associated network attributes. Essentially, we use 
three attributes: one node-level and another two edge-level attributes. The node level 
attribute is node frequency, which is associated with each disease in the node list (i.e., 
𝑉(𝑁𝑃)) of the patient’s network 𝑁𝑃. This attribute indicates how many times that 
particular disease has been recorded in the patient’s admission history. The lower bound 
for node frequency is 1, as the frequency is associated with graph nodes, and graph nodes 
will exist only if the corresponding disease is recorded at least once in admission history. 
On the other hand, a disease can be registered in all the admission records for a patient. 
Therefore, the upper bound for node frequency is equal to the number of admissions.  
Each edge of the disease network also has a frequency attribute similar to that of node 
frequency. Edge frequency for an edge from disease 𝑑1 to 𝑑2 represents the number of 
times a patient has progressed from disease 𝑑1 to disease 𝑑2. The lower bound for edge 
frequency is 1. The upper bound for edge frequency is reached when a disease pair is 
present in each of the admissions. In that case, the frequency is counted once for each 
admission and once for all the subsequent admissions. If there are 𝑛 admissions, there are 
𝑛 − 1 consecutive admissions. Therefore, given 𝑛 is the number of admissions, the bounds 
for edge frequency are: 
1 ≤ 𝑑𝑑𝑒𝑑 𝑜𝑓𝑑𝑓𝑓𝑑𝑛𝑓𝑓 ≤ 2𝑛 − 1  
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The third attribute is also associated with each edge, and represents the time information 
related to the edge. An edge connects two diseases, indicating that these two diseases 
have occurred in the same or consecutive admissions, while the time attribute shows the 
duration of that progression between two admissions. This time attribute has two parts: 
average time delay and standard deviation. Both are statistical measures of time 
information. As a particular progression between two diseases can occur multiple times, 
thereby increasing the other node attribute (edge frequency), we take the duration 
(admission time) for each of the similar progressions and calculate the statistical average 
and standard deviation. Collectively these two measures constitute the edge attribute. 
Figure 4.2 shows the process of constructing an individual disease network and its 
attributes.  
 
Figure 4.2: Individual disease network and attributes 
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 4.2.3 Baseline Network 
A baseline network represents the overall health trajectory of a population. Similarly to 
individual disease networks, the baseline network reveals the disease progression or 
health trajectory for the population as a whole.  
The baseline network is generated from the individual disease networks of patients who 
constitute the overall population of the baseline network. Individual disease networks are 
statistically aggregated, and the attributes are updated iteratively to form the baseline 
network. The process of the aggregation is discussed in detail later in this chapter (see 
Section 4.7).  
 4.2.4 Graph attributes of the Baseline Network 
The baseline network has similar attributes to the individual disease networks. Instead of 
revealing the health status of an individual, they reveal health status at a population level. 
The node frequency attribute shows the number of times the associated disease has 
occurred in a population during their admissions, while the edge frequency attribute 
indicates the number of times people have progressed between the diseases associated 
with the source and target nodes of that particular edge. The time duration attribute 
reveals the longitudinal nature of the progression: that is, the average duration of the 
progression and the standard deviation measure the spread of the time duration between 
that particular pair of diseases in the whole population.  
4.3 SNA-Based Definition Used in the Framework 
The baseline network, along with its attributes, reveals the health trajectory of a 
population of chronic disease patients. Social network and graph theories provide several 
measures that can reveal underlying dynamics and structure of the network that may be 
otherwise hidden. For our framework, we use some of the node-level measures. These 
measures are discussed below. 
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 4.3.1 Degree, in-degree and out-degree centrality 
Degree centrality indicates activity or prominence. It is a node-level measure, meaning 
that we can calculate the centrality measures for each node. However, the definition can 
be extended to the context of the whole network, and therefore it can be used as a 
network-level centrality measure as well. For the case of a simple graph (i.e., unweighted 
and undirected), the degree centrality of a node shows the number of neighbouring nodes 
that are directly connected with the node in question. This essentially means the number 
of edges that the node has: if a node has a high number or edges, this indicates that the 
node is more connected in the network, and therefore bears a high degree centrality. 
Thus, the degree centrality measure indicates the activeness or participation strength of a 
node. 
We need to extend the concept of degree centrality of a simple graph towards our 
baseline network, which is directed and weighted. The baseline network may also contain 
self-loops. For directed networks, there are two additional variants of degree centrality, 
known as in-degree and out-degree centrality. The in-degree centrality of a node shows 
the number of neighbours that directly connect to that node via directional edges: that is, 
in-degree centrality is the sum of inbound edges. Similarly, out-degree centrality is the 
count of outbound edges. If a node has high in-degree centrality, that means more nodes 
in the network are choosing it. Therefore, in-degree centrality is a measure of popularity 
in the network, especially applicable to social networks. Similarly, a high out-degree 
centrality indicates that the node is choosing or creating bonds with more neighbours. 
Therefore, out-degree is a measure of activeness. The degree centrality measure dictates 
the overall activity or prominence of a node by summing up its in-degree and out-degree 
centrality measures. Finally, for the baseline network of diseases, the edges have 
associated weight in terms of edge frequency. So, for the in-degree centrality of a node, 
we sum up the edge frequency attributes that are incident to that node instead of just 
counting the number of incident edges. Similarly, the out-degree centrality of a node is 
calculated by summing up the edge frequencies of outgoing edges from that particular 
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node. As before, overall degree centrality is the sum of in-degree and out-degree 
centrality.  
Mathematically, we can formulate the definitions of degree-related centralities as follows: 
• Suppose a baseline network 𝑁𝐵 or 𝑁𝐵(𝐷,𝐸), with 𝐷 as set of nodes and 𝐸 as set of 
edges.  
• 𝑁𝐵 has 𝑎 nodes, denoted as 𝑑1,𝑑2, … ,𝑑𝑚.  
• 𝐸 is the set of edges.  
• 𝐸𝑑𝑥𝑑𝑦 is any edge from node 𝑑𝑥 to 𝑑𝑦 , where 𝐸𝑑𝑥,𝑑𝑦 ∈ 𝐸. 
• Edge frequency of 𝐸𝑑𝑥,𝑑𝑦 is denoted by the function 𝑜𝑓𝑑𝑓(𝐸𝑑𝑥,𝑑𝑦). 
Therefore, the in-degree centrality of node 𝑑𝑖 is 𝐶𝐷𝑖𝑛𝐷𝑖  and calculated as 
𝐶𝐷𝑖𝑛𝐷𝑖 = �𝑜𝑓𝑑𝑓�𝐸𝑑𝑥,𝑑𝑖� ,𝑤ℎ𝑑𝑓𝑑 𝐸𝑑𝑥,𝑑𝑖 ∈ 𝐸 
Similarly, out-degree centrality of node 𝑑𝑖 is 𝐶𝐷𝐷𝐷𝐷𝐷𝑖  and calculated as 
𝐶𝐷𝐷𝐷𝐷𝐷𝑖 = ∑𝑜𝑓𝑑𝑓�𝐸𝑑𝑖,𝑑𝑥� ,𝑤ℎ𝑑𝑓𝑑 𝐸𝑑𝑖,𝑑𝑥 ∈ 𝐸  
Finally, the overall degree centrality of node 𝑑𝑖 is 𝐶𝐷𝐷𝑖  and calculated as 
𝐶𝐷𝐷𝑖 = 𝐶𝐷𝑖𝑛𝐷𝑖 + 𝐶𝐷𝐷𝐷𝐷𝐷𝑖  = �𝑜𝑓𝑑𝑓�𝐸𝑑𝑥,𝑑𝑖� + �𝑜𝑓𝑑𝑓�𝐸𝑑𝑖,𝑑𝑥� 
 
Figure 4.3 shows an example of calculations for in-degree, out-degree and degree 
centrality in the baseline network. 
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Figure 4.3: Degree based centrality measures in a baseline network 
 4.3.2 Disease cluster 
A cluster within a social network is a group of actors who share lots of interaction with 
each other, and relatively fewer interactions with the actors outside of the cluster. Actors 
within the same cluster may indicate that they are functionally similar. This is particularly 
true for social networks, where relations (e.g., friendship, kinship, gene-association) follow 
the homophily or ‘birds of a feather’ principle, and similar actors tend to form more links 
with each other. Similarly, as discussed in Chapter 2, diseases do not occur in isolation, 
and where diseases share similar pathophysiological, environmental or behavioural risk 
factors, they tend to occur together. Therefore, the presence of edges between nodes and 
their edge frequencies are not expected to be random or uniformly distributed in the 
baseline network. Rather, comorbid diseases are expected to be closer and have more 
connections between them; thus, they may form clusters. For that reason, in our baseline 
network for T2D, we focus on looking at the clusters of diseases that frequently occur 
together. 
  
 
99 
 
The process of identifying clusters in networks is done by a community detection 
algorithm. The implementation method varies substantially between algorithms. In one 
such method, one group of algorithms tries to detect clusters by first dividing the whole 
network into different sub-networks (either arbitrarily or a preset number) by removing 
(cutting) certain edges. Then the algorithm sums up the edge frequencies of the edges 
that are removed (i.e., the edges that lie between different sub-networks). The algorithm 
then repeats the process by eliminating a different set of edges and calculates the total 
edge frequency for inter-network edges. The process continues until the minimum sum of 
edge frequencies is found, and each sub-network is treated as one cluster. This method is 
called the minimum-cut method, as it finds the minimum sum of edge frequencies that 
are cut in order to partition the network into clusters.  
One of the challenges of cluster detection is that, if the network is too large (which is 
often the case), finding the optimum solution deterministically is often exhaustive and 
computationally expensive. Therefore, most community detection methods apply 
‘heuristics’, which means that they relax some of the restrictions of the problems and 
apply some assumptions. In most cases, this gives a much faster performance, at the cost 
of some accuracy, which is reasonable in many scenarios. The method we use in this 
research is also based on heuristics, and the algorithm for implementation is proposed by 
Blondel et al. (2008). The method uses an objective function (i.e., modularity) that is 
attempted to be maximised iteratively. The baseline network is partitioned into different 
clusters and the modularity is calculated for the partition. Modularity is the measure of 
the density of links inside communities as compared to links between communities 
(Newman and Girvan, 2004), giving a scalar value between -1 and 1. The network is 
transformed into an undirected network by ignoring the directional property of the edges. 
If a pair of nodes has edges in both directions, their frequency attributes are added up and 
a single undirected edge is considered instead of two directed edges between the nodes 
(i.e., diseases). 
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For the baseline network 𝑁𝐵, modularity 𝑄 is calculated according to the definition of 
Newman (2004) as follows: 
𝑄 = 12𝑎�[𝑜𝑓𝑑𝑓 �𝐸𝑑𝑖,𝑑𝑗�
𝑖,𝑗 −
𝑘𝑑𝑖𝑘𝑑𝑗2𝑎 ] 𝛿(𝑓𝑑𝑖 , 𝑓𝑑𝑗) 
where 𝑜𝑓𝑑𝑓 �𝐸𝑑𝑖,𝑑𝑗� is the undirected edge frequency between 𝑑𝑖 and 𝑑𝑗, 𝑘𝑑𝑖 =
∑ 𝑜𝑓𝑑𝑓 �𝐸𝑑𝑖,𝑑𝑗�𝑗  is the sum of the frequencies of the undirected edges attached to node 
𝑑𝑖, 𝑓𝑑𝑖  is the community to which node 𝑑𝑖 is assigned, and the 𝛿(𝑥, 𝑓) is 1 if 𝑥 = 𝑓 and 0 
otherwise. Finally, 𝑎 = 1
2
∑ 𝑜𝑓𝑑𝑓 �𝐸𝑑𝑖,𝑑𝑗�𝑖,𝑗 . Figure 4.4 shows the concept of clustering in a 
sample baseline network. 
 
Figure 4.4: Cluster detection in a sample baseline network 
 
4.4 Database Preparation and Filtering 
Administrative datasets are heterogeneous and complex. As the dataset is collected over 
several years in different healthcare facilities, we should first inspect the attributes and 
formatting of the dataset, look for inconsistencies and correct them before doing any 
actual analysis. The dataset should be organised into a structured database that is suitable 
for our analysis. Further, we need to consider privacy issues, because of the sensitive 
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nature of the data. In this regard, before beginning the actual analysis, we need to inspect 
thoroughly, sanitise and organise the dataset, which involves different steps. This section 
discusses the main components of the database preparation step. 
 4.4.1 De-identification 
Healthcare datasets may contain sensitive information, including social security or 
Medicare number, patient’s name, home address and exact date of birth. As a result, 
before beginning the analysis itself, we should take adequate measures to ensure that the 
data is properly sanitised. For most of the part, our research framework does not require 
any such information that may be deemed sensitive in nature (e.g., patient’s name, 
address or Medicare number); the only exception is that we need the date of birth to 
calculate the patient’s age, as it is an important risk factor for most chronic diseases. 
However, we do not need to know ages precisely to the day, so we can remove the day 
and month information from the date of birth, keeping the birth year only. This will 
significantly reduce risks of re-identification. Next, names and postcodes are stripped from 
the dataset, as they are not required. Names are, however, replaced by random and 
uniquely generated IDs to identify patients, as data about the same patients is spread over 
several database entities. While removing personal information, one should also consider 
provisions for linking these dispersed records (discussed previously in Section 3.4.1) with 
other data obtained from different sources. If the dataset will have possible linkage 
requirements, personal identification should be removed in such a way that it can be 
linked with other datasets later on. For our framework, we do not have any linkage 
requirements; therefore, this issue did not arise. 
 4.4.2 Database organisation 
After the data is properly sanitised, the framework focuses on the proper organisation and 
structure of the data. In most cases, healthcare data comes in an electronic format (e.g., 
database), and normally the dataset is structured following the owner organisation’s 
standard. However, it may not still be enough to apply our methods readily on the dataset 
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before doing some preliminary reorganisation. One potential set of problems with the 
received dataset is that of integrity. For example, same data may be present in multiple 
records over different data tables. One possible reason for this duplication is that hospital 
data can be recorded in several stages. A patient file is maintained during the hospital 
stay, where different doctors can input their detailed diagnostic and clinical notes; doctors 
may also refer to medical tests, whose reports are also attached in the file. The patient file 
is often maintained in paper format until a clinical coder prepares the HCP data from it. 
The billing department also keeps track of the medical items against which the patient or 
the insurers are billed. The health insurers, therefore, may receive the data in two 
different forms: the patient’s HCP data, and the claim data for the same patient from the 
billing department. These two forms may both be transmitted to the researchers, 
incurring data duplication.  
Another potential problem with a dataset can be discrepancy: that is, part of the 
admission information for a patient may be available in one record, and another part of 
the same admission information may be present in another record in the received data, 
depending on the ways in which they were recorded and structured. Therefore, if we were 
to keep the original database structure intact, we would need to run the methods on 
multiple tables to obtain the full set of information. Therefore, we should organise the 
dataset before doing the analysis and ensure that the data integrity is ensured. 
The SQL-based relational data structure is adequate for the framework. The design of the 
database should firmly implement the primary key–foreign key relationship to ensure 
consistency. For example, we know that a patient can have multiple admissions. On the 
other hand, each admission should be associated with exactly one patient. Also, no two 
patients can have the same identifier. These relationships can easily be implemented in 
SQL-based database designs by making the patient identifier in the patient table the 
primary key, and creating a foreign key in the admission table that must point to the 
primary key. In this way, there would be no possibility, even accidentally, of breaching the 
integrity of the patient–admission relation. Further, the main entities—patient, provider, 
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admission, treatment and DRG—should be logically separated in the database by putting 
them into different separate tables. This database design is also capable of applying 
complex queries, either directly in the database client engine or through the framework. 
As part of the analysis methods, we often need to perform such queries in order to run 
some complex analyses, and the relational design will significantly improve performance, 
and moreover ensure data security. 
From the above discussion, we can discern clear reasons why it can be necessary to 
reformat or restructure the original dataset. We have already discussed the logical 
database structure for the framework in the previous chapter (see Section 3.5) in great 
detail. Therefore, in the next section, we move on to discuss assessing the data. 
 4.4.3 Preliminary assessment 
This is the final step in a three-step process of preparing the dataset. In this step we focus 
on assessing the coding quality present in the data and, based on that assessment, 
removing any records that do not have sufficient information to be considered in the 
analysis. This will ensure that the data is noise-free to the greatest possible extent, which 
can otherwise affect the overall performance and accuracy of the framework. In assessing 
the data, we will look for several data characteristics across the entities. These 
characteristics are given as follows: 
• All patients should have sufficient duration of time represented in their records 
over which we can trace their admission histories. If we include patients with 
insufficient time information, it may introduce outliers and noise in the disease 
progression network. The exact upper and lower bounds of time duration depend 
on the quality and nature of the dataset, as well as the pathophysiology of the 
specific chronic disease that the framework is analysing. Data sourced from health 
insurers can include the patient’s joining date and termination date (the lack of 
which may indicate that they are still members); these can be used to calculate the 
duration of a patient’s record, as we can assume that during that time all 
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admission information was sent to the insurers. Sometimes joining and 
termination dates can be omitted or obfuscated for privacy reasons. In that case, 
we can consider the duration between first and last admissions. For the part of the 
framework where we construct the baseline network from chronic disease (i.e., 
T2D) patients, we examine the period of their record up to the point when they are 
first diagnosed. Therefore, the effective duration is calculated from the joining 
date (if available) or first admission date until the admission date at which the first 
chronic disease code appeared. 
• Some patients may have medical conditions that require recurrent admissions. For 
example, a patient may have a physical injury requiring frequent admissions for 
dressing. Alternatively, a patient may need regular medical services (e.g., dialysis). 
As a result, their comorbidity information will be recorded each time they are 
admitted. Allowing these records can lead to overestimation of their 
comorbidities, and thus may introduce bias. Therefore, we should set a threshold 
that allows patients a certain maximum number of admissions per year. 
• There should also be a minimum threshold in terms of admission numbers to be 
considered in the framework. As the framework initially constructs a disease 
progression network for an individual, having a very small number of admissions 
will not give reliable information on how the diseases progressed. Also, 
theoretically we need at least two admissions for each patient, each of which 
should have valid disease codes, in order to depict transitions over time.  
• Some diagnoses or treatment codes that do not affect the chronic disease 
progression or onset should be excluded from the framework. For example, 
accidental or physical injuries that are not related in any way to the chronic disease 
should be omitted. Codes related to consultation with a GP and general diagnostic 
tests (e.g., full blood count) do not carry significance for our task of predicting 
chronic disease. In addition, some specific physical conditions or attributes present 
in the admission record may not make sense if considered alone. Therefore, those 
conditions or attributes should also be ignored from the analysis. For example, if 
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conditions like fever, vomiting or vertigo are present during admission, they are 
recorded in the HCP data; however, these conditions do not contribute to the 
framework, and hence are put in the exclusion list. 
4.5 Disease Code Grouping 
The framework uses disease codes, typically in the form of ICD codes, as the core data 
items. A typical administrative dataset of moderate size should have a large number of 
these disease codes. For example, in our implementation of the framework we used the 
ICD-10-AM version of the codes; this version has approximately 20,000 unique and active 
codes (ACCD, 2015), many of which are likely to be present in the dataset. It would be 
difficult to run analyses and comprehend the results if we considered all codes 
individually. Therefore, we need to group the disease codes to shorten the overall number 
of nodes in the baseline network. There are two ways of accomplishing this, and we 
implemented both of them in the analysis. A short summary of each method is given 
below.  
 4.5.1 ICD code collapse 
ICD codes, as well as other clinical codes, follow a hierarchical structure for logical 
classification, readability and ease of use for both humans and software. The codes have a 
main segment that refers to a disease group or similar complication. Optional suffixes can 
be added to reveal further information about the diseases, such as their aetiology, 
anatomical site or severity. For example, disease codes E08.311 and E08.319 both refer to 
diabetes mellitus due to an underlying condition with unspecified diabetic retinopathy. 
The only difference is that the former is related to symptoms with macular oedema, and 
the latter is linked to symptoms without macular oedema. These differentiations are 
mostly done for the physician’s reference, record keeping and billing purposes, and our 
calculation does not require the level of specificity represented by the longer ICD codes. 
Besides, including them may induce a false sense of community structure (i.e., cluster) in 
the baseline network, because codes that are derived from the same core ICD are already 
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related by their classification, and are expected to have close ties with each other, thereby 
forming clusters. These pseudo-clusters may undermine the actual clusters of interest that 
may reveal useful information. Moreover, including deeper levels of ICD codes could shift 
prevalences (i.e., frequency distributions) from the core ICD groups to themselves, and 
thus may not give a proper picture of prevalence. Therefore, we need to trim the trailing 
suffixes of the ICD codes that provide only supplementary information about the core 
disease. For our framework, we only keep the first three characters of the ICD codes 
during calculation. 
 4.5.2 Selective comorbidities 
In this method, we first select a group of comorbidities, and each node of the baseline 
network corresponds to one comorbidity. A comorbidity is essentially a generic disease or 
health condition (e.g., type 2 diabetes, obesity). The comorbidities are selected in such a 
way that only the relevant diseases or health conditions are included. For example, in our 
research we are focused on chronic diseases, specifically type 2 diabetes. So, we should 
choose those comorbidities or health conditions that are likely to be relevant and possibly 
occur together with diabetes. There are already well-established comorbidity indices that 
provide related lists. For our research, we adopt the Elixhauser index, one of the most 
common indices. Our framework uses this index at its base, and adds a few more 
comorbidities or health condition that seem important according to the context. We have 
already discussed the Elixhauser and other comorbidity indices in Chapter 3 (see Section 
3.6.2).  
4.6 Cohort Selection 
After preparing the dataset and filtering out the records that have insufficient 
information, we now focus on the process of creating baseline network. Figure 4.5 shows 
the steps of the cohort selection process detailed within the overall framework. 
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Figure 4.5: Process of cohort selection 
In our framework’s application to T2D, there are two cohorts: the cohort of patients 
diagnosed with T2D, and the cohort of patients who are non-chronic—that is, they do not 
have T2D. Throughout the analysis, we will refer to the cohort of diabetic patients as 𝐶𝑇2𝐷  
and the cohort of non-diabetic patients as 𝐶′𝑇2𝐷.  
There are well-defined ICD codes for T2D and other chronic diseases. These codes are 
used to decide whether a patient will belong to the T2D cohort or the non-T2D cohort. To 
do that, the patients’ diagnosis codes at each admission are compared against the T2D ICD 
code; if a match is found, the patient is flagged as a member of cohort 𝐶𝑇2𝐷. Then the 
date of that admission is saved in the ‘first diagnosed date’ field of the patient table, as 
that date represents the first time the patient was diagnosed with T2D. If no match is 
found, the cohort flag is set to indicate that the patient belongs to cohort 𝐶′ 𝑇2𝐷 and the 
‘first diagnosed date’ is kept blank. 
After the patients are divided into two cohorts, they are used to develop a baseline 
network using their admission history. The partitions within the cohorts are used for 
validation. Before going into the details of these processes, we need to discuss the process 
of shortening the ICD codes in order to keep the size of the baseline network within a 
limit.  
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4.7 Statistical Aggregation for Baseline Networks 
We generate two baseline networks in this step. The first baseline network, referred to as 
𝑁𝐵+𝑣𝑣, is derived from the cohort of the patients diagnosed with T2D. Similarly, the other 
baseline network, referred to as 𝑁𝐵−𝑣𝑣, is derived from the cohort of the patients not 
diagnosed with T2D (i.e., from 𝐶𝑇2𝐷′ ). These two baseline networks represent the typical 
health trajectories of T2D patients and non-T2D patients respectively. As discussed in the 
definition earlier, the baseline network includes the ICD-10 disease codes as its nodes. An 
edge between the nodes (disease codes) represents a relation between those two 
diseases, indicating that these two diseases tend to occur in the same or consecutive 
admissions. Two edge attributes are associated with each edge: strength and progression 
delay. The strength attribute denotes the number of times two diseases have occurred 
simultaneously or in consecutive admissions. The second attribute, progression delay, 
denotes the average timespan between occurrences of the former disease and the later 
one.  
Generation of any baseline network through the process of statistical aggregation is 
calculated in two steps. First, all admission histories are inspected for each respective 
cohort, and the corresponding disease codes are merged into an intermediate time-
detailed network. In this network, the edges contain information on all time gaps in 
disease occurrence between two consecutive admissions. Figure 4.6 shows a typical 
merging of two patients’ histories into an intermediate time-detailed network. For 
example, there are two directed edges from 𝐷1 to 𝐷2, which means that these two 
diseases have occurred one after another in both ways: that is, 𝐷1 has occurred after 𝐷2 
and 𝐷2 has also occurred after 𝐷1. 𝐷2 has occurred after 𝐷1 at time gap 0 (in the same 
admission for Patient 1) and at 𝑑2 − 𝑑1 (in consecutive admissions for Patient 1). 
Conversely, 𝐷1 has occurred before 𝐷2 twice: at time gap 0 (in the same admission for 
Patient 1) and at time gap 𝑑4 − 𝑑3 (in consecutive admissions for Patient 2). Note that, 
when two diseases occur simultaneously in a single admission, this appears in both of the 
directed edges between them. 
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Figure 4.6: Construction of intermediate time-detailed network 
To generate the intermediate time-detailed graph, an empty graph is created first. Then 
two sets, 𝐴𝑐 and 𝐴𝑝, are created to hold the disease codes for the current and previous 
admissions. These two pointers traverse the entire admission history of a patient, and 
each time the disease codes of consecutive admissions pointed to by 𝐴𝑐 and 𝐴𝑝 are 
calculated to insert the edge information to build the graph. Below is the algorithm used 
to construct the time-detailed graph.  
procedure timeDetailedNetwork (list pd) 
 - create empty graph G 
 - for each patient p in pd 
 -  create empty set Ac,Ap 
 -  for each admission a from second to last admission of p 
 -   assign Ap to disease codes prior to admission of a 
 -   tp = time of Ap  
 -   assign Ac to disease codes of a 
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 -   tc = time of Ac  
 -   for each disease code pairs dp1, dp2 in Ap 
 -    insertEdge (G, dp1,dp2,0) 
 -   end for 
 -   for each disease code pairs dc1, dc2 in Ac 
 -    insertEdge (G, dc1,dc2,0) 
 -   end for 
 -   for each disease code pairs d1, d2 in Ap and Ac  
 -   such that d1 ϵ Ac and d2 ϵ Ap 
 -    insertEdge (G, d1,d2,tc-tp) 
 -   end for 
 -  end for 
 - end for 
end procedure 
 
procedure insertEdge (Graph G, Node source, Node target, time Δt) 
 - if source not exists in G 
 -  insert source in G with strengthsource = 0 
 - end if 
 - if target not exists in G 
 -  insert target in G with strengthtarget = 0 
 - end if 
 - insert edge entry between source and target with time gap = Δt 
 - increase strength of target by 1 
end procedure 
 
The second part of the baseline network generation method deals with the merging of the 
time gap information between the consecutive disease codes of the time-detailed graph. 
Because of the vast number of occurrences of disease codes all together in the patients, it 
is impractical to consider all the time gap information contained in the disease codes. 
Besides, it would also be computationally expensive and would complicate the 
comparison steps of the next part. To merge all occurrences of consecutive disease codes 
and corresponding time gap information into a single time duration, we considered the 
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mean values of time gaps ± one standard deviation. In case the lower bound becomes 
negative, we set zero as the lower bound. Figure 4.7 illustrates merging time gap 
information to convert a time-detailed graph into a baseline network. 
 
Figure 4.7: Merging of time gap information to convert a time-detailed graph into a 
baseline network 
Overall, in this step of the framework, we generate two baseline networks. These are 
referred to as 𝑁𝐵+𝑣𝑣  and 𝑁𝐵−𝑣𝑣, the former for the T2D patients and the latter for the non-
T2D patients. In the next step, we adjust the parameters of the T2D patients from the 
𝑁𝐵−𝑣𝑣  network using the attribution effect. 
4.8 Adjustment for Attribution Effect 
In general, attribution theory focuses on understanding the factors that are responsible 
for a particular event. In medicine, especially in medical diagnostics, attribution refers to 
the process of making inferences about the factors responsible for a particular medical 
condition (i.e., patient behaviour or behavioural outcome). The attribution principle can 
be put as follows: if an outcome M is the result of attributes A, B and C, and an outcome N 
is the result of attributes B, C and D, then we can say that B and C both are present and 
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probably responsible for M and N. Now, if a patient has attributes B or C or both, and we 
are asked which outcome he or she will have, provided that M and N outcomes are 
exclusive—that is, one cannot have both—then it is difficult, if not impossible, to tell 
whether M or N will occur, because B and C are present in both outcomes. However, if the 
patient also has either attribute A or C, we can make a better decision, as these attributes 
are unique to their outcomes. Therefore, to properly predict outcome or risk, we should 
take the attribution effect in consideration. 
The two baseline networks from the previous step create a similar scenario. Suppose, for 
example, that we find that a disease is more prevalent in positive baseline network, 𝑁𝐵+𝑣𝑣, 
as that disease has higher node frequency; this does not necessarily mean that this 
disease will be a definite risk factor for chronic disease. Perhaps that particular disease is 
also prevalent in the non-chronic disease patient cohort, or in the negative baseline 
network, 𝑁𝐵−𝑣𝑣. Therefore, we should not look for more prevalent comorbidities in 𝑁𝐵+𝑣𝑣, 
but rather we should focus on finding prevalent comorbidities in 𝑁𝐵+𝑣𝑣  that are also less 
prevalent in 𝑁𝐵+𝑣𝑣. In other words, we should look for more exclusive diseases in 𝑁𝐵+𝑣𝑣  by 
looking at the differences in prevalence, and in the process, adjust for the attribution 
effect. 
To keep the analysis process logically separated, we do not update the attributes in the 
baseline network for T2D patients. Rather, we generate another instance of a baseline 
network from 𝑁𝐵+𝑣𝑣  and 𝑁𝐵−𝑣𝑣. We refer to this network simply as baseline network 𝑁𝐵, 
which is a composite of 𝑁𝐵+𝑣𝑣  and 𝑁𝐵−𝑣𝑣  generated through attribute adjustment. The 
nodes and edges of the new baseline network are essentially the union of the nodes and 
edges of 𝑁𝐵+𝑣𝑣  and 𝑁𝐵−𝑣𝑣, which means that the following relations hold true: 
• 𝑉(𝑁𝐵) = 𝑉�𝑁𝐵+𝑣𝑣� ⋃ 𝑉(𝑁𝐵−𝑣𝑣) 
• 𝐸(𝑁𝐵) = 𝐸�𝑁𝐵+𝑣𝑣� ⋃ 𝐸(𝑁𝐵−𝑣𝑣) 
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Each node of 𝑁𝐵, say 𝑑𝑖𝑁𝐵 , is calculated as the relative difference between that node’s 
frequencies in 𝑁𝐵+𝑣𝑣  and in 𝑁𝐵−𝑣𝑣. There will be two scenarios that we need to consider for 
this calculation. First, if the node is present in 𝑁𝐵−𝑣𝑣, then it can be expressed as: 
𝑜𝑓𝑑𝑓 �𝑑𝑖𝑁𝐵 |𝑑𝑖𝑁𝐵 ∈ 𝑉�𝑁𝐵−𝑣𝑣�� = �𝑜𝑓𝑑𝑓 �𝑑𝑖𝑁𝐵+𝑣𝑣� − 𝑜𝑓𝑑𝑓(𝑑𝑖𝑁𝐵−𝑣𝑣 )𝑜𝑓𝑑𝑓(𝑑𝑖𝑁𝐵−𝑣𝑣 ) ,𝑤ℎ𝑑𝑛 𝑑𝑖𝑁𝐵 ∈ 𝑉�𝑁𝐵+𝑣𝑣� 
−1, 𝑜𝑑ℎ𝑑𝑓𝑤𝑎𝑎𝑑  
Recall that 𝑉(𝑁𝐵−𝑣𝑣) is the set of edges (vertices) of the baseline network 𝑁𝐵−𝑣𝑣. If the 
node 𝑑𝑖𝑁𝐵  is not present in 𝑁𝐵−𝑣𝑣, the calculation will give a divide-by-zero error (i.e., 
infinity result). Therefore, if the particular node is absent from 𝑁𝐵−𝑣𝑣, we assign its 
frequency in 𝑁𝐵 equal to the maximum relative frequency difference calculated for the 
nodes that are present in both the baseline networks 𝑁𝐵−𝑣𝑣  and 𝑁𝐵−𝑣𝑣. Mathematically, 
the node frequency for such nodes of the baseline network 𝑁𝐵 can be defined as follows: 
𝑜𝑓𝑑𝑓 �𝑑𝑖𝑁𝐵 |𝑑𝑖𝑁𝐵 ∉ 𝑉�𝑁𝐵−𝑣𝑣�� = max𝑑𝑗𝑁𝐵∈𝑉(𝑁𝐵−𝑣𝑣)𝑜𝑓𝑑𝑓(𝑑𝑗𝑁𝐵) 
After obtaining the baseline network’s node attributes in the above process, the attributes 
are normalised in the range of 0 to 1 inclusive for analysis and comparison purposes. The 
process is quite straightforward: each node frequency is divided by the maximum node 
frequency of the baseline network. Mathematically, 
𝑜𝑓𝑑𝑓 �𝑑𝑖𝑁𝐵� = 𝑜𝑓𝑑𝑓 �𝑑𝑖𝑁𝐵� − min𝑑𝑗∈𝑉(𝑁𝐵) 𝑜𝑓𝑑𝑓(𝑑𝑗)max
𝑑𝑗∈𝑉(𝑁𝐵) 𝑜𝑓𝑑𝑓(𝑑𝑗) − min𝑑𝑗∈𝑉(𝑁𝐵) 𝑜𝑓𝑑𝑓(𝑑𝑗) 
In the same manner, each edge of 𝑁𝐵 is calculated from the same edges in the T2D and 
non-T2D baseline networks, considering the attribution effect. The equations and 
boundaries also remain similar, as above, except that edge notations are used instead of 
nodes.  
Now that we have established the new baseline network, it is considered to represent the 
trajectory of T2D patients, where the attributes (node, edges, frequency etc.) represent 
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unique characteristics of progression, as we have considered the attribution effect. In the 
next step, we will use this baseline network for risk prediction. Unless otherwise specified, 
in subsequent calculations, we will always refer to this attribute-adjusted network (i.e., 
𝑁𝐵) when we mention the baseline network. Figure 4.8 illustrates the process of 
attribution adjustment for the nodes. 
 
Figure 4.8: Example process of attribution adjustment for nodes 
4.9 Risk Prediction 
This is the second part of our framework, and perhaps more analytically complex than the 
previous ‘baseline creation’ part. In this phase, we predict the risk of developing the 
chronic disease for a test patient who has not yet been diagnosed with that disease. To 
accomplish this, we compare the medical history of that patient with the baseline network 
of the chronic disease (i.e., T2D) derived in the first part. Note that the baseline network 
has some important properties, including the number of times the disease has occurred in 
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all the patients diagnosed with chronic disease, denoted as strength; the average time gap 
between any disease b’s occurrence after any disease a; and the sequence of disease 
occurrence, called the direction of the network. When matching the test patient’s network 
with the baseline network, we consider the following principles: 
1. The patient’s chance of developing the chronic disease is increased when he 
has a history of diseases that have a high strength in baseline network. 
2. The patient’s risk is increased if he has more diseases from the baseline 
network (this principle is analogous with collaborative filtering). 
3. The patient’s risk is increased if his sequence of diseases largely matches the 
sequence of those diseases in baseline network.  
4. The patient’s risk is increased if the time gap between any two diseases in the 
patient matches the time gap of those two diseases in the baseline network. 
In addition, we consider behavioural, sex- and age-related risk factors, as these are often 
associated with the onset of chronic disease. We discuss how to calculate risk score 
considering these factors in the sections below. 
 4.9.1 Age, sex and behavioural risk factors 
People approaching elderly ages are often at higher risk for chronic diseases, because of 
various pathophysiological, environmental and lifestyle factors. This is especially true for 
T2D, as there is strong evidence that age is a risk factor. Some chronic diseases are also 
likely to have a gender bias. In an attempt to keep the framework generic, we also kept a 
sex-based risk score for diabetes. Finally, some behavioural risk factors, such as alcohol or 
smoking, are also considered, as these act as risk factors for T2D. Whether or not the 
patient has a current or previous history of alcohol or smoking is coded in the HCP data 
and reflected in the patient records. Therefore, looking at the patient’s recorded list of 
diagnoses, from the specific ICD codes that represent behavioural risk factors like smoking 
and alcohol use, we can determine a behavioural risk score for a patient. 
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The age risk factor (𝑓𝑜𝑎𝑎𝑎) is a continuous score, ranging from 0 to 1. We divide the 
patient’s actual age (in years) by the difference between the maximum and minimum ages 
in the cohort in order to normalise the age score within the range 0 to 1. The sex risk 
factor (𝑓𝑜𝑠𝑎𝑥) is essentially a categorical score, and needs no further calculation, as the 
patient record in the dataset already has the flag to indicate whether the patient is male 
or female. Finally, the score for behavioural risk factors (𝑓𝑜𝑏𝑎ℎ𝑎𝑎) has the discrete value of 
0 if the patient does not have any ICD codes that are considered as risk scores (e.g., 
smoking) and 1 if at least one match is found. 
After the scores for age, sex and behavioural risk factors are set, the framework can then 
move forward to calculate the scores for the graph- and social network-based risk factors 
of a test patient, comparing them with baseline network. 
 4.9.2 Longitudinal Distance Matching 
In this part of the prediction framework, we compare the disease network of a test non-
chronic patient with the baseline network and give scores against three graph theory and 
network-based scores. We call the overall comparison method ‘longitudinal distance 
matching’. The network comparison method and this name are motivated by the concept 
of the ‘String Edit Distance’ algorithm, also known as ‘Levenshtein distance’ (Levenshtein, 
1966). String edit distance methods are widely used in spell checkers, word suggestion 
and optical character recognition. ‘Edit distance’ is defined as the minimum number of 
operations (insertions, deletions or substitutions) required to change one word into 
another. For example, to change ‘worde’ to ‘world’, we need to delete ‘e’ from the end of 
‘worde’ and then insert ‘l’ before ‘d’. Thus the cost of this conversion is one deletion and 
one insertion. This algorithm considers the sequence of the words and calculates the 
minimum cost of conversion; this is analogous to our target. According to our assumption 
above, if the baseline network has the disease sequence ‘a-b-c-d’, then a patient’s disease 
sequence ‘a-b-c’ is more similar to the baseline than another patient’s disease sequence 
‘a-c-d’. Although both patient sequences have same number (three) of overlap with the 
baseline network, the former patient’s edit distance is smaller. 
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However, for our case, we have two disease networks—the baseline and the test patient’s 
network—instead of a flat sequence of characters, as in typical string edit distance 
problems. In addition, the two networks have several attributes that also need to be 
matched. These factors make the two scenarios different in terms of data structure and 
implementation. Besides, the edit distance method would be computationally expensive 
for our case if we were to adapt it for our large sequence of diseases with networked 
structure. Further, the number of diseases in a test patient’s network should be 
considerably smaller than the overall baseline network, resulting in a great number of 
mismatches between the two networks. Therefore, we match the graph similarity against 
three different network-based risk factors and find the corresponding similarity-matching 
scores. Scores for each risk factor have a mathematical formulation, and their motivations 
come from network theory and SNA (see Chapter 2). These scores are discussed below. 
Graph node match score: This measures the similarity between the test patient network 
(𝑁𝐷𝑎𝑠𝐷) and the baseline network (𝑁𝐵) in terms of disease prevalence. As diseases are 
depicted as the network nodes, this measure is considered to calculate the ‘node-based 
risk factor’, or 𝑓𝑜𝑛𝐷𝑑𝑎. The measure also considers the prevalence intensity, or node 
frequency, of the baseline and test patient networks while calculating the score. 
Therefore, for a test patient, a high value in graph node match score is only possible under 
these following three scenarios: 
1. The test patient has more diseases that are also present in baseline network. 
2. These diseases (that are common in both networks) have higher prevalence in 
the baseline network. 
3. These diseases (that are common in both networks) have higher prevalence in 
the test patient’s network. 
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Mathematically, we can define scores for the node-based risk factors 𝑓𝑜𝑛𝐷𝑑𝑎 of any node 
𝑑𝑖𝑡𝑣𝑡𝑡  of a test patient’s disease network 𝑁𝐷𝑎𝑠𝐷 as follows: 
𝑓𝑜𝑛𝐷𝑑𝑎𝑑𝑖𝑡𝑣𝑡𝑡
= �𝑚𝑎𝐷𝑐ℎ 𝑠𝑐𝐷𝑠𝑎𝐷𝐷𝐷𝑎𝑡 𝑝𝑠𝑎𝑎𝑎𝑡   𝑑𝑜𝑑𝑎𝑡 𝑝𝑓𝑑𝑣𝑎𝑡 ≠ 00,  𝑜𝑑ℎ𝑑𝑓𝑤𝑎𝑎𝑑  , where 
𝑎𝑎𝑑𝑓ℎ 𝑎𝑓𝑜𝑓𝑑 =  � 𝑜𝑓𝑑𝑓�𝑑𝑖𝑡𝑣𝑡𝑡� ∗ 𝑜𝑓𝑑𝑓 �𝑑𝑗𝑁𝐵� ,𝑤ℎ𝑑𝑓𝑑 𝑑𝑖𝑡𝑣𝑡𝑡 =|𝑉(𝑁𝑡𝑣𝑡𝑡)|
𝑖=1
𝑑𝑗𝑁𝐵  
𝑑𝑜𝑑𝑎𝑡 𝑝𝑓𝑑𝑣𝑎𝑡 =  � 𝑜𝑓𝑑𝑓�𝑑𝑖𝑡𝑣𝑡𝑡�|𝑉(𝑁𝑡𝑣𝑡𝑡)|
𝑖=1
 
The numerator, the ‘match score’, essentially multiplies the frequency of a common 
disease in both baseline network and test patient’s disease network, and sums the results 
over all common diseases of both networks. The denominator is used to normalise the 
score in terms of the overall sum of frequencies for the nodes of the test network. If the 
denominator is 0, the score is kept at 0 to avoid divide-by-zero error, although the 
possibility of this does not arise, as we checked earlier during the filtering step. 
Graph pattern match score: Like the node-based risk factor, the graph pattern match 
score measures similarity in the disease transition: that is, the calculation considers the 
number of matching edges and their corresponding frequencies. The risk factor against 
which the score is given is denoted as the edge-based risk factor, or 𝑓𝑜𝑎𝑑𝑎𝑎. The equations 
are also similar to those of the graph node match score. The only difference is that, 
instead of disease prevalence, the calculation involves the transition prevalence between 
disease pairs; that is, it looks for edge frequency.  
Graph cluster match score: This measure is scored against the cluster-based risk factor, 
𝑓𝑜𝑐𝑡𝐷𝑠𝐷𝑎𝑠. The process is slightly different from the previous two network-based risk 
factors. This risk factor is based on the social network theory of clustering. The motivation 
behind the score is that diseases do not occur in isolation, but rather, a group of diseases 
tend to occur together: these diseases have a higher number of transitions (i.e., existence 
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of edges, high frequency) between them and lower number of transitions to diseases of 
other groups. Therefore, this score measures the proportion of edges in the test patients 
network that lie inside the same cluster in the baseline network. 
To calculate the score, the framework first runs a clustering algorithm (Blondel, et al., 
2008) in the baseline network. The algorithm assigns ID numbers to all nodes (diseases) of 
the network. If two diseases in the network receive the same ID, it indicates that the 
diseases are in the same cluster. Once the baseline network nodes receive the clustering 
IDs, the test network is brought to measure the cluster similarity. To do that, each of the 
edges of the test network is considered. If the nodes that make up the edge have the 
same clustering ID in the baseline network, we count that as a cluster match. The final 
match score is the sum of all cluster matches normalised by the number of edges present 
in the test network. Therefore, 
𝑓𝑜𝑐𝑡𝐷𝑠𝐷𝑎𝑠=  𝑓𝑜𝑓𝑛𝑑 𝑜𝑜 𝑑𝑑𝑒𝑑𝑎 𝑎𝑛 𝑁𝐷𝑎𝑠𝐷  𝑤ℎ𝑜𝑎𝑑 𝑓𝑜𝑓𝑓𝑑𝑎𝑝𝑜𝑛𝑑𝑎𝑛𝑒 𝑛𝑜𝑑𝑑𝑎 ℎ𝑎𝑣𝑑 𝑎𝑎𝑎𝑑 𝑓𝑡𝑓𝑎𝑑𝑑𝑓 𝐼𝐷 𝑎𝑛 𝑁𝐵
𝑓𝑜𝑓𝑛𝑑 𝑜𝑜 𝑑𝑜𝑑𝑎𝑡 𝑑𝑑𝑒𝑑𝑎 𝑎𝑛 𝑁𝐵  
4.10 Parameter Estimation Model 
The framework utilises a parameter estimation model to optimise the weighting factors 
for the parameters that are generated in the above calculation. In the framework, we 
have six risk factors as independent variables, which are listed in Table 4.1. 
In our current analysis, risk factors for sex were calculated from the literature review on 
T2D. If the prevalence of chronic disease is higher for females, they are assigned a higher 
weight (between 0 and 1) and males are assigned a lower weight. The exact assignment of 
values depends on the relevant findings on the prevalence of the disease in question as 
reported in the literature.  
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Table 4.1: List of risk factors considered in the framework 
Risk factor type Name Value type Notation 
Socio-
demographic 
Age Continuous 𝑓𝑜𝑎𝑎𝑎 
Sex Discrete 𝑓𝑜𝑠𝑎𝑥 
Behaviour Discrete 𝑓𝑜𝑏𝑎ℎ𝑎𝑎 
Graph/health 
trajectory based 
Graph node match Continuous 𝑓𝑜𝑎𝑁𝐷𝑑𝑎 
Graph pattern match Continuous 𝑓𝑜𝑎𝑃𝑎𝐷 
Network cluster 
match 
Continuous 𝑓𝑜𝑐𝑡𝐷𝑠𝐷𝑎𝑠 
 
The overall set of risk factors is defined as: 
𝑓𝑜 = {𝑓𝑜𝑎𝑎𝑎 , 𝑓𝑜𝑠𝑎𝑥 , 𝑓𝑜𝑏𝑎ℎ𝑎𝑎𝑎 , 𝑓𝑜𝑎𝑁𝐷𝑑𝑎 , 𝑓𝑜𝑎𝑃𝑎𝐷 , 𝑓𝑜𝑐𝑡𝐷𝑠𝐷𝑎𝑠} 
 
As discussed in the previous section, we obtain scores against each risk factor in 𝑓𝑜 for all 
test patients who are not yet diagnosed with the chronic disease (i.e., T2D). For each risk 
factor, we define a scaling or weighting factor that normally has a value within the range 
of -1 to 1 inclusive. This range covers equal magnitude of negative and positive values 
relative to zero. Now, the overall risk factor for a patient is the weighted sum of the 
scores: this means that we multiply each of the test patient’s individual risk scores with 
their corresponding scaling or weighting factors, and then add them together. Therefore, 
the risk score of a test patient is: 
𝑆𝐷𝑎𝑠𝐷 = �𝑎𝑜𝑖 × 𝑓𝑜𝑖|𝑠𝑟|
𝑖=1
 
Here, 𝑓𝑜𝑖 is the ith risk factor (i.e., age, sex, gNode) and 𝑎𝑜𝑖 is the weighting factor of the 
corresponding risk factor. |𝑓𝑜| indicates the size of the set of risk factors in a generic 
sense; in our present case, it is 6. 
121 
 
Optimum values of the weighting factors for each risk score are calculated from a 
parameter estimation model by training it on a cohort of test patients with known 
outcomes in terms of whether or not they develop T2D. The purpose of this estimation is 
to decide which factors are the better determinants of the chronic disease. In other 
words, the model looks for the effect of the risk factors on the outcome, which is whether 
or not the patient will develop T2D. For the process of determining so, the model tries to 
adjust weighting factors for each risk factor and calculates the accuracy of the framework 
by applying it on a sample of test patients. The adjustments of the weighting factors are 
done iteratively, and the combination that gives the maximum accuracy is set to the 
optimum values. Figure 4.9 illustrates the process of choosing the optimum threshold 
value and accuracy for a particular combination of weighting factors for a group of test 
patients whose T2D conditions are known. 
 
Figure 4.9: Process of choosing optimum threshold value and accuracy 
 
122 
 
At first, the framework selects a group of T2D patients from cohort 𝐶𝑇2𝐷 and a group of 
non-T2D patients from cohort 𝐶′𝑇2𝐷. A detailed process of choosing test patients from 
cohorts is discussed in the next section. For this part, we focus on the process that the 
estimation model relies on. Let us assume we choose a test cohort of T2D patients and 
refer it as 𝐶𝐷𝑎𝑠𝐷+𝑣𝑣  , where 𝐶𝐷𝑎𝑠𝐷+𝑣𝑣 ⊂ 𝐶𝑇2𝐷. We also test the cohort of non-T2D patients 
and refer it as 𝐶𝐷𝑎𝑠𝐷−𝑣𝑣 , where 𝐶𝐷𝑎𝑠𝐷−𝑣𝑣 ⊂ 𝐶′𝑇2𝐷 and �𝐶𝐷𝑎𝑠𝐷+𝑣𝑣� = �𝐶′𝐷𝑎𝑠𝐷−𝑣𝑣� ; that is, the 
test cohorts are of same size. The framework then incrementally assigns values to each of 
the weighting factors, starting from -1 up to 1, with an increment size of 0.1. This range 
and increment size can be changed depending on the context later on. Now, the 
assignment of different sequential values results in different combinations of weighting 
factors. We can, in fact, calculate the number of possible combinations using the following 
formula: 
𝑁𝑓𝑎𝑁𝑑𝑓 𝑜𝑜 𝑓𝑜𝑎𝑁𝑎𝑛𝑎𝑑𝑎𝑜𝑛𝑎 = (𝑓𝑝𝑝𝑑𝑓 𝑁𝑜𝑓𝑛𝑑 –  𝑡𝑜𝑤𝑑𝑓 𝑁𝑜𝑓𝑛𝑑 + 1) × |𝑎𝑜| 
For each combination of the weighting factor values, the parameter estimation model 
computes the optimum accuracy of prediction for the current weighting factor values. This 
is done first by calculating the actual risk score, which is the sum of risk factor scores 
multiplied by the current weighting factor values for all the test patients. Then the model 
iteratively sets and increments a threshold score, and considers a test patient at risk of 
T2D if his risk score is above or equal to the threshold value. If not, then the test patient is 
considered non-T2D. Now, as the test patient’s actual T2D status is known, we can easily 
check whether or not this prediction is correct. Thus we count the percentage of correct 
predictions made for this threshold value, and then update the threshold by incrementing 
it to a predefined size. Finally, the threshold value that gives the maximum accuracy is 
considered as optimal from this particular combination of weighting factors. 
As we can recall, the framework has generated different combinations of scale factors, 
and for each combination it tries to discover the possible accuracy of prediction and the 
corresponding threshold value for considering a T2D patient. Depending on the increment 
size and the upper and lower bounds for the weighting factors chosen, it may take some 
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time to calculate all possible combinations. Within this full execution cycle, the model 
should find several maxima, and the model remembers the combinations that resulted in 
those maxima. Now, after the execution is over, the combinations that gave the highest 
accuracy percentage can be regarded as the optimal values for the weighting factors. 
Alternatively, the model can start another pass, now focusing on a smaller range around 
the previously identified maxima. This time, the increment size can be made much smaller 
in order to search for better precision. Undertaking several passes is important, because if 
the increment size if the first step is set too large, the model can miss actual optimum 
values. Therefore, iterative passes with smaller ranges around the maxima identified in 
the last iteration and smaller increment sizes should give optimum values. Also, as 
mentioned earlier, when calculating accuracy for each iteration, the model also calculates 
the threshold value to determine whether a score will be considered T2D positive or T2D 
negative. If the score is greater than the threshold value, the corresponding patient is 
considered T2D positive, and T2D negative otherwise. The combination that gives the 
optimum accuracy threshold for that combination is then set as the optimum threshold, 
because that particular threshold value is responsible for the accuracy.  
Once the optimum weighting factors are determined from the parameter estimation 
model, the framework is now ready to function. The output of the model takes two forms. 
First is the baseline network 𝑁𝐵, which can be used to understand the chronic disease 
(i.e., T2D) progression. The second output is the optimum weighting factors, along with 
the prediction model presented here that can be used to assess the risk of chronic disease 
(i.e., T2D) of any new patient. To do that, we calculate the scores described in Section 
4.9.2. Individual scores are multiplied by the weighting factors determined by the 
parameter estimation model, and then summed up to obtain the final score. If the final 
score is greater than or equal to the threshold value, the patient is considered to have a 
very high risk. The risk assessment process can be iterated over multiple test patients to 
make a comparison or to assess who is at higher risk. 
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Having described the framework and its operation, we now discuss the performance and 
validation methods for the framework.  
4.11 Performance and Validation 
 4.11.1 k-fold validation 
We employ k-fold validation as a method of cross-validation to test how our model can be 
scaled or generalised onto another dataset for the same chronic disease without changing 
any parameters. In k-fold cross-validation, the members of the original cohort are 
randomly assigned to 𝑘 equally sized, mutually exclusive partitions (Kohavi, 1995). Out of 
these 𝑘 partitions, a single partition is assigned as reserved. Members of this partition are 
used as the validation data for testing the model, while members in the remaining 𝑘 − 1 
partitions are used for training the model. After the training and testing related to this 
partition assignment is completed, the process of training and testing is repeated for 
another 𝑘 − 1 times. In each repeat of the process, another unique subsample out of the 
𝑘 partitions is used for testing or validating. Therefore, training and testing are run a total 
of 𝑘 times, and each time the testing data are unique, as that single partition is uniquely 
chosen from 𝑘 different partitions. The 𝑘 results from the folds can then be averaged or 
otherwise combined to produce a single estimation. The advantage of this method over 
repeated random sub-samplings is that all observations are used for both training and 
validation, and each observation is used for validation exactly once. 
For our framework, we used the commonly followed 10-fold cross-validation (i.e., 𝑘 = 10). 
We divided the cohorts of T2D and non-T2D patients (i.e., 𝐶𝑖 (𝑇2𝐷) and 𝐶′𝑖 (𝑇2𝐷)) each into 
10 partitions of equal size. These partitions are denoted as 𝐶𝑖 (𝑇2𝐷) for partitions from the 
T2D cohort (i.e., 𝐶𝑇2𝐷) and 𝐶′𝑖 (𝑇2𝐷) for partitions from the non-T2D cohort (i.e., 𝐶′𝑇2𝐷); 𝑎 is 
the serial of the cohort. 
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The following relations hold true for the cohorts and cohort partition membership: 
a. 𝐶𝑇2𝐷 = ⋃ 𝐶𝑖 (𝑇2𝐷)10𝑖=1  
b. 𝐶𝑖 (𝑇2𝐷) ∩ 𝐶𝑗 (𝑇2𝐷) = ⌀, where 1 ≤ 𝑎𝑗 ≤ 10 
c. 𝐶′𝑖 (𝑇2𝐷) = ⋃ 𝐶′𝑖 (𝑇2𝐷)10𝑖=1  
d. 𝐶′𝑖 (𝑇2𝐷) ∩ 𝐶′𝑗 (𝑇2𝐷) = ⌀, where 1 ≤ 𝑎𝑗 ≤ 10 
For the k-fold validation (𝑘 = 10), we generated the baseline networks from the first nine 
partitions of chronic and non-chronic patients—from 𝐶1(𝑇2𝐷) to 𝐶9(𝑇2𝐷) and from 𝐶′1 (𝑇2𝐷) 
to 𝐶′9 (𝑇2𝐷). The baseline networks are then attribute-adjusted, and then weighting 
factors are estimated from the same nine cohorts. After that, the model is tested on the 
remaining T2D and non-T2D partitions—on 𝐶10(𝑇2𝐷) and 𝐶′10 (𝑇2𝐷). The process is then 
repeated by using other cohorts individually (9th, 8th etc. up to 1st) for testing, each time 
using the remaining cohorts as framework building (i.e., baseline network creation). 
 4.11.2 Precision and recall 
Precision and recall are two measures are used to determine how well the model is 
performing. Precision reveals the fraction of the result that is relevant. In contrast, recall 
shows the fraction of relevant results that the model is returning. In our framework, we 
test it against patients whose chronic conditions are known: that is, we know whether 
they are T2D positive or T2D negative. Now, after generating the baseline network and 
finding the weighting factors and threshold values, we can test the framework. If for any 
test patient the computed score is greater than or equal to the threshold value, we 
conclude that he is at higher risk, meaning that he is progressing towards becoming T2D 
positive. If, in reality, the patient is diagnosed with T2D, the prediction is correct, while if 
the patient does not have T2D in his medical history, then we say that the model has given 
a false positive result. Conversely, if the prediction model says that the patient is not at 
risk and the test patient has in fact developed T2D, it means that the model has given a 
false negative result, which is also not desirable. The last option is that, in both predictions 
and in reality, the patient is not shown to have T2D. This is another case in which the 
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prediction is correct. Table 4.2 shows the possible outcomes of the test results and their 
corresponding success or failure status. 
Table 4.2: Different types of outcomes from tests 
Actual patient status Prediction from framework Validation  Success/Error 
T2D +ve T2D +ve True positive Success 
T2D +ve T2D -ve False negative Error (Type II) 
T2D -ve T2D +ve False positive Error (Type I) 
T2D -ve T2D -ve True negative Success 
Precision, therefore, in our case, is an indication of how many patients, out of all the 
patients who are predicted to be at high risk of T2D by the framework, are actually T2D 
positive. Thus, 
𝑝𝑓𝑑𝑓𝑎𝑎𝑎𝑜𝑛 = 𝑑𝑓𝑓𝑑 𝑝𝑜𝑎𝑎𝑑𝑎𝑣𝑑
𝑑𝑓𝑓𝑑 𝑝𝑜𝑎𝑎𝑑𝑎𝑣𝑑 + 𝑜𝑎𝑡𝑎𝑑 𝑝𝑜𝑎𝑎𝑑𝑎𝑣𝑑  
Inversely, recall is an indication of how many patients, out of all the patients who are 
actually T2D positive, are correctly identified as at high risk by the framework. Therefore, 
𝑓𝑑𝑓𝑎𝑡𝑡 = 𝑑𝑓𝑓𝑑 𝑝𝑜𝑎𝑎𝑑𝑎𝑣𝑑
𝑑𝑓𝑓𝑑 𝑝𝑜𝑎𝑎𝑑𝑎𝑣𝑑 + 𝑜𝑎𝑡𝑎𝑑 𝑛𝑑𝑒𝑎𝑑𝑎𝑣𝑑  
4.12 Performance Based on Alternate Implementation Criteria 
In the whole framework, there are three criteria that have alternate options for execution. 
Two of these can be seen in the diagram of the framework (see Figure 4.1 at the beginning 
of this chapter). The first option is to implement the attribution effect during the baseline 
creation step. The attribute adjustment can give higher weights to the diseases or 
progressions that are more exclusive to the positive baseline network of chronic patients 
than to the negative baseline network of non-chronic patients. Therefore, attribution 
adjustment is likely to give better prediction performance, and hence we keep it as default 
execution path. The alternative is to not consider attribute adjustment, but rather to 
construct a baseline network simply from the chronic patients’ positive baseline network. 
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The second option for an alternate execution path arises during the disease prediction 
part of the framework. To train and test the model, we considered three different models. 
Two of them are linear models, namely the parameter estimation model and the binary 
logistic regression model. The other is from a data mining-based binary tree classification 
model. All of these models utilise the same baseline network and risk factors at the 
backend, but differ in the way the models are executed, as well as their performance. 
The third option for alternate execution is based on the disease code grouping. By default, 
the framework uses the Elixhauser comorbidity index, which is a pre-selected group of 
relevant diseases derived based on clinical practice. The other alternative is to use 
collapsed ICD codes to three main characters. However, in that way, the number of 
diseases in the baseline network would be high, and irrelevant codes may be present in 
the baseline network. 
In our implementation of the framework, we are interested in exploring the performance 
variations between the different alternate methods mentioned above. Therefore, we ran 
the framework on the same dataset in multiple turns. In each of the turns, we chose 
different combinations of the alternate options. Then we measured the performance of 
the framework in terms of accuracy, precision and recall percentage. The performance 
variations and possible reasons behind them are discussed in the section 5.9 offering 
insights based on the implementation context.  
4.13 Summary 
In this chapter, we have discussed in detail the methods that make up the framework. The 
conceptual definitions of the graph theory-based measures used in the framework were 
introduced and explained. From there, we discussed different components of the 
framework in the order they are to be executed on the actual dataset. Finally, we 
introduced the methods that are to be used in validating the framework. Having explained 
the framework in full detail, we now move to the next chapter, in which we apply the 
framework on the healthcare dataset and discuss the results of the implementation.  
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Chapter 5: Results and Discussions 
In this chapter, we present the empirical aspects of our implementation of the framework 
in a healthcare data context, and discuss our findings from the analysis. The underlying 
methods for the analysis have already been described in Chapter 4. Contextual 
specifications about the healthcare dataset we used for analysis have also been 
introduced in Chapter 3. We begin with the basic statistics of the dataset, followed by the 
different constraints on the filtering process. Next, we show the results for the various 
components of our analysis framework. Finally, we present the validation process of the 
framework. 
5.1 Descriptive Statistics 
We received the original dataset in the form of relational database records saved in a 
PostgreSQL database. The full dataset contains hospital admission information for around 
749,000 people who were members of a range of private healthcare funds based in 
Australia. The dataset is essentially a snapshot of these patients’ health status over the 
years for which they were a member of the heath funds and admitted to hospital for 
treatment within that period. Each patient record also includes basic information such as 
demographics and joining and termination dates (if applicable) of fund membership. 
Patients’ admission records are in another linked table: each admission record contains 
both diagnosis information, in the form of ICD-10-AM, and claim information that was 
lodged with the insurers, with details of the providers and the services provided. Table 5.1 
shows the basic properties and statistics of the original dataset that are of interest. 
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Table 5.1: Overall statistics of the dataset 
S/L Database Table Name Total Records 
Imported 
Specific Properties or Range 
1 Members 748,982 
Male 339,321 (45.3%) 
Female 409,661 (54.7%) 
2 Members having admission 405,428 
Male 180,705 (44.57%) 
Female 224,723 (55.43%) 
3 Members with diagnosis information 384,538 
Male 171,206 (44.52%) 
Female 213,332 (55.48%) 
4 Claim 19,118,056 
Earliest services 
date 
November, 
1996 
Latest service 
date June, 2015 
5 Admission 1,387,181 
Earliest 
admission date June, 2000 
Latest admission 
date June, 2015 
6 Admission diagnosis 9,346,349 
7 Claim metadata 77,224,290 
8 Provider 446,964 
9 Provider Group 1,388 
 
Table 5.1 shows that within the overall dataset population of around 749,000, the 
proportion of the female population (54.7%) is slightly larger than that of the male 
proportion (45.3%). Given that in Australia the male-to-female sex ratio at birth is 
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approximately 105:100 (ABS, 2014), the higher female proportion in the overall dataset 
may seem a bit biased. However, in reality, this imbalance is possible for several reasons. 
First, the higher male-to-female ratio in the population at birth decreases with age, 
because of the higher male mortality rate at younger ages. Second, this effect is further 
influenced by the working age group (i.e., 15–64 years) through net overseas migration, 
which historically has seen the departure of more males than females. Further, above age 
70, the male mortality rate is significantly higher than the female mortality rate. These 
facts drag down the male-to-female sex ratio as age group increases. This trend is 
particularly likely to be represented in our dataset, whose population mostly belong to 
older age groups, because young people generally do not tend to opt for private health 
cover. Therefore, as the dataset is dominated by the elderly population, which in reality 
has a higher proportion of females, the represented higher female ratio of 54.7% seems 
logical in our context. 
Also evident in Table 5.1 is the fact that not all members were admitted within the period 
that the dataset covered. Only half of the members (54%) were admitted at least once to 
hospitals. A small proportion (5%) of these admitted members do not have any diagnoses 
or disease information, leaving around 385,000 members with the valid diagnosis 
information necessary for inclusion in the framework. 
Before moving on to the analysis, we want to look at the admission trends for the whole 
population to check for any biases or significant trends that we will need to consider in the 
subsequent filtering process. Figure 5.1 shows the admission trends for the whole 
population. It includes both the total number of admissions and the number of unique 
patients accounting for those admissions on a per-month basis. Both trends show a slight 
increase over the years the data is recorded. The trend lines indicate that in every month, 
on average, around 153 more admissions took place against the increment of around 97 
unique patients. This means that average admissions per patient were increasing over the 
period. Overall rates of growth in admissions and patients are significantly higher than the 
population growth rate of Australia, which fluctuated between around 1.3% and 2.3% 
131 
 
(ABS, 2016) during the period. This indicates that more patients were joining the funds 
and therefore entering the system. Also, the ageing part of the population requires more 
admissions.  
Another noticeable feature from Figure 5.1 is the zigzag pattern in the monthly 
admissions, which pulled down admission numbers during December and January. This 
pattern can be attributed to the fact that during the holiday season, members may not 
opt for elective surgeries, because as private patients they have the privilege to choose 
times for elective surgeries. The pattern may also be attributed to the fact that the 
hospitals may be understaffed for providing non-emergency services during these periods. 
 
Figure 5.1: Monthly admission statistics for entire dataset 
After understanding these basic properties of the overall population, our next focus was 
to organise the dataset according to our predefined structure. As described in Chapter 3, 
like any other raw healthcare dataset, the original PostgreSQL format had some integrity 
issues, and data were segmented over multiple tables. The dataset also lacked strict 
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primary key–foreign key relationships across tables, and database indexes were not 
properly formed, which resulted in slow read performance. Further, the framework 
requires sending frequent read and write requests to the native database. As a result, we 
needed to transfer the required data into a Microsoft SQL Server database and organise it 
according to the research’s specific format. We will refer to the data that we fetched and 
transferred from the original database to the new SQL server as the research database. 
To do most of the database filtering, integrity checking and framework implementation, 
we developed a custom software. The software3 was built upon the .NET framework in C# 
programming language, and thus is capable of leveraging the built-in and extensively 
supported interface with Microsoft SQL Server, in which we hosted the research database. 
The first task of the software was to check for data integrity in the original database, to 
filter out the patients who either did not have any admissions or did not have any 
diagnosis information during their admissions. Next, the software identified the diabetic 
patients by looking for the diabetes-related ICD codes in the diagnosis information in the 
admission records of the valid patients. The ICD codes for diabetes are E10 to E14, so 
anyone whose diagnosis information begins with at least one of these codes was flagged 
as diabetic in the original dataset. We found a total 18,353 such patients. As we needed 
an equal number of diabetic and non-diabetic patients, and out of these estimated 18,000 
patients only a smaller sample would be used for the framework, we did not need to 
include all the available non-diabetic patients. Therefore, we randomly sampled around 
14,000 non-diabetic patients. The flagged cohorts of diabetic and non-diabetic patients 
were then copied from the original database to the research database using the software. 
The research database thus contained patients’ basic demographic information and 
complete admission history along with diagnosis codes. Table 5.2 shows the basic 
statistics of the research dataset.  
                                                            
3 Please refer to the Appendix F and J for further details of the software and screenshot of the interface. 
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Table 5.2: Basic statistics for research dataset 
 Total records 
Overall Diabetic (all forms) Non-diabetic 
Number of patients 
Overall 32,820 18,353 14,467 
Male 16,755 (51%) 10,368 (56.5%)  6,387 (44.15%) 
Female 16,065 (49%) 7,985 (43.5%) 8,080 (55.85%) 
Number of admissions 32,1249 48,790 272,459 
Average admissions per patient 9.79 2.658 18.833 
 
From Table 5.2, the first noticeable difference is the male-to-female ratio in the non-
diabetic patients. Recall that in the original dataset, the male-to-female ratio (see Table 
5.1) was about 45.3% to 54.7%. A similar ratio was found among the sampled non-diabetic 
patients in the research dataset. However, for the diabetic patients, the opposite is 
observed. The male population (56.5%) is larger than the female population (43.5%). If we 
look at known statistics on the prevalence of diabetes between genders, according to the 
Australian government (AIHW, 2016), men have a higher prevalence (60%) than women 
(40%). These statistics are for 2011–12 and include type 1, type 2 and type unknown 
diabetes, and exclude gestational diabetes, which is analogous to our diabetic population 
in the research dataset. Other research (Logue, et al., 2011) has suggested that men are 
diagnosed with type 2 diabetes at lower BMIs than women, which may contribute to the 
higher prevalence among men than women. As type 2 diabetes is the dominant type in 
our diabetic population, it is logical that this higher prevalence among males carries over 
to our dataset. Importantly, this difference also suggests that ‘sex’ may be an indicator for 
predicting risk. However, we need to do further analysis to determine whether or not this 
difference is really significant for our population. We did this analysis later on when 
testing the influence of different predictors (e.g., age, sex) in predicting risk for diabetes. 
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Having organised the research dataset, we now needed to filter out irrelevant or 
cumbersome records and select the cohorts for the analysis. Two distinct cohorts were 
required, one of diabetic patients and another of non-diabetic patients. We kept the 
cohort size the same for both cohorts so that we would not need to normalise the 
baseline networks by population size at a later stage of the analysis. Now, to select the 
cohort of diabetic patients from the research dataset, we had a total of 18,353 patients 
from which to choose. These patients have a different distribution of diabetes-related ICD 
codes (i.e., E10 to E14) on which they were initially identified. Table 5.3 shows the 
prevalence of the different types of diabetes according to the ICD codes. The type 2 
diabetic condition is more prevalent than type 1 in an 8:1 ratio, matching the Australian 
statistics for 2011–12 (AIHW, 2016), which found that around 84.9% of the estimated 
diabetic population has type 2 diabetes and 11.9% has type 1 diabetes. The table also 
shows a slightly higher prevalence of type 1 and 2 diabetes among males, especially type 
2. Other types of the condition have very little significance of representation compared to 
type 1 and type 2. Malnutrition-related diabetes is a rare condition, and the Australian 
population, especially those in the dataset (i.e., privately insured), do not tend to be 
malnourished. Therefore, as expected, malnutrition-related diabetes is absent. 
Table 5.3 (next page) shows only the absolute numbers for the different types of diabetes, 
not the comorbidities between them, as one can have multiple types of diabetes. We have 
explored these comorbidities and report them in Figure 5.2 (next page). The figure shows 
people having only type 2 diabetes (15,918 in total) as the dominating group, followed by 
individuals having only type 1 diabetes (1,357 in total). A smaller number of people (669 in 
total) have both type 1 and type 2 diabetes. Apart from this group, other combinations of 
different diabetic conditions are not significantly represented in the dataset, as suggested 
by Figure 5.2. 
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Table 5.3: Prevalence of different types of diabetes 
ICD 
code 
Description Prevalence 
Overall Male Female 
E10.* Insulin-dependent (type 1) diabetes mellitus 2,085 1,110 
(53.24%) 
975 
(46.76%) 
E11.* Non-insulin-dependent (type 2) diabetes 
mellitus 
16,812 9,584 (57%) 7,228 (43%) 
E12.* Malnutrition-related diabetes mellitus 0 0 0 
E13.* Other specified diabetes mellitus 135 62 (45.9%) 73 (54.1%) 
E14.* Unspecified diabetes mellitus 279 183 (65.6%) 96 (34.4%) 
 
 
Figure 5.2: Comorbidity pattern within different forms of diabetes 
For the diabetic patient cohort, we only considered type 2 diabetes (T2D) as the chronic 
disease, and the subsequent framework, therefore, predicts risk for T2D only. The reason 
for this is that T2D has known risk factors and is potentially preventable or manageable at 
early stages of detection, therefore making it suitable for analysis and risk prediction 
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modelling. In addition, T2D is the most prevalent of the different types of diabetes, as 
shown in Figure 5.2 and Table 5.2. In contrast, type 1 diabetes is a type of autoimmune 
disease whose causes are not definitely known; therefore, we avoided including it in the 
framework. Other types of diabetes (e.g., under E13 and E14 code groups) were also 
excluded, as their prevalences are quite low and their exact specifications are unknown. 
Thus, we now had 16,812 T2D patients from which to choose the diabetic cohort and 
14,467 non-diabetic patients from which to choose the non-diabetic cohort. The filtering 
process was performed based on a set of rules that are described in the next section. 
5.2 Criteria for Cohort Selection 
In this section, we describe the rules or criteria by which we chose the diabetic (type 2) 
and non-diabetic cohorts from the research dataset. These rules were set after we 
explored the fundamental properties of the patients in the research dataset, including the 
number of admissions per patient, time between first and last admissions, and ICD or 
diagnosis codes present in the admission histories. During this assessment, we tried to 
determine the quality of the research dataset. It was found that not all patients had 
sufficient information to be included in the cohorts. Therefore, based on these 
assessments, we determined the rules that were sequentially applied to obtain the 
cohorts. We briefly list these rules in the following subsections. Note that from this point 
on, when we mention the ‘diabetic cohort’, we always refer to the cohort of type 2 
diabetes patients. 
 5.2.1 Criteria for selecting the diabetic cohort 
1. The patient must be diagnosed with type 2 diabetes: that is, he must have the ICD 
code E11 in the diagnosis list for any admission. The admission date when the ICD 
code E11 first appeared is considered as the ‘date of first diagnosis’ in subsequent 
analysis. 
2. The patient must have at least two or more admissions before the ‘date of first 
diagnosis’. The reason for this is that without two consecutive admissions, we 
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cannot construct transitions between comorbidities across admissions, making it 
impossible to generate an individual disease network. Also, the admissions that are 
counted must have at least one valid ICD code. Due to the coding practices of 
hospitals or for some same-day admissions, ICD codes were not found for a small 
number of admissions. Without any ICD codes, there is no point in including an 
admission, and therefore such admissions were not considered. 
3. There should be at least two months (60 days) between the first admission 
(containing ICD codes) and the ‘date of first diagnosis’. This gap ensures that the 
individual disease network represents a meaningful time frame for observing 
disease development. On the other end, we did not consider any maximum 
threshold for the timeline. The research database itself represents around five and 
half years’ effective duration (September 2009 to March 2015) between which the 
admissions occurred. This by default acts as the upper threshold for time duration. 
4. The total number of admissions per year should be less than or equal to 30. 
Anyone having a greater rate than that was excluded from the cohort. Both 
number of admissions and time are counted between the first valid admission and 
the ‘date of first diagnosis’. The reason behind this rule is that some patients may 
require frequent admissions for ongoing treatments such as chemotherapy or 
kidney dialysis. These recurrent admissions are not accompanied by unique 
diagnoses or illnesses, but rather represent a course of treatment for a single 
underlying cause. Including these frequent admissions would disproportionately 
increase related comorbidities such as cancer or kidney diseases and create bias. 
Therefore, we assessed patients having chemotherapy or dialysis-related 
admissions by looking at the number of admissions they had and the time range 
over which these admissions took place. It was observed that a threshold rate of 
30 admissions per year would mostly eliminate this group of patients; therefore, 
this rate was chosen.  
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 5.2.2 Criteria for selecting the non-diabetic cohort 
1. The patient must not be diagnosed with diabetes. For clarity, this includes not only 
type 2, but all types of diabetes. It means that diabetes-related ICD codes E10–E14 
should never be present in the diagnosis list of any admission for non-diabetic 
cohort patients.  
2. As in the diabetic cohort, patients in the non-diabetic cohort must have at least 
two admissions with valid ICD codes. As non-diabetic patients do not have a ‘date 
of first diagnosis’, their entire admission history is considered to obtain the total 
number of effective admissions. 
3. As in the diabetic cohort, patients in non-diabetic cohort also must have a 
minimum amount of time to be considered for the cohort. This is set as two 
months or 60 days between their first and last admissions. This duration is 
calculated from the ‘date of admission’ of the first admission until the ‘date of 
separation’ of the last admission. 
4. As in the diabetic cohort, we considered the effect of frequent admissions related 
to ongoing services such as chemotherapy or dialysis and removed those patients 
from the cohort. However, for the non-diabetic patients, we chose the threshold 
slightly differently. Rather than choosing a threshold rate of admissions, we chose 
a ratio of admissions having ICD codes of interest. These codes, as listed in Table 
5.4, indicate healthcare services that require a high volume of admissions for a 
course of treatment. Note that, in addition to dialysis and chemotherapy, we 
included rehabilitation care as an ICD indicating frequent admissions, because we 
found that often a significant number of recurrent admissions would occur for 
rehabilitation care that may include physiotherapy or occupational therapy for the 
same course of treatment. Now, to determine the threshold ratio of these types of 
admissions, we first counted the number of admissions having those ICD codes of 
interest within the full admission history, then we divided that number by the total 
number of admissions to obtain the ratio. We observed that, for patients requiring 
frequent admissions due to ongoing treatments such as chemotherapy, this was 
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generally greater than 75%. Therefore, for the non-diabetic cohort, we only 
included patients with frequent admission ratios less than or equal to 75%. 
Table 5.4: List of ICD codes to determine frequent admissions 
ICD codes Description 
Z49.1 Haemodialysis 
Z51.1 Pharmacotherapy session for neoplasm (chemotherapy) 
Z50.9 Care involving use of rehabilitation procedure, unspecified 
 
We chose the eligible patients for the diabetic and non-diabetic cohorts by sequentially 
applying the above-mentioned criteria. Then, among the eligible patients, we randomly 
sampled 2,300 diabetic patients as the diabetic cohort and an equal number of non-
diabetic patients as the non-diabetic cohort. A multiple of ten was chosen because we 
wanted to apply k-fold validation with 𝑘 = 10 on the cohorts, requiring that the cohorts be 
divisible into ten equal-sized partitions. At this point, all cohorts had sufficient information 
for each patient and were ready to be used in the analysis. We now discuss some key 
characteristics of the final cohorts.  
5.3 Characteristics of the Diabetic and Non-diabetic Cohorts 
Figure 5.3 shows the age distribution of the diabetic and non-diabetic cohort patients. For 
the diabetic cohort, age was calculated up to the date of first diagnosis. For the non-
diabetic cohort, age was calculated up to the mid-point in time of the data duration; that 
is, if a non-diabetic patient’s dates of first and last admission are 1 January 2010 and 31 
December 2011, then the mid-date of 31 December 2010 is used to calculate that 
patient’s age. 
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Figure 5.3: Age distribution of the diabetic and non-diabetic cohorts 
Figure 5.3 shows that the age distribution of the diabetic cohort is slightly amassed to the 
right compared to the non-diabetic cohort. It also shows that most diabetic patients 
experience onset of disease at 45+ years, peaking around 60 years. This is analogous with 
the overall Australian statistics (AIHW, 2016), which show that the prevalence rate of type 
2 diabetes is 5% for 45–54 year-olds and 16% for 55–64 year-olds, almost three times 
higher. For the non-diabetic cohort, frequency in age begins to increase somewhat earlier, 
at around age 35, and peaks around 60–70 years. The older age distribution for the 
diabetic cohort suggests that age can be an indicator for predicting risk. However, some 
part of the distribution overlaps across both cohorts, which also suggests that patients 
within this range may incorrectly be predicted if we consider age as the only risk factor. 
Later on, we discuss the tests performed to identify whether or not the difference in age 
distribution is significant, and attempt to determine the effectiveness of age as a risk 
predictor.  
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Figure 5.4: Time between first and last considered admission for diabetic and non-
diabetic cohorts 
Figure 5.4 gives an idea of the distribution across the two cohorts of the effective time 
period for the analysis. For the diabetic cohort, it shows the time from the first admission 
to the date of first diagnosis. This time period can be treated as lookback period during 
which we have the data to understand what disease codes are appearing in those diabetic 
patients leading to their diagnoses. For diabetic cohort, the figure shows a slightly 
fluctuating trend over different lookback periods. The average lookback period for the 
diabetic cohort is about 2.5 years (29.5 months). For the non-diabetic cohort, a similar 
trend is observed. 
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5.4 Code Range Selection 
Having identified our diabetic and non-diabetic cohorts, the next step was to generate the 
two baseline networks from each of them. Before doing so, we needed to find the 
appropriate scope of the ICD code ranges for the analysis. We found around 7,000 
different ICD codes in the diagnosis lists accompanying admission records. As discussed in 
Chapter 4, many of these ICD codes do not indicate particular diagnoses or diseases; 
rather, they specify other attributes, such as the place of the incident. Also, some 
diagnoses, like fever or vomiting, represented in forms of the ICD code, are not necessarily 
relevant to predicting diabetes risk. Therefore, we have two options—one is to select a 
group of ICD codes that are relevant, and the other is to consider all ICD codes up to the 
first three characters. We discuss these options in the subsections below.  
 5.4.1 Selective comorbidities based on the Elixhauser index 
We used selected comorbidities as the main method of grouping ICD code ranges in the 
framework. In this method, we used a translation table that maps each comorbidity with 
its corresponding ICD codes. If any ICD codes are matched with entries in the diagnosis list 
of a patient’s admission history, the corresponding comorbidity is flagged as present for 
that admission. Therefore, the nodes in the baseline networks are not the individual ICDs, 
but rather comorbidities that indicate that the patient has at least one or more ICD codes 
related to that comorbidity. We used the Elixhauser index as the basis for the 
comorbidities. The original index had 30 comorbidities, later modified to 31 comorbidities 
(Garland, et al., 2012). Among these 31 comorbidities, two were related to diabetes. 
Because our goal is to predict risk of diabetes, we excluded these two comorbidities. Table 
5.5 shows the 29 comorbidity categories. Detailed lists of the corresponding ICD codes 
that represent these comorbidities are given in the Appendix G. 
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Table 5.5: List of Elixhauser comorbidities used in the framework 
S/L Comorbidity S/L Comorbidity 
1 Congestive heart failure 16 Lymphoma 
2 Cardiac arrhythmias 17 Metastatic cancer 
3 Valvular disease  18 Solid tumour without metastasis 
4 Pulmonary circulation disorders 19 Rheumatoid arthritis/collagen vascular 
diseases 
5 Peripheral vascular disorders 20 Coagulopathy 
6 Hypertension, uncomplicated 21 Obesity 
7 Hypertension, complicated  22 Weight loss 
8 Paralysis 23 Fluid and electrolyte disorders 
9 Other neurological disorders 24 Blood loss anaemia 
10 Chronic pulmonary disease 25 Deficiency anaemia 
11 Hypothyroidism 26 Alcohol abuse 
12 Renal failure 27 Drug abuse 
13 Liver disease 28 Psychoses 
14 Peptic ulcer disease excluding bleeding 29 Depression 
15 AIDS/HIV  
 
We used the ICD codes for the above 29 comorbidities from the listing provided by Quan 
et al. (2005). The original task was to translate the earlier version of the ICD-9-CM code for 
comorbidities and define a newer ICD-10 coding algorithm. Because the ICD standard used 
in our dataset is ICD-10-AM, we manually examined the ICD codes in the original listing 
against the corresponding ICD-10-AM codes to check whether any definitions had been 
updated. However, all the ICD codes in the original listing were the same as those in the 
ICD-10-AM code dictionary. Therefore, we did not need to modify the original ICD listings 
for the 29 comorbidities. 
Along with the Elixhauser comorbidities, we studied the literature to find what specific 
comorbidities and conditions are often prevalent in diabetic patients. The reason for doing 
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so is that the Elixhauser index was designed to predict in-hospital mortality. The chronic 
comorbidities of the index are obviously relevant in predicting diabetes risk, but they may 
exclude conditions that are related to diabetes but not to the task of predicting in-hospital 
mortality. Upon critical examination, we added six more comorbidities and health 
conditions, bringing the overall number of comorbidities to 35. The newly added 
comorbidities are listed in Table 5.6 with their corresponding ICD-10-AM codes alongside.  
Table 5.6: Comorbidities and health conditions added to Elixhauser index 
S/L (continuing from 
previous table) 
Comorbidity or health condition ICD-10-AM 
30 Cataract H25?, H26? 
31 Anaemia, unspecified D64.9 
32 History of long-term medication, insulin Z92.22 
33 Macular degeneration H35.3 
34 Presence of coronary angioplasty implant 
and grafts 
Z95.5 
35 Presence of aortocoronary bypass graft Z95.1 
 ‘?’ indicates wildcard mask: that is, ‘H25?’ means any ICD codes starting with ‘H25’ (e.g., H25.0, H25.1). 
In the above table, ‘Presence of coronary angioplasty implant and grafts’ and ‘Presence of 
aortocoronary bypass graft’ do not primarily indicate any comorbidity. Rather, they are 
health conditions that indirectly indicate underlying comorbidities for the condition that 
occurred. For example, these two conditions indicate that the patient had comorbidities 
like angina, ischemia or coronary heart disease that can lead to heart attack. These 
comorbidities are critical in predicting diabetes risk, and even though they are not 
explicitly coded, we can indirectly identify them by looking for the presence of these 
health conditions. Also, we did not merge these two health conditions with the heart-
related comorbidities already present in the Elixhauser index because these conditions do 
not occur at the same time, and we wanted to keep them logically separated. 
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As shown in Table 5.6, we also included long-term history of insulin treatment as a 
comorbidity condition. This was deemed necessary because we found a large number of 
patients in our diabetic cohort with this condition, and it has the potential to be an 
indicator. It should be noted that when someone takes insulin injections, it means that 
person is already diabetic. However, for our diabetic cohort, the effective timeframe 
considered was that before the patients were diagnosed with type 2 diabetes. The 
question then arises: why do these patients have a history of insulin medication before 
being diagnosed with type 2 diabetes? The most probable answer is that these patients 
had type 1 or another type of diabetes before being diagnosed with type 2, and needed to 
take insulin for their pre-existing, non-type-2 diabetes. This answer is particularly likely for 
type 1 diabetic patients, because type 1 is an autoimmune disease in which the pancreatic 
beta cells cannot naturally produce insulin, and therefore, patients always need to take 
insulin externally. Chances are that while treating with insulin for the other type of 
diabetes, these patients also developed type 2 diabetes, and hence it is justifiable to 
include insulin usage history in the comorbidity list. There is one limitation of this 
inclusion, which is related to coding quality. There may be chances that the patient was 
takin insulin solely for treating type 2 diabetes—because a portion of type 2 diabetes 
patients do really need to take insulin—but that those patients, despite having type 2 
diabetes, were not registered with the corresponding ICD code (e.g., E11) to indicate that 
they are type 2 diabetic, while their insulin usage was nevertheless registered. It is 
possible that this occurred because of the policy implementation issues that were 
discussed earlier (see Section 3.3.2). Nevertheless, in both cases insulin usage can function 
as a predictor for type 2 diabetes risk prediction, and hence we included it.  
 5.4.2 ICD code collapse 
As an alternate to the selected comorbidities method, we used the ICD codes to construct 
individual disease networks and the baseline network. This method is not used in the main 
framework, but rather we used it later to provide a comparison measure of performance 
against the performance results from the main method. The ICD codes were collapsed to 
146 
 
three characters indicating the core diagnosis. The remaining suffixes containing 
supplementary information about, for instance, the disease’s aetiology, anatomical site or 
severity were removed. In the diabetic and non-diabetic cohorts, we found 1,600 unique 
ICD codes when suffixes are ignored, which represents an 81.4% reduction from the total 
of 8,634 unique ICD codes when suffixes are included. Thus, this method can still capture 
individual diseases and understand their interrelations, but significantly reduces the 
volume of nodes in the overall baseline network. Unlike the selected comorbidity list 
method, the method of creating the baseline network with three-character ICD codes 
does not demand a manual selection of code groups. This creates a generic advantage 
over the selected comorbidity list, as the framework utilising the ICD code collapse 
method can be implemented without a clinical study of the associated comorbidities. On 
the other hand, because we are not filtering out or merging ICDs into groups, the code 
range is not fine-tuned, and therefore may introduce inaccuracies. As the number of 
nodes is quite large when considering individual ICD codes up to three characters, 
visualisation of the baseline network can be complex compared to the selective 
comorbidities method. Also regarding execution time, selective comorbidity is faster to 
implement than using collapsed ICD codes. The exact influence of choosing selective 
comorbidity or three-character ICD codes is measured later on in the performance and 
validation section (see Section 5.9). 
 5.4.3 Selection for socio-demographic factors 
In addition to the chosen diagnosis-related ICD codes, we chose three additional discrete 
and individual-level factors to include in the predictive model. These are (a) age, (b) sex 
and (c) behavioural risk factors.  
Age was the first individual-level risk factor we considered. As described in Section 5.3, for 
the diabetic cohort, age was calculated using the date of first diagnosis. For the non-
diabetic cohort, age was calculated using the mid-point in data duration (i.e., the date 
halfway between the date of the first admission and the separation date of the last 
admission). We note that age was only specified in years, because month and date of birth 
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were obfuscated for data privacy; nevertheless, age in years is sufficiently precise for our 
analysis. After finding the ages, we normalised the age scores within a range of 0 to 1. We 
identified the maximum age as near to 110, and therefore divided all the individual ages 
by 110 to obtain the age score to ensure that all age scores were within the range of 0 to 
1. 
The second individual-level risk factor was sex. This risk factor is essentially a categorical 
dichotomous variable, as it can have only two discrete values: male or female; however, it 
can be interpreted in different ways depending on the methods. In the validation part of 
the analysis, where binary logistic regression is used, the method automatically converts 
these categorical values to dummy variables, assigning 1 for male and 2 for female. For 
the binary classification method, variables are considered categorical. For the default 
method used in the framework, the parameter estimation model, we converted the sex 
categories into a dummy variable with -1 for male and +1 for female. The parameter 
estimation model then finds a suitable weighting factor between -1 to 1 to indicate the 
influence of sex in predicting T2D risk. The interpretation of the optimal value is as 
follows: when it is less than 0 and nearer to -1, the male risk score of -1 is multiplied by 
the negative factor, thus giving an overall positive value for male risk and negative value 
of female. This indicates higher risk association for males and lower risk association for 
females. Similarly, if the weighting factor is greater than 0 and nearer to 1, the female 
group has the higher risk association. If the sex does not have much influence in predicting 
risk, the weighting factor should give a value close or equal to 0, thus nullifying the overall 
sex score.  
The third risk factor was the behavioural risk factor. Like sex, behaviours are also 
considered as a categorical dichotomous risk factor, having two possible values: yes or no. 
However, there is a small difference in the overall combinations of sex and behavioural 
risk factors in predicting risk. The sex-based risk factor has three possible outcomes: the 
male group has a higher risk, the female group has a higher risk, or sex does not have any 
influence. For the behavioural risk factor, there are only two possibilities: either the 
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behaviour has an influence on overall risk or it does not. Therefore, in our parameter 
estimation model, we assigned 1 if the patient has behavioural risk factors present and 0 
otherwise. Binary logistic regression internally uses 1 and 2 as the dummy variable to 
indicate absence or presence of the risk factor, while binary tree classification uses the 
categorical variable as it is. In our framework, we examined smoking or tobacco use as the 
behavioural risk factor. Two ICD codes were checked to determine the presence of the risk 
factors. The first one was Z86.43, which indicates ‘Personal history of tobacco use 
disorder’, and the second was Z72.0, which indicates ‘Tobacco use (current)’. If either of 
these two ICD codes are present in any of the admissions within the effective lookback 
time for the patient, that patient’s behavioural risk factor is flagged as ‘yes’. Table 5.7 
provides a summary of individual risk factors. 
Table 5.7: Individual risk factors related to demographics and behaviour 
Risk 
factor 
Type of variable Possible values 
Age Continuous 0 to 1, normalised by dividing age (in years) by 110 
(maximum age). 
Sex Categorical 
dichotomous 
In parameter estimation model, -1 for male, 1 for 
female. 
In binary logistic regression 1 for female, 2 for male. 
Binary tree classification use categorical values as 
they are. 
Behaviour Categorical 
dichotomous 
In parameter estimation model, 1 for presence of 
factor, 0 otherwise. 
In binary logistic regression 1 for absence, 2 for 
presence.  
Binary tree classification use categorical values as 
they are. 
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5.5 Comparison Across Three Baseline Networks 
At this stage of the analysis, we generated the positive baseline network from the diabetic 
patient cohort and the negative baseline network from the non-diabetic patient cohort. As 
discussed earlier, we used selective comorbidities that grouped related ICD codes into one 
comorbidity category. Therefore, the nodes in these two baseline networks represent 
comorbidities and the edges represent transitions between comorbidities in subsequent 
admissions. Overall, these two baseline networks represent the health trajectories of the 
diabetic and non-diabetic patients. From these two networks, we calculated the 
difference by attribute adjustment and generated the final and summary baseline 
network4 that represents the unique properties of diabetic patients. We then calculated 
several network and corresponding node-level measures to understand the features of 
these three baseline networks. In this section, we discuss the findings from these 
networks. Figure 5.5 shows a block diagram of the three networks leading to the network 
and node level comparison. 
 
Figure 5.5: The three baseline networks and their network and node level comparison 
                                                            
4 Henceforth, we will refer this as final baseline network. Later on, when we discuss the prediction, we will 
simply refer this as baseline network, as this is the only network present at that stage. Therefore, whenever 
we simply mention Baseline Network in this thesis it will always refer to final baseline network.  
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First, we present the network-level measures of three baseline networks in Table 5.8. It is 
important to note that we used k-fold (𝑘 = 10) validation, as discussed in Chapter 4 (see 
Section 4.11.1). Therefore, we divided each cohort into 10 equal-sized partitions, then 
generated the baseline networks and subsequent risk prediction and validation 
components 10 times, each time using a different combination of partitions. This means 
that the baseline networks had 10 different versions as generated from the different 
partitions. It is not practical to report each of them individually; besides, the statistics 
were found to be quite similar across each iteration (see Section 5.9 for comparison). 
Therefore, we report the results of the baseline networks as obtained from the first fold 
(i.e., fold-0). In this fold, the first 6 partitions out of 10 were used to generate baseline 
networks that include 1,380 (i.e., 230 × 6) diabetic patients from the diabetic cohort and 
an equal number of non-diabetic patients from the other cohort.  
Table 5.8: Network properties of three Baseline Networks (BN) 
Criteria Positive BN Negative BN Final (summary) BN 
Number of nodes 34 33 34 
Number of edges 658 367 658 
Modularity 0.197 0.345 .045 to .055 
Number of communities 3 6 3 
Network diameter  3 3 3 
Average path length 1.453 1.654 1.453 
Graph density 0.586 0.348 0.586 
Average Clustering Co-efficient 0.72 0.579 0.72 
 
Table 5.8 shows that all three baseline networks show an almost equal number of nodes. 
This is not surprising, because we had already selected the groups of ICD codes that would 
be translated into single comorbidities. This increased the chance that there would be at 
least one ICD code from each of the comorbidities from each of the cohorts, and therefore 
that all three baseline networks would have the comorbidity. Among the 35 selective 
151 
 
comorbidities, HIV/AIDS is absent from the whole dataset, which is also normal. The 
negative baseline network also does not have the node indicating ‘long-term insulin use’, 
and thus has one less node than the other two. This is fitting with our previous discussion 
on including this health condition in the list. Insulin intake is a good predictor of type 2 
diabetes, as it means the patient has some type of diabetes. For our present case, it 
means the patient has type 1 or any other type of diabetes excluding type 2. (type 1 is the 
most probable case as it is more prevalent). For these types of diabetes, they are taking 
insulin indicating the patients already have metabolic problems. These conditions 
eventually lead to type 2 diabetes, thus making insulin intake a good predictor. Even if the 
patient actually was taking insulin solely for the purpose of managing a case of type 2 
diabetes not recorded in the admission data until after some period of insulin intake, the 
positive and negative baseline networks correctly reflect this—no non-diabetic patient 
takes insulin, and those who take insulin to manage other types of diabetes eventually 
develop type 2 diabetes, therefore making it a good predictor. 
The edge count in the positive baseline network is almost double that of the negative 
baseline network. This indicates that the positive baseline network is more dense or 
saturated: that is, diabetic patients have more transitions between comorbidities in 
subsequent admissions. This also suggests that diabetic patients have relatively more 
admissions and/or more exclusive comorbidities in subsequent admissions, thus 
increasing the edge count. The high graph density value for the positive baseline network 
also strengthens this fact. Graph density is the measure of edge saturation: that is, how 
many edges are present compared to the total possible number of edges. For the positive 
baseline network, the graph density is 58.6%, indicating that almost 6 out of every 10 
possible transitions are present, which is nearly double the rate of the negative baseline 
network (i.e., 34.8%, see Table 5.8 above). This high number of transitions in the positive 
baseline network indicates that diabetic patients represent a higher admissions burden 
and complex progression pathways over subsequent admissions. 
152 
 
We see an opposite picture for the modularity property: the negative baseline network 
has almost double the modularity of the positive one. Modularity is the measure of 
clustering, or the community formation tendency among the nodes. A cluster or 
community is a group of nodes that are closely interconnected compared to the others. It 
is expressed as a value between 0 and 1 inclusive, where 1 indicates the highest 
modularity and 0 indicates no modularity. To obtain a higher modularity score, the 
network would normally have some groups of nodes that have a high number of edges 
among themselves and a lower number of edges with nodes of different groups. As we 
have observed, diabetic patients have a large number of (58.6% of all possible) transitions 
between comorbidities; therefore, there is less chance that some nodes will have dense 
transitions between themselves and sparse transitions with others. In contrast, there are 
fewer transitions for the non-diabetic patients; therefore, they have a higher chance of 
group or community formation, and hence have a higher (almost double) modularity than 
the positive baseline network. Nevertheless, from a network standpoint, both modularity 
scores are still quite small, probably because we pre-fixed the maximum number of nodes 
(i.e., comorbidities) to 35. We may encounter higher modularity where the node size is 
larger. Apart from these two baseline networks, we now see the measure of the third 
network i.e., the final baseline network (to recall this network, please see Figure 5.5 at the 
beginning of this section). This final baseline network has a very small modularity as 
evident from the Table 5.8. This is because we generated this network via attribute 
adjustment. The edge frequency (i.e., edge attribute), which indicates frequency of 
transitions in both positive and baseline networks and was actually a large number in 
many cases, was normalised between 0 and 1. As the modularity algorithm takes edge 
frequency into account, the final baseline network received a lower modularity score. In 
reality, the final summary baseline network is not structurally different from the positive 
baseline network, as the summary baseline network is essentially a set union of nodes and 
edges of positive and negative baseline networks. For this research, we can observe that 
all of the summary baseline network’s structure was inherited from the positive baseline 
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network, with only a portion that has been attribute-adjusted from the negative baseline 
network.  
The number of communities is the outcome of modularity detection. A community is a 
group of nodes which have relatively more interconnection within themselves compared 
to the connection with other nodes. As discussed in the previous section, the negative 
baseline network has higher modularity than the positive one, and we can see that the 
resultant number of communities (i.e., 6) is also double than that of the positive baseline 
network (i.e., 3). The final baseline network also generated three communities despite its 
significantly lower modularity because it has a similar transition structure to the positive 
baseline network. We should note that modularity does not strictly correlate with the 
number of communities. Rather, modularity more closely indicates the quality of the 
communities, that is, how closely knitted the communities are. As we have observed that 
the baseline networks, especially the final one, have low modularity and a small number 
of communities, this indicates that the quality or interconnectedness of the communities 
is not very strong. The overall transition between nodes within the same community is 
probably not significantly different from the overall transition across inter-community 
nodes. This gives an indication that the cluster match score, which explicitly examines the 
similarities with the baseline network’s community structure to predict risk for the test 
patient, may not be very influential because the baseline network’s community structure 
is not very well formed. We test this influence in detail in Section 5.7. 
The remaining two measures—average path length and average clustering coefficient—do 
not exhibit important features in the present context. Path length is the distance between 
two nodes in terms of ‘hops’. For the positive and final summary baseline networks, every 
node is reachable from other nodes through 1.45 hops on average, and for the negative 
baseline network, the distance is slightly greater (1.65). This is because the nodes are 
connected by a large number of edges, thereby creating short-circuits and lowering 
average path length. It should be noted that relation between edge count and average 
path length is non-linear and depends on how the edges are attached to the nodes. 
154 
 
Generally, for the real-world networks, there is a certain threshold range, within which the 
increment of edge count quickly lowers the average path length. After that, if more edges 
are added, they do not provide many shortcuts to reach other nodes, i.e., do not lower 
the average path length much. In our case, we noted before that not all the edges are 
present in the three baseline networks and for the negative baseline network it is even 
smaller. Nevertheless, the number of edges present is big enough to lower the average 
path length to reach very small range (i.e., 1.45 to 1.65) for all three baseline networks. 
The next measure - clustering coefficient is the ratio of triangle structures, that is, three 
comorbidities having all of the six possible transitions between them. This coefficient is 
higher in the positive and summary baseline networks because they have a higher edge 
count. 
Having examined the network structure of the three baseline structures, we now turn to 
discuss the individual-level properties of the baseline networks: the prevalent comorbidity 
and transition pattern before and after attribute adjustment is implemented.  
5.6 Findings for Attribution Effects 
The final baseline network derived from the positive and negative baseline networks 
represents unique characteristics of progression. Having considered the attribution effect 
across the diabetic and non-diabetic cohorts, the resultant baseline network assigns a 
higher weight to comorbidities (i.e., node frequency) and their progression (i.e., edge 
frequency) for those that are more prevalent in diabetic patients. In the following 
subsections, we look at comorbidities and transitions that are prevalent in the diabetic 
and non-diabetic cohorts, and discuss the ones that have attributed more to the final 
baseline network. Further, we discuss the community or cluster formation in the baseline 
network.  
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 5.6.1 Prevalent comorbidities 
Table 5.9 shows the top 10 most prevalent comorbidities in the positive and negative 
baseline networks. We can easily notice that the top comorbidities listed in the positive 
baseline network show significantly higher prevalence compared to the negative baseline 
network. For example, the most prevalent comorbidity in diabetic patients (cardiac 
arrhythmias) has nearly 7,000 cases), where even the most prevalent comorbidity for the 
non-diabetic patients has just over 1,200 cases and cardiac arrhythmias did not came in 
the top list in non-diabetic patients. A similar trend is observed in the other ranks. 
Because both networks are derived from the same number of patients, this suggests a 
complex and frequent comorbidity burden for the diabetic patients. 
Table 5.9: Top 10 most prevalent diseases for diabetic and non-diabetic patients 
S/L 
Diabetic patient (+ve baseline 
network) 
 Non-diabetic patient (-ve baseline 
network) 
Comorbidity condition Prevalence   Comorbidity condition Prevalence  
1 Cardiac arrhythmias 6,938  Depression 1,284 
2 Solid tumour without 
metastasis 
5,314  Solid tumour without 
metastasis 
1,102 
3 Metastatic cancer 2,955  Metastatic cancer 706 
4 Cataract 2,093  Renal failure 426 
5 Depression 821  Other neurological 
disorders 
411 
6 Hypertension, 
uncomplicated 
712  Weight loss 228 
7 Renal failure 660  Alcohol abuse 187 
8 Anaemia, unspecified 391  Lymphoma 176 
9 Congestive heart failure 387  Drug abuse 159 
10 Alcohol abuse 386  Chronic pulmonary disease 149 
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From Table 5.9, it is also evident that there are differences between the two networks in 
terms of the prevalence of the same comorbidities: that is, some comorbidities are more 
prevalent in one of the two networks. For example, the most prevalent comorbidity in the 
positive baseline network (cardiac arrhythmias) is absent from the top 10 list of the 
negative baseline network. Solid tumour without metastasis is almost five times more 
prevalent in diabetic patients, although both networks have it as the second highest 
comorbidity. This indicates that these comorbidities are more associated with diabetes. 
Conversely, some comorbidities are more prevalent in non-diabetic patients (e.g., 
depression, weight loss), therefore indicating that these are not really associated with 
determining diabetes risk. Thus, based on the relative differences in individual-level 
properties—that is, via attribute adjustment of comorbidities and transitions—we 
assigned the risk factors in the final summary baseline network. The algorithm for 
attribute adjustment is given in the subsection 4.8. It should be noted that after the 
attribute adjustment, the score for risk factors are normalised for the final baseline 
network, i.e., the values are represented in the range between 0 and 1 inclusive. Figure 
5.6 shows the top 10 comorbidities or conditions that attributed most for diabetic patients 
in the final baseline network. 
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Figure 5.6: Top 10 comorbidities and conditions that attributed most for diabetes 
patients 
The figure shows that the highest weight of 1 is given to ‘cardiac arrhythmias’ and ‘long-
term use of insulin’. Cardiac arrhythmias was the most prevalent comorbidity in the 
positive baseline network, and also had a very small prevalence in the negative baseline 
network, therefore achieving a high ratio in attribute adjustment. Because this was the 
maximum ratio, it was given the weight of 1 and all other weights were scaled between 0 
and 1 accordingly. As discussed earlier, long-term use of insulin was exclusive to diabetic 
patients. Therefore, although its prevalence did not make the top 10 list in the positive 
baseline network, it received the highest prevalence score in the final baseline network. 
Except for liver disease and cataracts, the other comorbidities received scores of less than 
0.2 as prevalence or node attributes. This reflects the fact observed earlier that most 
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comorbidities in diabetic patients are also present in non-diabetic patients, often with 
little differentiation. 
 5.6.2 Prevalent transition patterns 
We now look at the transition pattern between the comorbidities in the final baseline 
network. Table 5.10 shows the most significant transitions, that is, the transitions with the 
highest edge weight attribute. For this reporting, we included only unique transitions and 
excluded self-loops, or transitions to the comorbidity itself in subsequent admissions; 
however, self-loops were kept in the baseline network for risk prediction. The prevalent 
transitions show many comorbidities are associated with heart-related problems like 
valvular disease or congestive heart failure. The inter-related comorbidity transition 
pattern for the diabetic patient is also evident from the table. For example, the most 
common transition—from renal failure to valvular disease—indicates problems in two 
different body systems. Renal failure is a kidney disease; for diabetic patients, lack or 
imbalance of insulin production can lead to high blood sugar levels. This makes the 
kidneys filter too much blood to get rid of the excess sugar, and the excessive strain can 
lead to kidney disease (American Diabetes Association, 2013). Factored with old age, late 
diagnosis and other comorbidities, this can lead to renal failure. On the other hand, 
valvular disease is a disease associated with the four valves present in the heart (National 
Heart, 2015). Its risk factors include other heart diseases, obesity and diabetes (Benjamin, 
et al., 1994). Now, renal failure and valvular disease may appear unrelated, but for 
diabetic patients this is a common transition, as diabetes is a risk factor for both. As we 
have observed that the baseline network’s highest edge attribute value is assigned to this 
progression, this indicates that the transition from renal failure to valvular disease is 
nearly exclusive to diabetic patients compared to non-diabetic. The other top transitions 
shown in Table 5.10 indicate similar exclusiveness for diabetic patients, having edge 
attributes of over .99 (not shown in the table) on a scale of 0 to 1.  
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Table 5.10: Top 10 most frequent progressions between comorbidities or health 
conditions in subsequent admissions according to the final baseline network 
Initial condition Next condition 
Renal failure Valvular disease  
Deficiency anaemia Solid tumour without metastasis 
Presence of coronary angioplasty implant and 
graft 
Congestive heart failure 
Solid tumour without metastasis Other neurological disorders 
Renal failure Hypertension uncomplicated 
Metastatic cancer Renal failure 
Hypertension uncomplicated Presence of coronary angioplasty implant 
and graft 
Cataract Congestive heart failure 
Solid tumour without metastasis Renal failure 
Solid tumour without metastasis Chronic pulmonary disease 
 
At this point, we provide a visualisation of the final baseline network. As we used selective 
comorbidities for this network, the number of nodes is restricted to a number small 
enough that we can show all the node labels. Figure 5.7 shows the final baseline network. 
We used gephi (Bastian, et al., 2009), a social network analysis software to generate the 
figure. In the figure, each node represents a particular comorbidity or health condition 
and is mentioned on the label. The sizes of the nodes and labels are proportional to their 
corresponding prevalence. The colours of the nodes and label outlines indicate the cluster 
they belong to. We discuss cluster membership in the next subsection. We applied a 
force-directed graph layout to position the nodes in such a way that fewer edge overlaps 
occur between them. This eventually places nodes with high co-occurrences in closer 
proximity, thus facilitating the visualisation of cluster formation. The baseline network 
shows ‘cardiac arrhythmias’ and ‘prediabetes medication’ (insulin usage) dominating the 
network. The network shows a large number of edges between the nodes, with the colour 
indicating the cluster they are originating from. Although the edge thickness was set to be 
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proportional to edge weight, this is not very clear in the visualisation, because a large 
number of edges have high weights with relatively little difference between them, 
therefore giving the impression that the edges have an equal thickness in the baseline 
network.  
 
Figure 5.7: Baseline network after attribute adjustment 
 5.6.3 Clustering membership in baseline network 
We applied cluster or community detection algorithm proposed by Blondel et al. (2008). 
We have already discussed the algorithm in details in section 4.3.2. The algorithm was 
built-in the Gephi software which was used for detecting the clusters. We found three 
clusters in the baseline network. As we discussed earlier in Section 5.5 related to the 
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network properties of baseline networks, the modularity score is not very high, indicating 
that the baseline network does not exhibit a strong community structure. This is because 
diabetic patients have quite complex and extensive disease trajectories, thus making the 
positive and final baseline network quite saturated. Nevertheless, the algorithm found 
three distinct communities that have stronger transitions between comorbidities within 
the group. In the previous Figure 5.7, we saw the membership and approximate structure 
of the clusters within the baseline network. We now list the individual clustered 
comorbidities in Table 5.11. 
We can see that the clusters are of relatively equal size in terms of comorbidity count. 
Cluster 1 has the highest number of comorbidities (i.e., 13). The comorbidities within this 
cluster are mostly related to heart diseases, as we can observe cardiac arrhythmias, 
hypertension, the presence of bypass grafts and chronic pulmonary disease included in 
the cluster. We also observe cancer and anaemia-related comorbidities as members of 
Cluster 1.  
Cluster 2 shows the long-term use of insulin and liver disease as the most prevalent 
comorbidities within the cluster. This membership is significant because of the 
pathophysiological relations between these two and diabetes. We attempt to describe 
this briefly. Two vital hormones are secreted by the pancreas that play a significant role in 
regulating blood glucose level: these are insulin and glucagon. When we have a major 
meal, blood glucose level rises sharply, and the insulin is released from the pancreas to 
maintain the balance. Insulin increases glucose uptake in muscle and adipose tissue and 
promotes glycolysis (i.e., breaking down of glucose) and glycogenesis (i.e., glycogen 
formation from glucose) in liver and muscle (Szablewski, 2011). Thus insulin helps to lower 
the glucose level. Conversely, when blood glucose level falls low, glucagon is released that 
promotes glucose production and elevates glucose concentration to normal. This vital 
process of balancing insulin and glucagon to maintain blood glucose is called ‘glucose 
homeostasis’, and the liver plays an important role in it. The liver is the principal site of 
glucose deposition when insulin is released to lower blood glucose (Sherwin, 1980). 
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Table 5.11: Cluster membership among comorbidities in the baseline network listed 
according to the prevalence rate 
S/L Cluster 1 Cluster 2 Cluster 3 
1 Cardiac arrhythmias Long-term use of insulin Cataract 
2 Hypertension, 
uncomplicated 
Liver disease Presence of coronary 
angioplasty implant and 
graft 
3 Presence of aortocoronary 
bypass graft 
Valvular disease  Congestive heart failure 
4 Deficiency anaemia Macular degeneration Pulmonary circulation 
Disorders 
5 Hypertension, complicated  Fluid and electrolyte 
disorders 
Coagulopathy 
6 Solid tumour without 
metastasis 
Obesity Anaemia unspecified 
7 Metastatic cancer Alcohol abuse Peripheral vascular 
disorders 
8 Blood loss anaemia Other neurological 
disorders 
Lymphoma 
9 Renal failure Psychoses Rheumatoid 
arthritis/collagen vascular 
diseases 
10 Paralysis Depression  
11 Chronic pulmonary disease Drug abuse  
12 Hypothyroidism Weight loss  
13 Peptic ulcer disease 
excluding bleeding 
  
 
When the body is in a fasting state and glucose levels decrease, the liver is solely 
responsible for the delivery of glucose to the bloodstream. Now, if the body (i.e., muscle, 
fat and liver) cannot use the insulin effectively, this can lead to insulin resistance, higher 
blood glucose concentration and eventually type 2 diabetes. In the case of insulin 
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resistance, beta cells in the pancreas continue trying to lower the glucose level by 
increasing insulin production, as the normal level of insulin is not working efficiently. At a 
certain point in time, the beta cells fail to keep up with increased demand for insulin, 
leading to diabetes (National Institute of Diabetes and Digestive and Kidney Diseases, 
2014) and requiring external insulin uptake. On the other end, abnormal glucose 
homoeostasis can lead to liver diseases because of its central role in the process. 
Therefore, we can observe the relation between liver disease and insulin uptake, and their 
prevalence and membership within the same cluster.  
Among the other comorbidities in Cluster 2, we can observe the behavioural and related 
disorders (e.g., depression, psychoses, drug and alcohol abuse). Obesity and weight loss 
can also be related to depression or drug abuse. Therefore, their inclusion in the same 
cluster makes sense. 
Cluster 3 has the smallest number of comorbidities (i.e., 9). We can notice few heart-
related comorbidities and conditions present in this cluster, such as the presence of, for 
example, coronary angioplasty implants and grafts, congestive heart failure and 
pulmonary circulation disorders. The other cluster memberships are not of great 
importance to discuss here.  
This concludes the discussion of the findings on the first part of the framework—
constructing the baseline network through attribution adjustment. In summary, we used 
the first 6 of 10 partitions as part of fold-0 to create the baseline network. This gave us a 
total of 1,380 diabetic and an equal number of non-diabetic patients to form the baseline 
network. In the next section, we discuss the risk prediction part of the framework. 
5.7 Parameter Estimation 
In this part, we generate the predictive model and analyse the effect and contribution of 
parameters in the model. Recall that we have identified a total of six parameters 
potentially contributing to disease risk: two are demographic (age and sex), one is 
behavioural (tobacco use status), two are graph similarity-matching (node and pattern 
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match scores) and the last is social network-based cluster matching. The next step is to 
generate the predictive model that estimates the various contributions of the parameters 
in the model.  
As discussed in the framework section, we employed three types of predictive modelling: 
the default parameter estimation model proposed by us, binary logistic regression and 
binary tree classification. The first two models assume a linear relationship between the 
parameters, and the influence of the parameters is interpreted via their weighting factors. 
The third model, the binary tree classification model, is not a linear or strictly 
mathematical model, but rather is widely used as a data mining method. This classification 
method determines a sequence of optimum boundary check rules on the parameters to 
classify them into one of the predicted outcomes. The parameter’s influence is 
determined as an ‘importance measure’, which is a direct numerical measure. All of the 
parameter estimation methods used need a training set of patients whose risk outcome is 
known. As we had divided the cohorts into 10 partitions, we used the 7th, 8th and 9th 
partitions for training. This gave us 690 (i.e., 230 × 3) diabetic patients from the diabetic 
cohort and an equal number of non-diabetic patients from the other cohort eligible to be 
included in the training. Recall that the 1st to 6th partitions (total 2,760 patients from both 
cohorts) were used to generate the baseline networks. Figure 5.8 shows the part of the 
framework that performs the analysis related to parameter estimation. 
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Figure 5.8: Parameter estimation component of the framework 
As shown in Figure 5.8, we first compared each patient’s individual disease network in the 
training network with the baseline network and calculated the graph similarity and cluster 
match scores. The other demographic and behavioural risk scores do not need a baseline 
network for comparison, as they are simply individual risk scores. Thus, we obtained six 
risk scores for each patient whose outcome was known (i.e., we knew whether or not 
these patients would eventually develop type 2 diabetes). Therefore, in the prediction 
model, we assume that the ‘actual risk’ is the dependent variable and the six risk factors 
(i.e., age, sex, behavioural factors, graph node match scores) are independent variables.  
Once we had obtained values for the independent variables for each test patient, we tried 
to explore their relationship with the dependent variables. As the primary step, we 
generated scatter plots for each of the independent variables with the dependent 
variables. The scatterplot matrices are shown in Figure 5.9. 
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Figure 5.9: Scatterplot matrices for the risk factors 
In all the scatterplot matrices of the above figure, we have at least one categorical 
variable (i.e., the dependent variable). Therefore, the scatterplot does not form a 
continuum. When both of the variables are categorical (e.g., sex vs. outcome and 
behavioural risk vs. outcome), there are only four spots where the points can be placed. 
Therefore, we used a jitter function, which randomly shifts the points slightly across the 
categorical variables’ own axis. We also set small transparencies for the points to 
distinguish between the overlapping scores. As mentioned, one or both of the scatterplot 
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variables can be categorical. Therefore, we look for a virtual horizontal division line that 
can effectively separate the points into the opposite side of the division line. If the points 
evenly reside on both sides of the division line, it indicates that their relation is not one of 
directly correlation. For Figure 5.9 (c) and (e), we can see that sex and behavioural risk 
factors seem to be evenly distributed vertically, and they cannot be separated, as 
observed from plain inspection. The same applies for the behavioural risk factors, and we 
can sense that these two risk factors may not be influential in the linear prediction 
modelling (i.e., in the parameter estimation model and binary logistic regression model). 
The binary classification may give some importance to these two because it is not strictly a 
linear model. For the scatterplot of age vs. outcome (Figure 5.9 (a)), we can observe a 
trend towards higher age risk scores for the diabetic patients. Even so, if we think of a 
horizontal threshold line, and a large number of age scores belonging to non-diabetic 
patients fall above the threshold line, these points will give false positive scores if we 
consider age as the only variable. Next, in Figure 5.9 (b), we can see that the graph node 
match score vs. outcome shows a stronger trend than the others. It shows that most of 
the diabetic patients received higher graph node match scores than the non-diabetic 
patients. And the latter cohort’s node match scores have been gravitated towards the 
zero line. This gives us the idea that graph node match score should be a good predictor. 
However, just by looking at the scatterplot, we cannot obtain the exact parameter 
evaluation and accuracy results. We need to generate the predictive model using the 
three methods mentioned. In the following subsections, we discuss the contribution of 
the risk factors as obtained from each of the methods.  
 5.7.1 Influence of risk factors from parameter estimation model 
The parameter estimation model iteratively finds optimal parameter values against each 
of the independent variables so that the overall scores for the diabetic patients are above 
a certain threshold and scores for the non-diabetic patients are below that threshold. For 
this analysis, the independent variables that are categorical were converted to dummy 
variables. The weighting factor range was selected as -1 to 2 inclusive. It should be noted 
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that earlier (in section 4.10) we mentioned that weighting factors are normally chosen 
within -1 to 1 inclusive. And, then the model iterates through possible combinations of 
weighting factors and finds the optimal weighting factors for each the risk factors. The 
significance is that if the optimal weighting factor is negative, it indicates corresponding 
risk factor affects the prediction negatively. In other words, the more the risk factor value, 
the less chance of having the chronic disease and vice versa. If the optimum weighting 
factor is 0, that means the risk factor does not have any influence on the prediction. Now, 
the relation between multiple optimal weighting factors is relative. If a model has two risk 
factors, then having an optimal weighting factor of 0.9 and 0.3 is same as having optimal 
weighting factors of 0.3 and 0.1, i.e., as long as the ratio is same between the optimal 
weighting factors and the threshold for prediction scales accordingly. For simplicity, we 
normally choose a range of -1 and 1 within which the model looks for optimal values. 
However, in our experiment, we chose a wider range to start with, i.e., from -1 to 2, and 
reported as such. Therefore, some of the optimal weighting factors may have become 
more than 1 while reporting later on. As we mentioned, optimal values are relative, 
therefore, choosing the range of -1 and 1 during the experiment would not affect the 
prediction outcome and accuracy in any way. It would just scale down the weighting 
factors and threshold accordingly. Now, we report the optimum weighting factors for the 
risk factors in Table 5.12. The result was obtained from the execution of fold-0; other folds 
gave similar results. 
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Table 5.12: Optimal weighting factors from parameter estimation model 
Risk factor  Optimal weighting factor 
Age 0.201 
Sex 0 
Behaviour 0.00001 
Graph node match 1.04 
Graph pattern match 0.1001 
Cluster match 0.0001 
 
The table shows that the graph node match score made the most important contribution 
to predicting the risk score, setting a weighting factor of 1.04. This is actually a promising 
result as graph node match score is one of the fundamental contributions proposed in our 
thesis. We can recall from the definition of graph node match score (see section 4.9.2, in 
“Graph node match score” part) that the score increases when the test patient’s 
comorbidities and their frequencies largely overlap with those in the baseline network. A 
high importance of this node match score, therefore, indicates that this proposed 
network-based measure is really influential in prediction. Also, it reinforces that the 
comorbidities and their frequencies differ significantly between diabetic and non-diabetic 
patients as captured by our baseline network. 
The second most important contribution is attributed to the age score, with a weighting 
factor of 0.2, which is significantly smaller than the previous one. The reason is probably 
because age score does not differ as much as node match score does between diabetic 
and non-diabetic patients. This can be seen from the earlier Figure 5.9 (a). Almost all 
diabetic patients have age scores higher than 0.4 (equivalent to 44 years, when not 
normalised). This is analogous with the clinical observation that most diagnoses of type 2 
diabetes occur after age 45 (American Diabetes Association, 2014). However, if we look at 
the age score of non-diabetic patients, we can see that a significant portion of them also 
have similar high age scores, i.e., greater than 0.4. Therefore, age cannot be a very good 
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predictor alone, as a significant number of non-diabetic patients are also as old as the 
diabetic patients. The third highest weighting factor having the value of 0.1 is attributed to 
the graph pattern match score, which is almost half that of the age risk score. The pattern 
match score matches the disease transition patterns of test patients with the baseline 
network. A test patient’s disease progression network is often sparse due to the low 
number of admission count in the dataset which results in a lower number of transition 
patterns. Subsequently, the resultant pattern match score might be too much granular for 
the dataset without capturing significant information. Hence, between diabetic and non-
diabetic patients, graph pattern match score did not differ much compared to the other 
two more significant predictors, i.e., graph node match score and age score. 
The other three risk factors did not achieve much significance in terms of their weighting 
factors. A discussion on why these three risk factors have lower or no significance is given 
later towards the end of this section. But before that, we look into the result of the other 
two models in order to observe whether they are giving similar results or not. 
 5.7.2 Influence of risk factors from logistic regression 
The binary logistic regression method models the dependent variable (i.e., the outcome) 
as the odd ratio against the linear sum of independent variables, each of which has a 
coefficient as a multiplying factor. For this analysis, the categorical variables were also 
converted to dummy variables before implementing the model. We ran the model in the 
‘R’ programming language. The exact code to execute the model is given in the Appendix 
H. We report the coefficient values in the Table 5.13. The result is obtained from the 
execution of fold-0; other folds gave similar results. 
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Table 5.13: Coefficient values against risk factors in binary logistic regression model 
Risk factor  Coefficient value 
Age 6.20462 
Sex -0.14172 
Behaviour 0.1749 
Graph node match 27.37487 
Graph pattern match 1.96632 
Cluster match 0.87465 
 
The table shows that the graph node match score again made the most important 
contribution to predicting the risk, obtaining a coefficient value of 27.37. This indicates 
that with each increase in the graph node match score, the log odds of developing 
diabetes were increased by 27.37. The second most important contribution is again 
attributed to the age score, with a coefficient value of 6.2. The graph pattern match score 
attracted the third highest weighting factor. These results are analogous with those of the 
parameter estimation model. 
 5.7.3 Influence of risk factors from binary tree classification method 
The binary tree classification method sequentially splits the training set of patients into 
two groups based on the range condition of any of the independent variables. The 
resultant two groups are either assigned with a prediction outcome or are further split 
again based on another range condition. We implemented the binary tree classification 
method on the dataset using the ‘rpart’ package in ‘R’ language. The relevant code listing 
is given in the Appendix. For most of the iteration over 10 folds, the binary tree 
classification made three splits: firstly based on graph node score, secondly based on age 
score and finally on pattern match score. For two cases, an additional split was made on 
the cluster match score. Also, in three cases, there was only one split based on the graph 
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node match score. Figure 5.10 shows the classification tree generated from the fold-0 
iteration, which has three splits. 
 
Figure 5.10: Classification tree generated from the binary tree classification method 
(output from fold-0 iteration) 
In the figure, we can see that three splits were made based on two risk factors, i.e., graph 
node (gNode) and age, in that order. Graph pattern match score did not come significantly 
in the fold-0. This is because the other two risk factors in the first three splits gave optimal 
accuracy according to the tree classification algorithm. From the figure it might seem that 
the second and third split based on the age score can be summarised and executed as one 
single split, i.e., with the condition: 𝑎𝑒𝑑 <  .3364. However, the algorithm still made two 
successive splits on the same risk score. Actually, this is possible according to the way the 
binary tree classification algorithm (Breiman, et al., 1984) works. The algorithm grows the 
tree by progressively splitting the tree based on one risk factor at a time. In each split, it 
does not know in advance about the next split condition. The algorithm is based on 
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heuristics or optimal assumption. According to that, in each split, the algorithm chooses 
one risk factor and boundary condition so that the drop in impurity is maximal (along with 
some other conditions). Impurity (Loh, 2011) is a measure of how well the tree splits the 
data based on factors such as misclassification count after split etc. Several measures of 
impurity exist, e.g., node impurity, entropy impurity, Gini index etc. Regardless of the 
impurity measure, the choice of risk factor during a split is based on local criteria. Hence, 
the second split was based on a boundary condition on age score (i.e., 𝑎𝑒𝑑 <  .5045). 
And when the decision of the third split was needed, the algorithm again found age as the 
optimal risk score to split on. There are ways to minimise or summarise the splits after 
generating the tree e.g., through pruning. As our tree was not very big, we did not apply 
pruning and reported the result as it is.  
The tree classification method outputs the relative importance of the individual 
parameters. For most of the cases in the 10 iterations, only three parameters were given 
importance. The remaining three, which are behaviour risk score, sex score and cluster 
match score, were not given any importance scores for most of the cases, as they were 
not utilised in the classification tree output. The importance scores assigned against each 
risk score over the 10 folds are shown in Figure 5.11. 
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Figure 5.11: Parameter importance over 10 folds in tree classification method 
(behaviour risk factor not shown) 
Figure 5.11 confirms that the graph node match score consistently obtained the highest 
importance scores of all parameters, mostly within the range of 60–70. In all cases, this 
was the first parameter to split the full training set, which indicates that using this 
parameter at first gives the most accuracy in the primary splitting, which is later fine-
tuned by the subsequent two parameters. The next parameter is age score, which 
received importance scores in the range of 16–26 across the folds. This was followed and 
often superseded by graph pattern match scores, in the range 14–23. In fact both pattern 
match scores and age scores often received similar importance. Overall, we can observe 
that the result is analogous with that of the binary logistic regression and parameter 
estimation models. 
To summarise, in this section, we have generated a predictive model that can assess the 
risk of diabetes. To train the model, we used three partitions for a total of 690 diabetic 
patients and 690 non-diabetic patients. We used three different methods for predictive 
modelling, and all of them yielded relatively similar output in terms of the influence of the 
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six parameters or independent variables. The graph node match score received the 
highest influence scores, and ones significantly greater than the scores assigned to the 
other parameters. The age score was the second most important risk factor in predicting 
diabetes risk, while the graph pattern match score received relatively smaller scores. 
We now proceed to discuss why the other three risk factors received lesser or no 
influence scores in the predictive modelling. We have observed that the male proportion 
was slightly higher in the diabetic cohort in the research dataset, but still it did not have 
much significance for the predictive modelling. We can attribute this to the fact that giving 
higher weighting factors or importance to the sex score would accurately predict risk for 
some patients, but the corresponding increase in accuracy due to this assignment would 
not be significant. Further, there would be a great deal of miscalculation in the forms of 
false positive and false negative results that would significantly reduce the accuracy. 
Because the predictive model looks for the best fit and it had six different parameters to 
balance, the sex score naturally received a lower weighting factor or importance, as there 
were other significant parameters that are capable of giving better accuracy. 
A similar argument can be made against the very low or no significance for the 
behavioural risk factors, which we defined as the presence of tobacco use or smoking. 
Now, we know that there is scientific evidence that smoking causes type 2 diabetes (HHS, 
CDC, 2015, 2014): smokers are 30–40% more likely to develop type 2 diabetes than non-
smokers. We may expect that this behavioural risk factor would attract some degree of 
importance in the predictive modelling. However, as observed, there were more 
significant risk scores (e.g., graph node and pattern match, age) that would outperform 
the accuracy results. Another crucial fact is that, although smoking seems to have a strong 
connection with diabetes, this does not mean that smoking does not cause any other 
diseases. In fact, the opposite is true. Smoking is responsible for many other diseases, 
including cancer and asthma. Here lies the vital clue: the administrative dataset 
represents the medical histories of patients, every one of which had some sorts of 
diseases. It is not the case that we generated the baseline network from a cohort of 
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diabetic patients and cohort of non-diabetic patients who were free from any smoking-
related comorbidities. Rather, many of the non-diabetic patients in the baseline and 
training partitions within the whole cohort had cancer, asthma, and other diseases in 
which smoking is implicated. For this reason, despite its strong link with diabetes, smoking 
(a behavioural risk factor) does not attract significance in the predictive modelling for our 
thesis. However, as our framework is adaptive, if the quality of the dataset is different 
where the non-diabetic cohort does not have significant smokers or has better quality of 
coding (sometimes smoking is poorly coded in the hospital admission data, see limitations 
in 6.3.6), the predictive model should give smoking risk factor a higher weight. 
We can also observe that none of the models assigned much weight or importance to the 
cluster match score. We actually forecasted this when we analysed the modularity 
structure of the baseline network in Section 5.5. The baseline network was quite 
saturated, as 58% of edges were present in the network. This made the modularity score 
lower; therefore, the relations between the comorbidities of the same cluster had little 
difference compared to the comorbidities of the different clusters. So, in the predictive 
model training phase, the cluster match scores between diabetic and non-diabetic 
patients did not show significant differences. Further, a large number of training patients’ 
cluster match scores were zero, because these patients had a small number of overall 
comorbidities in their admissions. Therefore, the cluster match score did not show any 
significance. 
5.8 Risk Assessment Results for Test Group 
At this stage, we apply the predictive modelling on the test cohort. There were three 
predictive modelling methods we implemented in the previous section. Therefore, we 
applied each of these separately on the test cohort. The test cohort was the only 
remaining partition out of the 10, after utilising the other nine partitions for the baseline 
network generation and training the predictive modelling. Therefore, we had 230 diabetic 
and 230 non-diabetic patients on whom to test the prediction results. Testing of the 
binary logistic regression and binary tree classification methods was done in the ‘R’ 
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language, and testing of the parameter estimation model was implemented in our custom 
software (see appendix F and J for some details of the software).  
We should also note that the binary logistic regression method gives its result in terms of 
either a log of ‘odd ratio’ or the probability (i.e., p-value). We chose to obtain the 
probability directly from the output against each of the test patients. To make the result 
comparable with other methods, we flagged the prediction result as ‘diabetic’ if the 
probability was greater than 50%, and ‘non-diabetic’ otherwise. In binary logistic 
regression, there are further provisions to adjust the threshold value by looking at the 
output probability with the actual risk and thus setting an optimal threshold point other 
than 50%. However, we skipped this adjustment, as we were already in the test phase, 
and the regression model was already trained. Table 5.14 shows the prediction results for 
the three predictive models applied on the test partition. The result was obtained from 
the first iteration (i.e., fold-0) of the k-fold (𝑘 = 10) validation process. 
Table 5.14: Prediction results for different models for fold-0 
 Binary logistic 
regression 
n=460 
Parameter estimation 
model  
n=460 
Binary tree 
classification 
n=460 
True positive 193 210 223 
True negative 191 181 172 
False positive 39 49 58 
False negative 37 20 7 
Accuracy (%) 83.48 85 85.87 
 
The binary tree classification shows the highest accuracy of 85.87%, followed by the 
parameter estimation model, which gave 85% accuracy. Binary logistic regression 
performed with slightly lower accuracy than the parameter estimation model, at 83.48%. 
In all methods, the false positive count is greater than the false negative. This is desirable 
for our framework. Because our aim is to predict the risk of chronic disease (i.e., diabetes), 
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we can afford some false positives—that is, some patients may be flagged as having a high 
risk of diabetes even though they are not actually on the diabetes pathway. Eventually, 
the clinical diagnoses or preventive measures that would be applied for the flagged 
patients would reveal the false positive nature of the prediction, which would have little 
adverse effect on the health condition of the patient, except that some amount of clinical 
resources may be wasted. Conversely, having more false negatives would leave a 
significant number of patients undetected who are in fact on the diabetes pathway. 
Unmanaged and undiagnosed diabetes can lead to further complications and often to an 
irreversible point at which it exerts significant health, clinical and economic burdens; 
therefore, it is always preferable to adopt slightly aggressive margins in detecting risk in 
order to reduce false negatives, at the cost of having some false positives. 
We can attribute the small amount of accuracy gain in our parameter estimation model 
over the logistic regression model to the way the result is interpreted. Although both of 
the models assume a linear relation, there is a small difference. The parameter estimation 
model gives the output as a single risk score. After obtaining all the scores from the 
training cohort, the model finds the optimal threshold score. All the patients scoring 
higher than the threshold score are flagged as diabetic, and non-diabetic otherwise. On 
the other hand, in the logistic regression, the linear model is generated against the log of 
the odd ratio. Therefore, the logistic regression reveals the increment amount of log odds 
ratio against any independent variables through the coefficient. Therefore, the log odds 
ratio increases linearly with the independent variables, not the actual probability itself. 
For our parameter estimation model, the risk score itself is in linear relation to the risk 
scores, or independent variables. This difference may affect the differences in the 
accuracy and contribute to the gain in favour of our parameter estimation model. 
Now, we try to explain the accuracy gain of the binary tree classification model, which 
outperformed the other two by a slight margin. The binary tree classification is not a linear 
model, as discussed earlier. In fact, it is more of a data mining-based classification 
method, and it does not target all the independent variables at once. Rather, for our 
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implementation, it partitions the whole test cohort sequentially, each time against one 
variable with a branching condition. This gives a logical advantage and better freedom in 
compartmentalising the individual effect of the variables. For example, the classification 
method has the freedom to split the classification tree several times based on the same 
variables using different boundary conditions. To illustrate, one split can be made based 
on graph node match score, say 𝑒𝑁𝑜𝑑𝑑 ≥ .5.  Now, if 𝑒𝑁𝑜𝑑𝑑 < .5, it can further make 
another split based on the different boundary value, say 𝑒𝑁𝑜𝑑𝑑 ≥ .3. Therefore, there 
would be three effective regions based on graph node match risk score, i.e., if 𝑒𝑁𝑜𝑑𝑑 ≥.5, if . 5 ≥ 𝑒𝑁𝑜𝑑𝑑 ≥ .3 and if 𝑒𝑁𝑜𝑑𝑑 < .3. Thus the tree-based classification method is 
able to look at the different continuum of a parameter’s score, partition it into two or 
more regions, and predict on the class membership individually for each of the regions. 
This advantage is not present in either of the other two linear models. 
The accuracy result from all three methods is quite satisfactory considering the complex 
and clinical properties of the data and the fact that the data has some practical 
limitations. We now discuss the inaccuracies that were observed in the models. Figure 
5.12 shows the risk scores of the test cohort according to the parameter estimation model 
and first fold (fold-0). The red points indicate the patients who are actually diabetic, and 
the blue dots indicate non-diabetic patients. The threshold lines indicate the values above 
which all of the patient scores are predicted as diabetic and vice versa. We have discussed 
the four possible validation outcome of the prediction—true positive, true negative, false 
positive and false negative, the first two being the correct predictions. The aim of any 
good predictive model is to measure the overall risk score (y-axis values) and set a 
threshold line in such a way that all the diabetic patients (i.e., red dots) lie over the line, 
and all the non-diabetic patients (i.e., blue dots) lie below the line. 
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Figure 5.12: Overall risk scores of the test cohorts, predicted outcomes and 
corresponding grouping according to the parameter estimation model 
From Figure 5.12, we can clearly see how the false predictions were made. Some diabetic 
patients (i.e., red nodes) fell under the threshold line, and were thereby flagged as false 
negatives, and some non-diabetic patients (i.e., blue nodes) went over the threshold line, 
resulting in false positives. The model cannot shift the threshold point up or down in such 
a way that more false positives and false negatives fall into the correct partition, because 
improving results for one would displace more of the other to the wrong region. The 
model always finds the optimum threshold yielding the highest possible accuracy given 
the overall risk scores. The quality of the prediction model, therefore, is mostly dependent 
on the definitions of the individual risk factors (e.g., age, sex, graph node match). For this 
research, we observed that the graph-based risk scores (e.g., node and pattern match 
score) and age scores were the best predictors in combination.  
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Now, if we look at the positions of the wrong predictions in Figure 5.12, we can clearly see 
that the false positive and false negative points are scattered around a narrow region near 
the threshold line. This indicates that these patients have very similar disease pathways 
(as we have a high influence of node match scores) and age scores to borderline diabetic 
patients, and thus their overall risk score is closer to the threshold. There is a high level of 
uncertainty associated with these patients, as they have a similar clinical footprint in the 
admissions data, but in reality may be either diabetic or non-diabetic. The model must 
balance their categorisations to ensure maximum accuracy. Because these results come 
from real-life clinical data, we argue that these false positive and false negative results 
scattered within a short range of the threshold line are normal and acceptable, and that 
the predictive model overall performed very well.  
As a future step, we could modify the model by defining this short strip around which the 
majority of the false positive and false negative patients are scattered, instead of drawing 
a threshold line. Patients inside this borderline range or strip could be defined as 
‘borderline patients’, whose disease risk cannot be clearly distinguished correctly, thus 
requiring further clinical investigation or data. With this modification, the model should 
give three types of prediction output: diabetic, non-diabetic and borderline. However, we 
leave this definition to future work, as this research has focused on creating a model that 
gives ‘yes’ or ‘no’ risk prediction. So far, the results yielded have been satisfactory. 
5.9 Validation and Comparison of Results 
In this section, we describe the process of validation of the framework in terms of 
accuracy, performance and consistency. We used k-fold validation with 𝑘 = 10 as the main 
validation method, which we have mentioned several times throughout this chapter. 
Using this method, we partitioned the research cohort of 2,300 diabetic and 2,300 non-
diabetic patients into 10 equal-sized partitions, referred to as fold-0, fold-1, … , fold -9. 
These partitions were used for three different purposes. Six of them were used for 
creating the baseline network, three were used for training the model and the remaining 
one for testing the model. We generated 10 combinations of the partitions so that in each 
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combination the test partition is different (see Section 4.1 for a detailed diagram) and the 
rest is distributed for baseline network creation and training purposes. We then 
implemented the full predictive modelling workflow using three methods (i.e., parameter 
estimation, logistic regression and binary classification) on different combinations or 
‘folds’. The accuracy results of the 10 folds are given below in Figure 5.13. 
 
Figure 5.13: Prediction accuracy (%) for all folds for all three methods 
The figure shows consistent results for all the three different predictive models across the 
folds. The binary tree classification method shows relatively better performance than the 
other two in all the folds. Except for folds 4 and 5, the parameter estimation method 
showed slightly better performance than the binary tree classification method. As the 
deviation across the folds is quite small, we can safely ignore it and consider the accuracy 
performance consistent across the folds.  
 5.9.1 Precision and recall result 
Figure 5.14 shows the precision and recall measures across all the folds for the three 
models. The measures are nearly consistent across the folds, as their deviation is not very 
high. One noticeable feature for all the measures is that the recall values are in most cases 
greater than the precision measures. Precision reveals the fraction of the result that is 
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relevant—that is, out of the all the patients who are predicted to be at high risk of 
diabetes, precision reveals how many are actually diabetic. Thus, if the false positive 
percentage is lower, it gives a higher precision result. In contrast, recall shows the fraction 
of relevant results that the model is returning—that is, it indicates out of all the patients 
who are actually T2D positive, how many the framework is correctly identifying as at high 
risk. Therefore, recall is inversely associated with false negatives. If the rate of false 
negatives is lower, it results in a higher recall value.  
We observed earlier that most of the false positive and false negative values were 
represented by closely situated points (i.e., for the parameter estimation model they were 
all near the threshold line). The relation between these two types of false outcome is 
opposite: if the model is adjusted to bring in more false positives as true negatives, some 
true positives near the borderline will be shifted to false negatives, and vice versa. 
However, we have observed that false positives are better than false negatives from a 
clinical perspective. Because of their relations with precision and recall, we prefer a higher 
recall value (hence lower rate of false negatives) over a higher precision value. As Figure 
5.14 showing this quite clearly, it indicates that the framework is performing as intended. 
 
Figure 5.14: Precision and recall measures for all folds for all three methods 
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 5.9.2 Effect of considering collapsed ICD codes 
So far, we have considered 35 selective comorbidities, represented by grouping related 
ICD codes into 35 comorbidity ‘buckets’. The motivation behind this was that we only 
want to consider comorbidities that are clinically validated and related to diabetes, and 
exclude all diseases or health conditions represented by ICD codes not included in the 
selective list. This limits the number of comorbidities (i.e., graph nodes), and as a result, 
the transitions are saturated: that is, the graph density increases and network modularity 
decreases. To validate the effect of using these selective comorbidity ‘buckets’, we 
returned to the start of the framework and re-ran the whole procedure without any 
selective comorbidities. Instead, we used all the ICD codes in the dataset minus their 
suffixes (i.e., all ICD codes were shortened to three characters). We used the k-fold 
validation and the three predictive modelling methods in the same manner as before. 
Table 5.15 shows the result. 
Table 5.15: Comparison between different predictive models using collapsed ICD codes 
and selective comorbidities 
 
Binary logistic 
regression 
Parameter estimation 
model  
Binary tree 
classification 
Accuracy (%) SD Accuracy (%) SD Accuracy (%) SD 
Collapsed ICD 
codes 
85.56 11.95 88.59 11.39 90.26 9.67 
Selective 
comorbidity 
82.56 1.55 85.5 1.23 86.217 1.16 
SD = Standard Deviation 
 
The table shows that using all ICD codes collapsed to three characters results in a certain 
amount of accuracy gain for all three predictive models (in expense of higher standard 
deviation, we will discuss later). This is quite an interesting result at first. In particular, the 
binary tree classification, which outperformed the other two methods in the previous run 
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of the framework using selective comorbidities, also outperforms the others when all ICD 
codes are used—in fact, it does so by a greater margin, reaching 90% accuracy. Across the 
three methods the accuracy gain is almost consistent – about 3%-4% gain for each. In both 
comorbidity and selective ICD code approaches, the age, sex and behaviour risk scores 
remained the same, as they are individual scores and do not depend on the baseline 
network. Therefore, the accuracy gain must have come from the graph and cluster match 
scores. After examining carefully the overall individual risk scores and the way the 
additional accuracy was derived, we can observe a few reasons behind the accuracy gain.  
The first and probably most important reason for the accuracy gain is that the selective 
comorbidity approach, which was derived from the Elixhauser index, has a limited number 
of ICD codes. Therefore, a large number of ICD codes not included in the selective 
comorbidity approach are eventually included in the collapsed ICD code approach. Some 
of these ICD codes were distinctive of the diabetes patient’s cohort, and therefore 
received high weightings in the baseline network via attribute adjustment, eventually 
resulting in higher accuracy. We can argue that the selective comorbidity condition lists 
only the clinically validated ICD codes and in turn comorbidities, and if all ICDs are used, 
there is a large number of ICDs present that may not necessarily indicate disease. 
However, we have observed from the accuracy gain that some of these otherwise unused 
ICDs in the selective comorbidity list were actually useful in predicting risk, and hence are 
useful to study. These ICDs may not be directly related to any disease or comorbidity, but 
they may indirectly point to some underlying comorbidities that are more exclusive for 
diabetes, and hence help in the prediction.  
Another reason for the accuracy gain in the collapsed ICD approach may be that it creates 
a larger number of nodes in the graph. Relatedly, because individual nodes are 
considered, the number of transitions in the resulting overall baseline network does not 
saturate the whole network. This lower saturation level resulted in lower network density 
and higher modularity, and therefore, the number and quality of clusters are higher than 
in the selective comorbidity approach. This resulted in higher measures of importance for 
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the cluster match score in the predictive models—recall that the cluster match score was 
not significant in the other approaches. The improved cluster result also influenced the 
overall performance gain. Especially for the binary classification method, which has some 
advantages over the linear models in that it is better adapted to the increased number of 
nodes and finer clusters in the baseline network, overall performance gain was better 
than the other two predictive models. 
The collapsed ICD code approach has some disadvantages. First, not all of the codes are 
clinically validated or checked. Although from a data mining and exploratory research 
perspective, this method is useful and allows for more accurate prediction, a clinical 
validation may be necessary at least to filter out some irrelevant codes to prevent 
overestimation. Second, we observe a higher standard deviation in the accuracy 
percentage for all three predictive models. Binary tree classification has a slightly lower 
standard deviation of 9.67. The other two models exhibited 11.95 (binary logistic 
regression) and 11.39 (parameter estimation model) as standard deviation. These 
deviations indicate that across the 10 folds of executions, collapsed ICD code approach for 
each of the three models showed fluctuating accuracies – significantly more than those of 
selective comorbidity approach. In selective comorbidity approach, the standard 
deviations were very nominal, i.e., within 1.23 to 1.55 range. The higher standard 
deviation in collapsed ICD approach indicates that due to granularity in the baseline 
network data, this approach may be influenced by random noise, bias and over or 
underestimation – subsequently resulting into fluctuation of accuracy across the 10 folds. 
This, in turn, pulls up the standard deviation. Therefore, although the collapsed ICD code 
approach shows slightly better prediction, it comes at a price of higher standard deviation. 
And careful consideration should be made when applying it in other contexts, that is, for 
other datasets or chronic diseases. 
 5.9.3 Attribution effect 
We have claimed previously that attribute adjustment can give greater weight to the 
comorbidities or progressions that are more exclusive to the positive baseline network of 
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diabetic patients compared to the negative baseline network of non-diabetic patients. In 
this way, it allows for better prediction performance. In this section, we test this claim. We 
implemented the whole framework again using all the alternate options that we have 
introduced so far—using all three predictive models and both types of node format 
(selective comorbidity and collapsed ICD). This time, we did not use the negative baseline 
network to adjust the attributes of the positive baseline network. Rather, we merely 
normalised (scaled down) the node and edge attributes of the positive baseline network in 
the range of 0 to 1, and thus formed the final baseline network without attribution 
adjustment. All other elements of the framework implementation are executed as usual 
on all possible pathways. Table 5.16 below compares performance across all the different 
methods against the approaches with and without attribute adjustment. Also to note that 
we have reported the complete result set for all approaches and across all 10-folds in the 
Appendix I. It includes measures of true positive, true negative etc. as well as the 
precision, recall and accuracy. 
Table 5.16: Performance comparison between inclusion and exclusion of attribute 
adjustment 
Attribute 
adjusted? 
Node type of 
baseline 
network 
Binary logistic 
regression 
Parameter 
estimation model  
Binary tree 
classification 
Accuracy (%) SD Accuracy (%) SD Accuracy (%) SD 
YES 
Collapsed 
ICD codes 85.56 
11.95 88.59 11.39 90.26 9.67 
Selective 
comorbidity 82.56 
1.55 85.5 1.23 86.21 1.16 
NO 
Collapsed 
ICD codes 69.43 
2.00 69.76 2.16 75.54 1.41 
Selective 
comorbidity 78.13 
2.24 85.28 1.58 86.13 1.78 
SD = Standard Deviation 
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We observe from Table 5.16 that when selective comorbidities are used, the approaches 
with and without attribute adjustment do not differ much. At most, a performance gap of 
4.43% was observed for the binary logistic regression method (82.56 vs. 78.13) without 
attribute adjustment. This is not very significant because in any of the two methods 
(selective comorbidity plus with and without attribution adjustment) we can reach 86% 
accuracy (in tree classification). Now, there are some reasons for selective comorbidity to 
have very little effect of attribute adjustment. Because we limited the number of 
comorbidities to some specific selections beforehand, the prevalent or more exclusive 
comorbidities were already included in the selection. Moreover, the negative baseline 
network in practice has little to change through the process of attribute adjustment. This 
could be understood by looking at the network properties of the negative baseline 
network in Table 5.8 (see Section 5.5) before. The number of edges and network density 
were not high compared to the positive baseline network; in fact, they were almost half of 
the equivalent properties for the positive baseline network. This indicates that the 
negative baseline network did not contribute much to the attribute adjustment. Thus, 
when the same method was applied without attribute adjustment, whatever adjustment 
effect was missed later was compensated for by the training of the predictive model. The 
predictive modelling always has a training phase, in which we provided an equal number 
of actual diabetic and non-diabetic patients to adjust the scores, thresholds and split 
points, and eventually succeeded in compensating for the missing attribution effect. 
On the other hand, when collapsed ICD codes were used, the effect with and without 
using attribution adjustment made considerably bigger difference in accuracy: 
approximately 86% vs. 69% for logistic regression, 87% vs. 70% for parameter estimation 
and 90% vs. 75% for binary tree classification. We can clearly see that the method using all 
ICD codes did benefit a great deal from attribution adjustment, and this may be another 
reason why the fine-tuned graph attributes and resultant cluster information aided in the 
performance gain over selective comorbidity approach. As attribution plays a major role in 
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the collapsed ICD code approach, removing the adjustment results in imbalances in the 
node and edge weights to a degree, so that the individual graph- and cluster-based 
matching scores are infused with noise. Therefore, the predictive modelling cannot 
perform well. Even the best performing method in our research, the binary tree 
classification, reached only 78% accuracy.  
Finally, we want to briefly discuss the overall advantage, disadvantage and the 
applicability of the framework. First of all, the methods in the framework showed 
promising results. Especially the selective comorbidity approach exhibited high prediction 
accuracy and lower standard deviation across the 10 folds. Next, we have seen that 
different variations of our approach revealed different functional characteristics of the 
prediction model and properties of the baseline network. In terms of the predictive 
model, binary tree classification showed the best performance across all different 
approaches. This makes it a likely candidate for predictive modelling based on our 
framework. Also, in most cases, parameter estimation method performed almost as 
efficiently as the binary classification method. Now, in terms of choosing between 
selective comorbidity and collapsed ICD code, we have seen that the former approach 
yielded consistent, stable and moderately accurate results (i.e., around 86% accuracy, 
standard deviation of around 2; see Table 5.16). On the other hand, selective comorbidity 
approach along with attribution adjustment yielded the highest accuracy (90%) but 
proved to be relatively unstable (standard deviation of 9.67 for binary tree classification, 
see table 5.16). Attribution adjustment did not show much performance gain when 
selective comorbidity was used. On the contrary, it showed considerable performance 
gain (around 15% gain, regardless of the type of predictive model, see Table 5.16) when 
collapsed ICD codes were used. We already have discussed the possible reasons in the 
previous paragraphs. Finally, when it comes to the choice of appropriate approach based 
on our framework, for any new related dataset – the choice will depend on several 
factors. These include, but not limited to – dataset quality, coding quality, clinical 
knowledge on the disease and comorbidities in question as well as research approach etc. 
Each of the approaches has their own advantages and disadvantages as we have discussed 
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earlier. Selective comorbidity might be a preferred approach if the chronic disease, 
comorbidities and related codes are well understood and clinically well-defined. If the 
research is exploratory, i.e., focused on finding major diseases and transitions that are 
prevalent for particular chronic disease then collapsed ICD code-based approach might be 
appropriate. Regarding predicting model, in most cases, binary tree classification model or 
parameter estimation model can be used. Because binary tree classification model is well 
implemented in many software packages like R, it might be easier to implement. Now, 
regarding attribute adjustment – it should be a preferable choice when the dataset have 
patients from both cohorts, i.e., one having the particular chronic disease and the other 
not having that chronic disease. Finally, one should include the possible socio-economic 
risk factors as well, whenever available in the dataset. Some of these (i.e., age etc.) had 
shown significance in our prediction. And, even some of them had not; they might be 
proved influential in the similar research using different dataset. We now summarise this 
chapter in the next section. 
5.10 Summary 
In this chapter, we have implemented our framework, presented the result and discussed 
the findings in broad depth. Below is a summary of the procedural steps that we have 
implemented in this chapter.  
1. We filtered and sampled a research cohort of 2,300 diabetic and 2,300 non-
diabetic patients from an administrative database of 748,982 members and 
384,538 admissions. 
2. We divided the research cohort into 10 equal partitions. 
3. Using six partitions, we generated baseline networks for the diabetic and non-
diabetic cohorts, and, through attribute adjustment, generated the overall baseline 
network. 
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4. We used three different predictive modelling techniques: two of them were linear 
models, and one was a data mining-based classification tree model. Three of the 
10 partitions were used to train the models. We had six parameters whose 
significance was determined by the models.  
5. The remaining partition was similarly used to predict risk with the help of the 
baseline network. All three predictive models were utilised, and we compared the 
results. 
6. Steps 3 to 5 were repeated 10 times with different combinations of partitions, 
thereby constituting a k-fold validation. 
7. Steps 3 to 6 were repeated using collapsed ICD codes as graph nodes instead of 
selective comorbidities, and the results were compared. 
8. Steps 3 to 7 were repeated with the modification that in step 3 we did not do the 
attribute adjustment. The results were compared. 
 
Following the above steps, we implemented our framework on the health dataset and 
presented the results from different approaches. The overall performance in terms of 
prediction accuracy and stability was satisfactory. We discussed the advantages, 
disadvantages and consideration of different approaches of the framework at the later 
part of this chapter. In the Table 5.17 we present a short summary of it.  
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Table 5.17: Summary properties among different approaches used to implement the 
framework 
Properties 
Selective comorbidity ICD code collapse 
With att. adj. Without att. 
adj. 
With att. adj. Without att. 
adj. 
Accuracy High 
(83% - 86%) 
High 
(78% - 86%) 
High 
(in fact, highest, 
85% - 90%, but 
not stable) 
Low 
(69% - 75%)  
Stability Very stable 
(SD ≈ 1) 
Stable 
(SD ≈ 2) 
Not much stable 
(SD ≈ 11) 
Stable 
(SD ≈  1.4 - 2.2) 
Susceptibility 
to noise in 
dataset 
Not much  Not much Likely Likely 
Quality of 
clinical codes 
Good Mostly good As it is As it is 
Computation 
time5 
Fast Fastest Slowest Slower 
Predictive 
model that 
performs 
better 
Binary tree 
classification, 
parameter 
estimation 
Binary tree 
classification, 
parameter 
estimation 
Binary tree 
classification, 
parameter 
estimation 
Binary tree 
classification 
Potential 
application 
area or 
research 
suitability 
When 
comorbidities 
are well-defined 
and clinical 
knowledge is 
available or 
when the user 
wants to 
investigate 
specific 
comorbidities. 
Same as 
previous (left 
table cell), 
specifically 
when non-
chronic 
patients’ data is 
not available. 
Explorative 
approach, when 
limited 
knowledge is 
available on 
clinical codes 
and user wants 
to investigate 
potential risk 
factors (disease 
and transition 
pattern.). Need 
caution as not 
stable. 
Same as 
previous (left 
table cell), 
specifically 
when non-
chronic 
patients’ data is 
not available. 
Need caution as 
not much 
accurate. 
att. adj. = attribute adjustment 
  
                                                            
5 Computation time is approximate and relative. May vary based on the dataset size and algorithm used. 
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Chapter 6: Conclusion 
In this final chapter, we present the conclusion of the thesis. We start off by briefly 
describing what we intended to do in this thesis, how we implemented them and what we 
have found as the result. Next, we describe the implication of our study in different 
contexts. As this research deals with the real-world dataset, we faced a number of data-
related issues that might affect the result to a certain degree. Therefore, in the 
subsequent section, we discuss the potential limitations of the study. Finally, we give 
future research direction for researchers to utilise, extend and improve our framework. 
6.1 Overall Summary and Key Findings 
With a growing burden of chronic diseases on public health and the economy, researchers 
and other stakeholders are increasingly being challenged to understand disease 
trajectories in order to design and adopt preventive policy. In this thesis, we extensively 
reviewed the evolution of methods in the literature that are closely aligned with this 
research area, and discussed the methodological and empirical gaps that led to the 
undertaking of this research. We focused on the issue of understanding chronic disease 
progression and providing an early detection framework for high-risk patients without 
consuming excessive clinical resources. We leveraged the existing administrative health 
data, more specifically hospital admission records. 
We aimed to explore and answer two broad questions: (i) How can we utilise 
administrative data to understand chronic disease pathways? and (ii) Is it possible to 
reasonably predict chronic disease risk from the understanding of disease pathways? We 
took a network-based approach to answering these questions. A methodological 
framework was developed to systematically analyse the administrative data, understand 
the disease progression through a baseline network and then develop a predictive 
framework based on that baseline understanding. We also kept the framework generic so 
that it can be implemented on different healthcare data with minimum modification. We 
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further provided a rigorous discussion on the consistency and security issues associated 
with the administrative health data and how these issues can be addressed. 
We implemented our framework on real-world datasets to test their performance and 
applicability and the potential of the framework from a stakeholder or business 
perspective. Type 2 diabetes (T2D) was chosen as the chronic disease the framework 
would learn to predict, and on which to test its accuracy. As per the framework, we 
generated a baseline network for T2D. Diabetes-associated comorbidities and their 
progression over time were thoroughly discussed: we demonstrated that the baseline 
network can reveal insights about the progression of T2D and discussed how these 
insights are consistent with present understandings from a clinical perspective. We 
utilised these empirical understandings of the comorbidities that lead to type 2 diabetes 
to construct a prediction model in the second part of the implementation. 
The implementation further went to explore the effects of different execution pathways in 
terms of different methods of predictive modelling, inclusion vs. exclusion of attribute 
adjustment and level of ICD code groupings. This explorative analysis approach was 
necessary because, given the heterogeneous nature of administrative data and the 
existing knowledge on the progression of chronic diseases, one combination of methods 
might not always work well for other chronic diseases and administrative datasets. 
Further, we found that without attribute adjustment, the predictive framework shows 
relatively lower prediction accuracy. Especially, the accuracy was significantly lower when 
collapsed ICD code approach was used without attribute adjustment. This reveals the 
importance of comparing the disease trajectories of chronic patients with non-chronic 
patients in order to formulate a final baseline network that can properly expose the 
deciding factors that lead to chronic disease. Many approaches in the current literature 
seem to ignore the trajectory of non-chronic patients. Thus, the present research 
demonstrates that such neglect could create a major limitation; attribute adjustment is a 
major feature in our predictive modelling. 
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Overall, in all cases, the data mining-based binary tree classification model showed higher 
accuracy than the other two linear models. Also, parameter estimation model also 
performed quite closer to binary tree classification model in most cases. Next, we found 
that using collapsed ICD code approach with attribute adjustment shows the best 
performance, but it comes at a price of significant instability, i.e., higher standard 
deviation. If the same approach is used without attribute adjustment, the framework 
showed poor accuracy result. We discussed earlier that the collapsed ICD codes may 
induce noise or bias when implemented in other similar contexts. This is because the 
collapsing is unsupervised and, depending on the quality of coding, it can adversely affect 
prediction performance or stability or both. On the other hand, selective comorbidity-
based grouping derived from the Elixhauser index and clinical observation is capable of 
maintaining the grouping process with better control and precision. In our analysis, it 
showed reasonable and consistent accuracy across all the predictive models when 
attribution adjustments were applied. Also, towards the end of the last chapter, we 
discussed the potential applicability of different approaches used within the framework. 
Generally, for the research context where clinical knowledge about the coding, diseases 
and comorbidities are well-defined and understood, we should use selective comorbidity. 
On the other hand, if they are not well-defined or understood, then collapsed ICD code 
approach might be more helpful. Especially, it might be suitable when the research is 
focused on exploring the potential diseases and patterns as risk factors. Overall, we found 
that despite having different accuracy results, all the approaches put high importance on 
network-based measures. These measures are the unique contribution of our thesis and 
having high importance in the prediction model thus prove the significance of network 
analysis in healthcare data. 
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6.2 Implications of the Study 
 6.2.1 Research implications 
The incorporation of graph theory and SNA-based methods in the field of disease 
progression and prediction should be the primary contribution of this thesis in terms of 
the research implications. This network-based approach has not been widely used in this 
field, especially using administrative datasets. Therefore, this research is likely to 
contribute to the scientific community by showing the potential use of administrative data 
in understanding chronic disease progressions and predicting risk through the proposed 
framework.  
Within the framework, there are three methodological aspects that constitute novel 
contributions from this thesis. The first is the network representation of the disease 
progression from the individual admission history (i.e., from administrative data) of a 
particular patient cohort. We have described a detailed method for constructing such a 
network representation for chronic and non-chronic patient cohorts in Chapter 4. The 
steps of converting admission records to individual disease networks with attributes and 
subsequently merging them into positive or negative baseline networks through statistical 
aggregation should be the unique contributions of this part.  
The second methodological contribution is the concept of attribution adjustment between 
negative and positive baseline networks to form the final baseline network representing 
the overall chronic disease progression. The mathematical formulation of the process that 
was introduced to describe this part is unique to this thesis.  
Finally, in the disease prediction component, we proposed three different risk factors 
based on graph matching. The methods to find similarity on graph node, graph pattern 
and social network-based cluster matching have been presented in terms of mathematical 
equations. We have argued that these network similarity-based risk factors can potentially 
compare a baseline network with a test patient’s disease network to make a prediction on 
whether or not the test patient will develop the chronic condition. The implementation on 
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T2D has shown that these risk factors, along with age score, can offer reasonable accuracy 
in prediction. Although some network-based risk factors such as the cluster match score 
did not exhibit great importance, as other risk factors did, we have suggested that this is 
due to the nature of the baseline network formation and experiment setup, and argued 
that these risk factors are likely to be useful in other setups. Overall, the outcome 
validates our approach using network-based modelling and prediction methods. 
 6.2.2 Practical implications 
This research framework and corresponding experiment design was undertaken 
particularly with the goal to translate the outcome into knowledge for policy makers. 
Therefore, the research questions that we asked at the outset are aligned with the 
concerns of most policy makers and heath funders. Administrative data, in the form of 
admission records, contains more or less similar information across different countries. 
Our framework and experiment setup is based on such typical health records, and we 
implemented it on a real dataset from the Australian health context, thereby making the 
framework practical for implementation in other contexts as well, with few modifications. 
For example, the disease codes that are initially input to identify the chronic patients can 
be changed from T2D to other chronic diseases. For example, a researcher may want to 
understand the progression of essential hypertension. In that case, instead of putting 
E.11, the ICD-10-AM code for T2D, the researcher only needs to put I10, the ICD code for 
essential hypertension, to make the framework generate the baseline network for that 
disease. Further, the data model for the research framework is designed to be stored in 
relational database, making it easier to change, modify or interface with the 
administrative data within the framework. For example, if we want to generate a baseline 
network in terms of codes other than the ICD codes, this can easily be done by plugging in 
different code tables in the database. For example, in the Australian context, CMBS codes 
are used to describe the services (e.g., procedures, consultation) against which the 
provider bills the patients. Therefore, using CMBS codes instead of ICD will create a 
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baseline network showing the typical services and progression through one service to 
another for particular chronic disease patients.  
The most important practical implication of this research should be considered its 
potential as a software-based analytical and forecasting tool for policy makers, especially 
for insurance providers. Private health funds as insurance providers always strive to make 
better forecasts of their expenditure in coming years. Such forecasts are essential to 
ensure quality of service, customer satisfaction, survival in a competitive health market 
and maximising revenue. 
 
Figure 6.1: Different groups of members having different health status for a typical 
health fund and their shifts over time 
To give a very specific example in this context, most private health funds have large 
numbers of members from different age groups. Given the demographics and the type of 
fund, in most cases, the fund has members having different health status in terms of 
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chronic diseases. Figure 6.1 shows a typical grouping of members based on their current 
health condition. The numbers are fictional, but a realistic portrayal for many health 
funds. The figure also shows the trajectory after say, five years, in terms of how many 
members are shifted from one group to another. The figure does not show the inclusion 
of new members with time. Now, many of these transitions are not preventable at all, 
although they obviously cost money to the funders. For example, many very old patients 
who are currently critically ill or under palliative care will eventually die in few years. Also, 
many of the current patients who have chronic conditions like diabetes or cancer will 
either deteriorate over time or their conditions will be managed through clinical 
interventions, screening and lifestyle management.  
Managing chronic diseases, after a certain period of onset, is very costly. However, a 
potential window of opportunity lies in the period when the patients are borderline 
chronic or the disease is still in a manageable state. In numerous cases, as we have 
discussed earlier, progressions towards chronic disease do not involve enough symptoms 
to a sufficient degree that the patient becomes motivated to go for screening. When the 
window of opportunity to successfully intervene ends, the patient eventually ends up in 
the chronic disease stage, which often requires life-long management and incurs a heavy 
cost. As the Figure 6.1 shows, when they are at risk of chronic disease, health funds try to 
identify these patients whose transition are still potentially preventable. The funds 
encourage these borderline patients to undertake regular screening, consultation and 
early intervention whenever necessary. For example, in the Australian context, the 
Chronic Disease Management Program (CDMP) focuses on providing care coordination 
and self-management support to help people with chronic disease to better manage their 
condition and access appropriate services in order to improve health outcomes, prevent 
complications and reduce the need for hospitalisation (NSW Health, 2015). Many private 
health funds also want to encourage at-risk patients to enrol in CDMP or similar programs.  
However, the challenge is to identify the high-risk chronic or soon-to-be chronic patients 
who would benefit from CDMP enrolment or related screening. As there are a large 
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number of members in a typical health fund, and the dataset is dynamically updating, it is 
not feasible to manually track all of them. In most cases, the analytics team looks for 
simple indicators, such as age, total number of hospital admissions per year and average 
length of stay to identify high-risk patients. These can often give erroneous or false 
positive rankings, as they do not consider the type of ailments the patient has had and 
their progression over time while calculating risk. To better predict or assess the risk or 
severity of chronic diseases, our framework can suitably be integrated into health fund 
databases. The framework can then be utilised to rank the patients easily for the risk or 
severity of the chronic conditions, such as diabetes, congestive heart failure, coronary 
heart disease, COPD or hypertension.  
In fact, our implementation has already accomplished one such practical use of our 
framework, using a private health fund’s admission records or administrative dataset. The 
software was custom made following the three-tier application framework, and executed 
the complete framework. Therefore, it is quite easy to implement the methodology as a 
software or web-based tool that can leverage admission records, disease history and 
progression to rank patients more accurately. In consequence, this research could be 
translated into a valuable commercial tool for detecting high-risk chronic patients, thus 
enabling private funders to save costs, or greatly assist in formulating better policy around 
premiums, budget allocation and forecast. These can, in turn, help to provide a better 
quality of care to the members by early detection of chronic disease, help to manage the 
onset and possibly reduce hospital admissions. Further, the baseline network generated 
from the framework can help in identifying the set of complexities that affect quality of 
care, length of stay and cost. It can also suggest any patterns linking certain diseases and 
people of particular demographic groups or geographical areas. 
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6.3 Limitations of the Study 
Despite our best efforts, this research has several limitations. Most of these limitations 
come from the fact that the dataset is a real-world healthcare dataset. Like any other real-
world dataset, it has several shortcomings that cannot be fully mitigated, especially while 
maintaining research scope and time constraints. The major limitations of this research 
study are described below. 
 6.3.1 Absence of primary care data 
Chronic disease patients are only admitted into hospitals in serious cases. Accordingly, the 
diagnosis trajectory will consist of disease codes that are likely to be serious enough to 
occur during hospitalisation. In this scenario, some diagnosis codes might be missing or 
have low frequency that would otherwise be included or have high frequency if primary 
care data were available. Also, the first point of contact for non-emergency medical needs 
is usually the GP. Therefore, primary care data should contain a vast amount of 
information for understanding chronic disease progression. However, it is practically 
almost impossible to obtain primary care data on a large scale like the hospital admission 
data. This is because primary care facilities (e.g., GPs’ chambers, community health 
centres) are widely distributed and numerous. It is still difficult to monitor them centrally 
or state-wise under common recording and reporting schemes, like the way hospitals are 
managed now. At present, GPs take clinical notes in different formats, using different 
software packages that share little or no standard format. However, with the current 
development of electronic health records, it should be possible to obtain primary care 
data in the coming years. 
 6.3.2 Absence of public hospital data 
The healthcare data that we analysed using the framework originated from private health 
funds. The members present in the dataset did essentially choose private health cover. 
However, most of these patients were also subscribed to the public health fund, 
Medicare. They may also have attended public hospitals. Records for any such admissions 
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are not included in the dataset. This missing information may have introduced some bias 
in the analysis and affected its accuracy. However, there is no way to overcome this 
limitation except by means of data linking (see Section 6.4.1) with public hospital records, 
if they exist.  
 6.3.3 Admission time-related biases 
In our framework, when generating the positive baseline network for chronic patients, we 
chose the admission records up to the admission when the patients are first diagnosed 
with the chronic condition as present in their admission record. However, we should be 
careful about claiming ‘first diagnoses’ of chronic disease. The time is a rough estimation 
of the exact occurrence. The patient may have been diagnosed sometime long before, and 
might have been managing the condition themselves or through primary care. Rather, the 
time indicates the first hospitalisation when the condition was recorded, not necessarily 
the actual occurrence of first diagnosis. In our implementation, the effective timeframe 
for the baseline network for T2D patients is likely the sum of time until the onset of T2D 
plus the average time after which the T2D patients were admitted in hospital and T2D is 
recorded first time as comorbidity. 
Another possible bias may occur because of the private health cover policy. For non-
emergency medical treatments, especially for procedures, private patients can choose a 
suitable time, as well as their doctors. Therefore, if the elected time varies considerably, it 
does not show accurate time of the comorbidity onset. This can incur bias.  
 6.3.4 Possible bias in the number of admissions 
Some admissions for the members may be missing from the dataset due to their 
membership plan. The healthcare funds offer different types of cover for their members. 
While most members subscribe to the typical health cover, some may choose extra 
options like allied health cover (e.g., for dentistry, ophthalmology). Therefore, some 
hospital admissions may occur if the patient has a more extensive health cover. On the 
other hand, some admissions may not occur if the patient has a more basic health cover. 
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Alternatively, they can be admitted without cover, and in that case the admission will not 
be reported to the respective health fund. Further, the patients can switch between 
different packages within the same health fund according to their requirements. These 
may introduce bias in the number of admissions. 
 6.3.5 Suspension of membership 
There is a small chance of bias due to the fact that the members have liberty to suspend 
their membership. This can create bias in two ways. First, the member can terminate 
permanently and can choose a different private health fund, or no fund at all. Second, the 
member can suspend temporarily, and may choose other fund. After some period of time, 
they can resume their membership. This first event will not incur any bias in our analysis 
because, if they terminate the membership, our framework will only consider the 
progression up to the time of last admission. In contrast, for the second case, during the 
temporary suspension period, the framework will find no admission. However, upon 
resuming, if they are admitted again, that would be registered in the progression history. 
The framework will consider the disease progression from the last admission before 
suspension to the first admission after resuming the membership. This would incur a bias. 
Although, upon discussion with the data custodian, we found that the amount of such 
suspensions should be very small, it is still worth noting here. This type of bias also 
depends on the dataset design. For our case, it was not possible to filter out patients who 
had had suspensions or not, mostly due to the strict de-identification routines 
implemented during data transfer. However, other administrative datasets may have 
sufficient membership information to filter out such inconsistent entries beforehand.  
 6.3.6 Quality of coding 
We discussed earlier in Chapter 3 the issue of coding quality during the hospital 
admissions. Here we briefly recall the potentially associated bias due to this. First, 
healthcare policy changes frequently in terms of coding practice. Coding related to chronic 
diseases as primary or secondary comorbidity has undergone several policy updates 
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during the last decade. These caused the frequency of related ICD codes to surge or drop 
dramatically within months. Although most of our data was collected outside the major 
policy change period, a small part remains affected by this period of change. Second, the 
expertise of the individual clinical coder also affects the coding quality. Normally, trained 
healthcare professionals record the administrative data. The process can be affected by 
several factors, including experience, expertise, training, workload or reference-related 
resources. Several other factors, like the version of the coding software (e.g., DRG 
grouper), motivation and time constraints can also play a role in dictating the level of 
coding. Finally, coding standards (e.g., version, implementation) and funding for clinical 
coding can also play a role.  
Poor coding can result in fewer recorded comorbidities or behavioural risk factors (e.g., 
smoking), incorrect entries or sometimes over-coding. This can affect the accuracy of the 
model. For example, we manually did a random check on the false negative cases 
obtained from our models. It was found that, in most cases, they had a fewer number of 
comorbidities recorded during their admission histories. As a result, they obtained lower 
network- and cluster-based scores, which in turn, put them below the threshold value and 
identify as non-diabetic, i.e., false negative. While this could be purely by chance, the lack 
of comorbidities may also due to poor coding and may be worthwhile to investigate 
further. Now, in terms of policy and coding versions, as our research data is quite new and 
uses the latest ICD version, therefore, bias related to these should be minimal. Also, 
private funders usually cross-check the claims that come through service providers and 
patients during admission, along with the ICD codes in the admission summary. Claims are 
made against particular medical services, which are coded as CMBS codes. The matching 
process between CMBS codes and ICD codes can give an approximate indication of any 
coding inconsistency, over-claiming or fraud. In fact, fraud detection is another big 
research topic related to health funds. Within our research scope, the comorbidity coding, 
as checked by the funders, did not show a great deal of bias in terms of quality. 
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6.4 Future Research Directions 
During the research, we faced several challenges, mostly in terms of data quality and 
properties. A few methodological questions and opportunities also arose, which we aimed 
to explore. However, as there is always an inherent trade-off between available time and 
features to include, we needed to set a scope for the research. It is hoped that 
investigation of related features beyond our present scope will be undertaken in future by 
us or the research community. The major research directions based on the current 
framework are briefly discussed here.  
 6.4.1 Data linkage 
The research data that we used has a sufficiently large population, as it was acquired from 
one of the larger conglomerates of private healthcare funds in Australia. However, this is 
not the only health fund or data source; there are numerous private health funds, as well 
as the government healthcare system, Medicare, which covers healthcare services for the 
remaining population. One of the major reasons we needed to do rigorous filtering to 
choose patients is because not all patients had sufficient admission information within our 
research dataset. One of the reasons for this is that those patients may have terminated 
their membership and opted for other funds. Also, in some cases, members can 
temporarily subscribe to another fund for an interim period, and then again return to the 
original fund. Although absence for an interim period is very unlikely for our dataset, we 
still filtered out a number of patients who did not have sufficient information, some of 
whom may have opted for other funds. It may be worthwhile to track these patients. 
From a policy-level perspective for insurance providers, it would be interesting to see 
which particular patients have opted out, at what health status they did so and what 
policies could be adopted to keep these valuable customers with their funds.  
Further, our dataset only represents around five years of data, as the framework is 
focused on understanding disease progression over time. Therefore, if we want to track 
previous or subsequent medical history for these patients, we would need to obtain their 
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other datasets and merge or link them. This process is called ‘data linkage’, ‘record 
linkage’ or ‘data integration’. Linkage between healthcare datasets involves several 
considerations, including privacy issues, ethical and legislative guidelines and regulations. 
Further, both datasets should be matched based on unique identifiers such as Medicare 
number. If no definitive identifier is found, a combination of identifiers, such as name, 
address and age, can be used to identify patients over different datasets and merge their 
records. This process of data linkage is often executed by third parties or government-
approved organisations for legislative reasons, as data linkage needs to expose personal 
identifiers during calculation. 
 6.4.2 Inclusion of primary care data 
As discussed in the limitations section (see Section 6.3), the early treatment or diagnosis 
of chronic disease may be likely to occur through primary care by a GP. People normally 
go to GP as the first point of contact in non-emergency situations. Clinical notes made by 
GPs and their corresponding diagnostic results are extremely valuable resources. 
Unfortunately, on a large scale, these data are not collected centrally using a standard 
format or reporting scheme. There are still considerable amounts of primary care data 
from GPs and self-reported data kept by stakeholders such as state health departments 
for the Australian context. Incorporating those forms of data into the framework, either 
by linking them to existing data, if possible, or simply using the primary care data as a 
standalone set, could be an interesting research direction. Further, in the coming years, 
the Australian government will roll out electronic health records for patients, which will 
contain patients’ entire medical history, including medications and consultation 
information, stored centrally and accessible from everywhere. This huge and complete 
health database should open up new frontiers of research, especially in understanding 
disease progression and prediction-related topics, in which our framework can be 
extended easily. 
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 6.4.3 Effect of the lookback period 
The lookback period, related to understanding disease pathways, is the amount of time 
before the onset of disease within which we need to look at the medical history of the 
patients to understand how these comorbidities eventually led to the onset. This period is 
often set between one and five years, depending on factors such as population size and 
disease types. In our case, the data itself represented a five-year time period. Therefore, 
our lookback period had a maximum of five years. However, the lookback period was not 
uniform for all patients, as not all of them had first and last admissions dates five years 
apart. To maintain uniformity, we normalised the admission records by time duration. 
Therefore, admissions with smaller time gaps between first and last admissions were 
scaled up to five years’ lookback period in our experiment. It would be interesting to see 
whether choosing admissions for one year only before the first diagnosis date could offer 
different degrees of accuracy or understanding of the progression. This could be done 
using the existing dataset by filtering the patients who have at least one year of 
information before first diagnosis and then using only the admission for that year.  
 6.4.4 Extending the framework to the post-diagnosis phase 
In the first part of our framework, we generated two baseline networks, one for chronic 
and one for non-chronic patients, and then merged them to create the final baseline 
network through attribute adjustment. While constructing the positive baseline network 
from the chronic patients, we only considered admission records up to the point when the 
first chronic disease-related ICD code appeared in the admission. Therefore, we examined 
the disease progression prior to developing chronic disease through the final baseline 
network, which exposed the comorbidities and patterns that led to the onset. Keeping the 
same principles for the baseline network, we can alter the timeline of progression to 
include the post-diagnosis phase. We can consider admissions after the first chronic code 
appeared. When the positive baseline network is generated using this timeline, we can 
see what diseases and transitions are more prevalent after the chronic condition develops 
in patients. The negative baseline network of non-chronic patients should be kept the 
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same. We can then produce the final baseline network through attribute adjustment, 
revealing the potential diseases and transition patterns that occur more exclusively in the 
chronic patients after they are diagnosed with the disease. This experiment can easily be 
done using the existing dataset that we employed in this project. 
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Appendices 
Appendix A: Glossary 
Admission: The formal process of undergoing treatment in a hospital. See also – episode, 
separation.    
Australian Classification of Health Interventions (ACHI): A seven digit coding system for 
classifying interventions that has been used since 1998. It is based on MBS and was 
previously known as the Medicare Benefits Schedule-Extended (MBS-E). The first five 
digits of ACHI code indicate the MBS item number (if exists). The two-digit extension 
represents specific interventions included in that item.  
Australian Refined Diagnosis Related Group (AR-DRG): Australian admitted patient 
classification system which provides a clinically meaningful way of relating the number 
and type of patients treated in a hospital (i.e., casemix) to the resources required by the 
hospital. Each AR-DRG represents a class of patients with similar clinical conditions 
requiring similar hospital services. (source: AIHW). 
Baseline Network: A network representation of the health trajectory of chronic disease or 
any particular group of patients. 
Bound: The maximum (upper bound) or minimum (lower bound) possible value of a 
mathematical function (or equation) for any valid input. 
Care Type: The overall nature of a clinical service provided to an admitted patient during 
an episode of care. Examples are – acute care, palliative care, psychogeriatric care etc. 
Casemix: The concept of providing healthcare industry with a consistent method of 
classifying types of patients, their treatment and associated costs. See also – AR-DRG. 
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Chronic disease: A broad set of illnesses and health conditions that are non-
communicable and persist over a long period of time, such as – diabetes, cancer, 
cardiovascular diseases etc. 
Comorbidity: Diseases that occur together. In clinical coding context, the disease chiefly 
responsible for the admission is called principal diagnosis. Other present diseases or 
conditions are recorded as secondary diagnoses and are called comorbidities. See also – 
principal diagnosis. 
Cream skimming: (For insurance providers) Attract people with low additional or 
healthcare risk. 
Data linkage: The bringing together (linking) of information from two or more different 
data sources that are believed to relate to the same entity—for example, the same 
individual or the same institution. This can provide more information about the entity and, 
in certain cases, can provide a time sequence, helping to tell a story, show 'pathways' and 
perhaps unravel cause and effect. The term is used synonymously with 'data integration' 
and 'record linkage. 
Disease progression: The occurrence of different diseases of comorbidities over time and 
the transitions between them. See also – health trajectory. 
Episode: An episode (METeOR ID 491557) is the period between admission and separation 
that a person spends in one hospital, and includes leave periods not exceeding seven days. 
Admission and separation can be either formal or statistical. For our context, it is 
statistical, meaning that each episode refers to only one care type for clarity in reporting 
and resource allocation. If a patient’s care type changes during a hospital stay, such as, if 
transferred from acute care to palliative care, it is statistically separated into two 
episodes. 
Health Facility: A place where healthcare is provided, such as - hospitals, clinics, doctor’s 
chambers etc.  
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Health Fund: In Australian healthcare context, private health insurance is provided 
through organisations registered under the Private Health Insurance Act 2007. The 
registered organisations are called Health Fund. A list of health funds operating in 
Australia can be found at www.privatehealth.gov.au/dynamic/healthfundlist.aspx 
Health trajectory: Evolution of the health status of a single or group of patients over time. 
In this research context, we used diseases (i.e., ICD codes) as the indicator of health status 
or health trajectory. See also - disease progression. 
Individual disease network: The network representation of the disease progression of an 
individual using hospital admission records. 
International Classification of Diseases (ICD): Disease classification system published by 
the World Health Organisation (WHO) for worldwide use in translating the narrative 
descriptions of diseases, injuries and procedures contained in medical records into 
alphanumeric codes. 
Medicare (Australia): The universal health care scheme in Australia providing access to 
medical and hospital services for all Australian residents and certain categories of visitors 
to Australia.  
Medicare Benefits Schedule (MBS): Listing of the Medicare services subsidised by the 
Australian Government. The listing is available at MBS Online website 
(http://www.mbsonline.gov.au/). See also – Medicare. 
Pharmaceutical Benefits Scheme (PBS): The Australian Government program to provide 
subsidised medicines to Australian residents and certain categories of visitors to Australia. 
The schedule can be accessed from PBS website (http://www.pbs.gov.au/). See also – 
Medicare Benefits Schedule. 
Primary key: An identifier that is unique for each record in a database system such as 
driver’s license, vehicle registration number etc. 
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Principal diagnosis: (METeOR ID: 361034) The diagnosis established after study to be 
chiefly responsible for occasioning an episode of care. 
Providers:  An entity who provides the healthcare service. These include individual GPs, 
specialists (doctors, surgeons, anaesthetists etc.), nurses etc. In generic sense, healthcare 
facilities, i.e., hospitals, clinics etc. can also be a provider. 
Relapse: A recurrence of illness or symptoms of disease after a period of remission or 
improvement. See also – remission.    
Remission: Absence of signs or symptoms for a chronic disease or illness after the onset, 
as well as the time period during which such absence remains. A disease in remission state 
does not indicate completely cure. See also – relapse. 
Separation: (METeOR ID 327268) The process by which an episode of care for an admitted 
patient ceases. It can be formal or statistical. For our research context it is statistical 
meaning that it indicates the cessation of an episode of care for a patient within the one 
hospital stay. 
Simple Graph: An unweighted and undirected graph, i.e., edges do not have any 
directionality or weight. Also there is no self-loop, i.e., none of the nodes have edge that 
points to itself.  
Universal Health Care: Health system that provides healthcare and financial protection to 
the citizens of a particular country. Healthcare services under universal health care are 
often subsidised by the government. See also – Medicare. 
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Appendix B: Acronyms 
ACHI  The Australian Classification of Health Interventions 
ACS  Australian Coding Standards 
AIHW  Australian Institute of Health and Welfare 
AMA  Australian Medical Association 
ANOVA Analysis of variance 
AR-DRG Australian Refined Diagnosis Related Group 
BMI  Body Mass Index 
BN  Baseline Network 
CDMP  Chronic Disease Management Program 
CMBS  Commonwealth Medical Benefits Scheme 
COPD  Chronic Obstructive Pulmonary Disease 
DNA  DeoxyriboNucleic Acid 
DRG  Diagnosis Related Group 
E-R model Entity-Relationship model 
GP  General Practitioner 
HAMBS Hospital and Medical Benefits System, a not-for-profit company formed by 
Australian private health insurers to meet the present and future technological demands 
for its member funds. 
HCP  Hospital Casemix Protocol 
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HRCN  Hospital-rehab coordination network 
ICD  International Classification of Diseases 
ICU  Intensive care unit 
IDE  integrated development environment 
MBS  Medicare Benefits Schedule 
MPM  Mortality Protection Model 
NCCC  The National Casemix and Classification Centre 
NDSS  National Diabetes Services Scheme 
NSW  New South Wales 
PBS  Pharmaceutical Benefits Scheme 
PCCN  Patient-centric care coordination network 
PCN  Physician collaboration network 
RTM  Released To Manufacturing 
SAPS  Simplified Acute Physiology Score 
SN  Social Network. 
SNA  Social Network Analysis 
T2D  Type 2 Diabetes 
US  United States 
WHO  World Health Organization  
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Appendix C: Mathematical notation used 
Notation Description Explanation, bounds and possible values 
𝑁𝑃 Individual patient’s disease network  
𝑁𝐷𝑎𝑠𝐷 Test patient’s disease network  
𝑁𝐵+𝑣𝑣  Baseline Network of T2D patient cohorts  
𝑁𝐵−𝑣𝑣  
Baseline Network of non-T2D patient 
cohorts 
 
𝑁𝐵 
Baseline Network derived from 𝑁𝐵+𝑣𝑣  
and 𝑁𝐵−𝑣𝑣  
 
𝐺(𝑉,𝐸) Any generic graph G where V is the set of nodes (i.e., vertices) and E is the set of 
Edges. 
 
V(G) Set of all vertices (nodes) of a generic graph G Alternately, can be just written as V E(G) Set of all edges of a generic graph G Alternately, can be just written as E |𝑆| Number of elements in generic set 𝑆  
𝑛𝐷𝐷𝐷𝑎𝑡 Number of all patients.  
𝑛 Number of all filtered patients. 𝑛 ≤ 𝑛𝐷𝐷𝐷𝑎𝑡 
𝑛+𝑎𝑎 
Number of all filtered patients who are 
type-2 diabetic. 
 
𝑛−𝑎𝑎 
Number of all filtered patients who are 
not type-2 diabetic. 
𝑛 = 𝑛+𝑎𝑎 + 𝑛−𝑎𝑎 
𝐶𝑇2𝐷  
Cohort of all type 2 diabetic (T2D) 
patients 
 
𝐶′𝑇2𝐷  Cohort of all non-T2D patients  
𝐶𝑖 (𝑇2𝐷)  ith cohort of T2D patients. 𝑎 = {1,2, … ,10} 
𝐶′𝑖 (𝑇2𝐷) ith cohort of non-T2D patients. 𝑎 = {1,2, … ,10} 
𝑑𝑖 
ith comorbidity for the selective 
comorbidity approach 
𝑎 = {1,2, … ,35} 
𝑎 Total number of comorbidities that are considered. 
In our thesis, 𝑎 = 35 
𝑎𝑖 i
th Admission for a patient  
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𝐷 Set of comorbidities 𝐷 =  {𝑑1,𝑑2, … ,𝑑𝑚} 
𝐷𝑎𝑖 
Set of diseases or comorbidities that are 
recorded during admission 𝑎𝑖 
 
𝑓𝑜 
Variable to indicate risk factor 
𝑓𝑜 =  {𝑓𝑜𝑎𝑎𝑎, 𝑓𝑜𝑠𝑎𝑥, 𝑓𝑜𝑏𝑎ℎ𝑎𝑎𝑎, 𝑓𝑜𝑎𝑁𝐷𝑑𝑎, 𝑓  
𝑎𝑜𝑠𝑟𝑖  
Scaling or weighting factor for a risk 
factor i. 
 
𝑆𝑖 Overall risk score of a patient i  
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Appendix D: Letter of Human Ethics approval 
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Letter of Human Ethics approval (continued) 
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Appendix E: Actual E-R diagram used in the model 
In chapter 3, we gave an overview of the functional properties and specification of the 
dataset and entities within it that are related to the framework. We did not mention the 
actual entity and field names that are actually used in the analysis. There are also some 
entities that are used for as supplementary in the analysis. Following two figures show 
database design (E-R diagram) that was used by the software for analysis. 
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Appendix F: Technical details of the software and analytical tools used 
Purpose Software and version Comments 
Analysis Chronic Disease Risk 
Prediction Framework 
(CDRAF) 
v 3.1 
The core of the framework. Used to prepare 
dataset, implement the methods, analyses and 
the prediction. We developed the software from 
scratch. 
 Microsoft Visual Studio 
(Enterprise 2015) 
v 14.0.24720.00 Update 1 
The CDRAF software was developed using this 
Integrated Development Environment (IDE). 
Notable tools were – Visual C# 2015 (main 
programming language) and .Net Framework 
(version 
 Visual C# 2015  Integrated within Visual Studio IDE. It was the 
programming language used to develop the core 
(CDRAF) software.  
 R Studio 
v 0.99.463 
IDE for R programming. Used for implementing 
two predictive models and few graphs. 
 Microsoft Excel 
(2013 and 2010) 
A significant part of intermediate calculation and 
data interfacing were done in MS Excel 
Software 
library/pack
age 
ZedGraph 
v 5.1.7 
Planned for dynamic visualisation. Later decided 
to keep out of our research scope.  
 Npgsql 
v 3.1.0-alpha6 
Used for interfacing between PostgreSQL 
database and c# programming language with 
.NET environment 
 NuGet Package Manager 
v 3.3.0 
Integrated with Visual Studio IDE. 
Database 
engine 
Microsoft SQL server 
v 12.00.2000 (SQL Server 2014 
RTM) 
The research database was hosted in this engine. 
The main CDRAF software communicated with 
the engine to perform data read and write into 
the database. 
 PostgreSQL 
 
The originally received database was hosted in 
this engine. The main CDRAF software 
transferred the required data to our research 
database in MS SQL Server during the data 
preparation process. 
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Purpose Software and version Comments 
Database 
client 
SQL Server Data Tools  
v 14.0.50616.0 
This database management tool is integrated 
within Visual Studio IDE.  
 pgAdmin 
v 1.20.0 
Used for administering PostgreSQL 
Visualisatio
n 
Gephi 
v 0.8.2 
Baseline network was visualised using Gephi, a 
powerful Social Network Analysis (SNA) 
software. We also used it for disease cluster 
detection. 
 Adobe Photoshop CS6 
v 13.0 (Extended) 
 
 Microsoft office suit Mainly MS Power Point is used. 
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Appendix G: ICD-10-AM codes for identifying selective comorbidities6. 
S/L Comorbidities ICD-10 codes 
0 Congestive heart failure I099,I110,I130,I132,I255,I420,I425,I426,I427,I428,I429,I43?,I50?,P290,I2511 
1 Cardiac arrhythmias I441,I442,I443,I456,I459,I47?,I48?,I49?,ROOO,ROO1,ROO8,T821,Z450,Z950 
2 Valvular disease A520,I05?,I06?,I07?,I08?,I091,I098,I34?,I35?,I36?,I37?,I38?,I39?,Q23O,Q231,Q232,Q233,Z952,Z954 
3 Pulmonary circulation Disorders I26?,I27?,I280,I288,I289 
4 Peripheral vascular disorders I70?,I71?,I731,I738,I739,I771,I790,I792,K551,K558,K559,Z958,Z959 
5 Hypertension, uncomplicated I10? 
6 Hypertension, complicated I11?,I12?,I13?,I15? 
7 Paralysis G041,G114,G801,G802,G81?,G82?,G830,G831,G832,G833,G834,G839 
8 Other neurological disorders 
G10?,G11?,G12?,G13?,G20?,G21?,G22?,G254,G255,G31
2,G318,G319,G32?,G35?,G36?,G37?,G40?,G41?,G931,G9
34,R470,R56? 
9 Chronic pulmonary disease I278,1279,J40?,J41?,J42?,J43?,J44?,J45?,J46?,J47?,J60?,J61?,J62?,J63?,J64?,J65?,J66?,J67?,J684,J701,J703 
10 Hypothyroidism E00?,E01?,E02?,E03?,E890 
11 Renal failure I120,I131,N18?,NI9?,N250,Z490,Z491,Z492,Z940,Z1992,N179 
12 Liver disease 
B18?,I85?,I864,I982,K70?,K711,K713,K714,K715,K717,K7
2?,K73?,K74?,K760,K762,K763,K764,K765,K766,K767,K76
8,K769Z944 
13 Peptic ulcer disease excluding bleeding K257,K259,K267,K269,K277,K279,K287,K289 
14 AIDS/H1V B20?,B21?,B22?,B24? 
                                                            
6 For blue coloured comorbidities, some new ICD codes were added after inspection. The last 6 orange 
coloured comorbidities were added as addition to the original Elixhauser comorbidity index. 
 ‘?’ indicates wildcard mask that matches with any character. The dot (.) in ICD code is omitted. 
For details, refer to the Section 5.4.1 
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15 Lymphoma C81?,C82?,C83?,C84?,C85?,C88?,C96?,C900,C902 
16 Metastatic cancer C77?,C78?,C79?,C80? 
17 Solid tumour without metastasis 
C00?,C01?,C02?,C03?,C04?,C05?,C06?,C07?,C08?,C09?,C
10?,C11?,C12?,C13?,C14?,C15?,C16?,C17?,C18?,C19?,C2
0?,C21?,C22?,C23?,C24?,C25?,C26?,C30?,C31?,C32?,C33
?,C34?,C37?,C38?,C39?,C40?,C41?,C43?,C45?,C45?,C45?,
C46?,C47?,C48?,C49?,C50?,C51?,C52?,C53?,C54?,C55?,C
56?,C57?,C58?,C60?,C61?,C62?,C63?,C64?,C65?,C66?,C6
7?,C68?,C69?,C70?,C71?,C72?,C73?,C74?,C75?,C76?,C97
? 
18 
Rheumatoid 
arthritis/collagen vascular 
diseases 
L940,L941,L943,M05?,M06?,M08?,M120,M123,M30?,M
310,M311,M312,M313,M32?,M33?,M34?,M35?,M45?,
M461,M468,M469 
19 Coagulopathy D65,D66,D67,D68?,D691,D693,D694,D695,D696 
20 Obesity E66? 
21 Weight loss E40?,E41?,E42?,E43?,E44?,E45?,E46?,R634,R64 
22 Fluid and electrolyte disorders E222,E86?,E87? 
23 Blood loss anaemia D500 
24 Deficiency anaemia D508,D509,D51?,D52?,D53? 
25 Alcohol abuse F10,E52,G621,I426,K292,K700,K703,K709,T51?,Z502,Z714,Z721,F102 
26 Drug abuse F11?,F12?,F13?,F14?,F15?,F16?,F18?,F19?,Z715,Z722 
27 Psychoses F20?,F22?,F23?,F24?,F25?,F28?,F29?,F302,F312,F315 
28 Depression F204,F313,F314,F315,F32?,F33?,F341,F412,F432 
29 Cataract H25?,H26? 
30 Anaemia, unspecified D649 
31 Prediabetes medication Z9222 
32 Macular degeneration H353 
33 
Presence of coronary 
angioplasty implant and 
graft 
Z955 
34 Presence of aortocoronary bypass graft Z951 
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Appendix H: R commands and functions used 
R code for Binary Logistic Regression training: 
fold0LogitTrainData <- read.csv("~/directoryLocation/fold0Train.txt") 
 
fold0LogitTrain <- glm(formula=actualRisk~.,family="binomial",data= fold0
LogitTrainData) 
 
summary(fold0LogitTrain) 
 
R code for Binary Logistic Regression test: 
fold0LogitTestData <- read.csv("~/directoryLocation/fold0Test.txt") 
 
fold0LogitTest <- predict.glm(fold0LogitTrain,newdata = fold0LogitTestDat
a [,-7],type="response") 
 
fix(fold0LogitTest) 
 
R code for Binary Tree Classification training: 
library(rpart) 
 
fold0TreeTrainData <- read.csv("~/directoryLocation/fold0Train.txt") 
 
fold0TreeTrain <- rpart(actualRisk~., method="class",data= fold0TreeTrain
Data) 
 
summary(fold0TreeTrain) 
 
R code for Binary Tree Classification test: 
fold0TreeTestData  <- read.csv("~/directoryLocation/fold0Test.txt") 
 
fold0TreeTest <- predict(fold0TreeTrain, fold0TreeTestData, type="class") 
 
table (fold0TreeTest, fold0TreeTestData$actualRisk) 
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To plot the Binary Tree: 
plot(fold0TreeTrain, uniform=TRUE, branch=0.6,margin=.05) 
 
text(fold0TreeTrain, all=TRUE,use.n=TRUE, cex=.8) 
 
Code to create six parameters scatterplot (as in Figure 5.9): 
Note: The csv file should be in following format 
age,sex,behav,gNode,gPat,gClus,actualRisk 
0.627272727,M,Y,0.013738963,0.979840417,1,Diabetic 
0.618181818,M,Y,0.024879487,0.671667611,0.523809524,Diabetic 
0.663636364,M,N,0.02403873,0.625824694,0,Diabetic 
0.427272727,M,Y,0.12641904,0,0,Non-diabetic 
0.636363636,M,Y,0,0,0,Non-diabetic 
0.7,F,N,0.028718945,0,0,Non-diabetic 
0.645454545,F,Y,0.010333195,0,0,Non-diabetic 
 
It is then fetched in R as eachPntScore_forScatterplotOfRFs 
Actual R code is below 
#utility function for multiple plot 
multiplot <- function (...,plotlist=NULL, file, cols=1,layout=NULL){ 
  library(grid) 
  plots <- c(list(...),plotlist) 
  numPlots = length(plots) 
  if(is.null(layout)){ 
   layout <- matrix(seq(1,cols*ceiling(numPlots/cols)), 
        ncol=cols,nrow = ceiling(numPlots/cols)) 
  } 
  if(numPlots==1){ 
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   print(plots[[1]]) 
  } 
  else{ 
   grid.newpage() 
   pushViewport(viewport(layout=grid.layout(nrow(layout),ncol(layout)))) 
   for(i in 1:numPlots){ 
    matchidx <- as.data.frame(which(layout==i, arr.ind = TRUE)) 
    print(plots[[i]],vp = viewport(layout.pos.row=matchidx$row, 
          
 layout.pos.col=matchidx$col)) 
   } 
  } 
 } 
#MAIN CODE  
library(ggplot2) 
alphaVal = 0.5 
jitterWidth=0.45 
jitterHeight=0.2 
effectiveData=eachPntScore_forScatterplotOfRFs #this is the dataframe 
d0=data.frame(values=effectiveData$age,type=effectiveData$actualRisk) 
d1=data.frame(values=effectiveData$sex,type=effectiveData$actualRisk) 
d2=data.frame(values=effectiveData$behav,type=effectiveData$actualRisk) 
d3=data.frame(values=effectiveData$gNode,type=effectiveData$actualRisk) 
d4=data.frame(values=effectiveData$gPat,type=effectiveData$actualRisk) 
d5=data.frame(values=effectiveData$gClus,type=effectiveData$actualRisk) 
 
g0 = ggplot(d0,aes(type,values)) 
g0 = g0 + geom_jitter(alpha = 
alphaVal,aes(colour=type),position=position_jitter(width=jitterWidth))+labs(y="Age",x=element_b
lank()) 
g0 = g0 + theme(legend.title=element_blank()) 
g0 = g0 + theme(legend.position="none") 
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g1 = ggplot(d1,aes(type,values)) 
g1 = g1 + geom_jitter(alpha = 
alphaVal,aes(colour=type),position=position_jitter(width=jitterWidth,height=jitterHeight))+labs(y=
"Sex",x=element_blank()) 
g1 = g1 + theme(legend.title=element_blank()) 
g1 = g1 + theme(legend.position="none") 
 
g2 = ggplot(d2,aes(type,values)) 
g2 = g2 + geom_jitter(alpha = 
alphaVal,aes(colour=type),position=position_jitter(width=jitterWidth,height=jitterHeight))+labs(y=
"Behaviour risk",x=element_blank()) 
g2 = g2 + theme(legend.title=element_blank()) 
g2 = g2 + theme(legend.position="none") 
 
g3 = ggplot(d3,aes(type,values)) 
g3 = g3 + geom_jitter(alpha = 
alphaVal,aes(colour=type),position=position_jitter(width=jitterWidth))+labs(y="Node match 
score",x=element_blank()) 
g3=g3+scale_y_continuous(limits=c(0,0.3)) #we magnified the upper limit of y axis. Very few 
points are missed in the process. 
g3 = g3 + theme(legend.title=element_blank()) 
g3 = g3 + theme(legend.position="none") 
 
g4 = ggplot(d4,aes(type,values)) 
g4 = g4 + geom_jitter(alpha = 
alphaVal,aes(colour=type),position=position_jitter(width=jitterWidth))+labs(y="Pattern match 
score",x=element_blank()) 
g4 = g4 + theme(legend.title=element_blank()) 
g4 = g4 + theme(legend.position="none") 
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g5 = ggplot(d5,aes(type,values)) 
g5 = g5 + geom_jitter(alpha = 
alphaVal,aes(colour=type),position=position_jitter(width=jitterWidth))+labs(y="Cluster match 
score",x=element_blank()) 
g5 = g5 + theme(legend.title=element_blank()) 
g5 = g5 + theme(legend.position="none") 
 
multiplot(g0,g1,g2,g3,g4,g5, cols=2) 
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Score vs Outcome scatterplot (as in Figure 5.12) 
The demo data for the csv file input is like this 
score,predictionResult,actualRisk 
0.26075246,tp,Diabetic 
0.193418201,tp,Diabetic 
0.148513129,fn,Diabetic 
0.141614969,fn,Diabetic 
0.143728813,tn,Non-diabetic 
0.1206,tn,Non-diabetic 
0.180534846,fp,Non-diabetic 
 
It is fetched in R as scoreVsOutcomeVsPreditionData 
Main Code below (y intercept draws the straight line) 
library(ggplot2) 
d0=data.frame(values=scoreVsOutcomeVsPreditionData$score,type=factor(scoreVsOutcomeVsPre
ditionData$predictionResult,levels=c("tp","tn","fp","fn"))) 
g0 = 
ggplot(d0,aes(type,values))+geom_hline(yintercept=0.1601525,linetype="dashed",colour="red")#
draw the threshold line 
g0 = g0 + 
geom_jitter(aes(colour=scoreVsOutcomeVsPreditionData$actualRisk),position=position_jitter(widt
h=0.45))+labs(x="Outcome",y="Score",title="Score vs Outcome") 
g0 
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Appendix I: Accuracy and performance related result for all three predictive 
models in different settings 
Binary Logistic Regression with Attribution adjustment with Selective Comorbidity 
 TP TN FP FN Precision Recall Accuracy 
Fold 0 193 191 39 37 83.18966 83.91304 83.47826 
Fold 1 190 201 29 40 86.75799 82.6087 85 
Fold 2 188 192 38 42 83.18584 81.73913 82.6087 
Fold 3 185 9 46 45 80.08658 80.43478 80.21739 
Fold 4 182 185 45 48 80.17621 79.13043 79.78261 
Fold 5 189 195 35 41 84.375 82.17391 83.47826 
Fold 6 193 193 37 37 83.91304 83.91304 83.91304 
Fold 7 184 196 34 46 84.40367 80 82.6087 
Fold 8 188 194 36 42 83.92857 81.73913 83.04348 
Fold 9 189 186 44 41 81.11588 82.17391 81.52174 
Mean 188.1 174.2 38.3 41.9 83.11324 81.78261 82.56522 
SD 3.419064 55.24274 5.1 3.419064 1.990811 1.48655 1.548827 
 
 
Binary Logistic Regression without Attribution adjustment with Selective Comorbidity 
 TP TN FP FN Precision Recall Accuracy 
Fold 0 175 189 41 55 81.01852 76.08696 79.13043 
Fold 1 182 186 44 48 80.53097 79.13043 80 
Fold 2 174 187 43 56 80.18433 75.65217 78.47826 
Fold 3 168 167 63 62 72.72727 73.04348 72.82609 
Fold 4 167 185 45 63 78.77358 72.6087 76.52174 
Fold 5 172 180 50 58 77.47748 74.78261 76.52174 
Fold 6 175 186 44 55 79.90868 76.08696 78.47826 
Fold 7 166 194 36 64 82.17822 72.17391 78.26087 
Fold 8 179 194 36 51 83.25581 77.82609 81.08696 
Fold 9 180 188 42 50 81.08108 78.26087 80 
Mean 173.8 185.6 44.4 56.2 79.71359 75.56522 78.13043 
SD 5.287722 7.337575 7.337575 5.287722 2.789531 2.299009 2.242821 
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Binary Logistic Regression with Attribution adjustment with ICD code collapse 
 TP TN FP FN Precision Recall Accuracy 
Fold 0 173 162 68 57 71.78423 75.21739 72.82609 
Fold 1 177 159 71 53 71.37097 76.95652 73.04348 
Fold 2 162 173 57 68 73.9726 70.43478 72.82609 
Fold 3 212 229 1 18 99.53052 92.17391 95.86957 
Fold 4 221 227 3 9 98.66071 96.08696 97.3913 
Fold 5 225 227 3 5 98.68421 97.82609 98.26087 
Fold 6 225 229 1 5 99.55752 97.82609 98.69565 
Fold 7 221 226 4 9 98.22222 96.08696 97.17391 
Fold 8 170 174 56 60 75.22124 73.91304 74.78261 
Fold 9 170 174 56 60 75.22124 73.91304 74.78261 
Mean 195.6 198 32 34.4 86.22255 85.04348 85.56522 
SD 25.66009 29.96998 29.96998 25.66009 12.76742 11.15656 11.95107 
 
 
Binary Logistic Regression without Attribution adjustment with ICD code collapse 
 TP TN FP FN Precision Recall Accuracy 
Fold 0 172 157 73 58 70.20408 74.78261 71.52174 
Fold 1 179 152 78 51 69.64981 77.82609 71.95652 
Fold 2 171 142 88 59 66.02317 74.34783 68.04348 
Fold 3 166 142 88 64 65.35433 72.17391 66.95652 
Fold 4 167 143 87 63 65.74803 72.6087 67.3913 
Fold 5 169 142 88 61 65.75875 73.47826 67.6087 
Fold 6 171 152 78 59 68.6747 74.34783 70.21739 
Fold 7 166 146 84 64 66.4 72.17391 67.82609 
Fold 8 175 148 82 55 68.09339 76.08696 70.21739 
Fold 9 180 154 76 50 70.3125 78.26087 72.6087 
Mean 171.6 147.8 82.2 58.4 67.62188 74.6087 69.43478 
SD 4.779121 5.344156 5.344156 4.779121 1.884771 2.077879 2.00472 
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Parameter Estimation Method with Attribution adjustment with Selective Comorbidity 
 TP TN FP FN Precision Recall Accuracy 
Fold 0 210 181 49 20 81.08108 91.30435 85 
Fold 1 208 187 43 22 82.86853 90.43478 85.86957 
Fold 2 219 180 50 11 81.41264 95.21739 86.73913 
Fold 3 217 172 58 13 78.90909 94.34783 84.56522 
Fold 4 220 170 60 10 78.57143 95.65217 84.78261 
Fold 5 209 187 43 21 82.93651 90.86957 86.08696 
Fold 6 208 197 33 22 86.30705 90.43478 88.04348 
Fold 7 201 188 42 29 82.71605 87.3913 84.56522 
Fold 8 218 177 53 12 80.4428 94.78261 85.86957 
Fold 9 204 180 50 26 80.31496 88.69565 83.47826 
Mean 211.4 181.9 48.1 18.6 81.55601 91.91304 85.5 
SD 6.327717 7.673982 7.673982 6.327717 2.156062 2.751181 1.233779 
 
 
Parameter Estimation Method without Attribution adjustment with Selective 
Comorbidity 
 TP TN FP FN Precision Recall Accuracy 
Fold 0 659 518 172 31 79.30205 95.50725 83.91304 
Fold 1 658 531 159 32 80.53856 95.36232 87.6087 
Fold 2 660 525 165 30 80 95.65217 86.95652 
Fold 3 655 514 176 35 78.8207 94.92754 83.04348 
Fold 4 646 512 178 44 78.39806 93.62319 84.78261 
Fold 5 645 528 162 45 79.92565 93.47826 84.34783 
Fold 6 674 498 192 16 77.8291 97.68116 86.73913 
Fold 7 653 533 157 37 80.61728 94.63768 84.56522 
Fold 8 656 520 170 34 79.41889 95.07246 87.17391 
Fold 9 649 525 165 41 79.72973 94.05797 83.69565 
Mean 655.5 520.4 169.6 34.5 79.458 95 85.28261 
SD 7.940403 9.951884 9.951884 7.940403 0.854789 1.150783 1.579793 
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Parameter Estimation Method with Attribution adjustment with ICD code collapse 
 TP TN FP FN Precision Recall Accuracy 
Fold 0 178 168 62 52 74.16667 77.3913 75.21739 
Fold 1 184 159 71 46 72.15686 80 74.56522 
Fold 2 182 154 76 48 70.54264 79.13043 73.04348 
Fold 3 225 227 3 5 98.68421 97.82609 98.26087 
Fold 4 224 227 3 6 98.67841 97.3913 98.04348 
Fold 5 225 227 3 5 98.68421 97.82609 98.26087 
Fold 6 225 227 3 5 98.68421 97.82609 98.26087 
Fold 7 224 225 5 6 97.81659 97.3913 97.6087 
Fold 8 222 223 7 8 96.94323 96.52174 96.73913 
Fold 9 176 173 57 54 75.53648 76.52174 75.86957 
Mean 206.5 201 29 23.5 88.18935 89.78261 88.58696 
SD 21.74511 31 31 21.74511 12.38927 9.454398 11.38734 
 
 
Parameter Estimation Method without Attribution adjustment with ICD code collapse 
 TP TN FP FN Precision Recall Accuracy 
Fold 0 168 157 73 62 69.70954 73.04348 70.65217 
Fold 1 198 132 98 32 66.89189 86.08696 71.73913 
Fold 2 202 124 106 28 65.58442 87.82609 70.86957 
Fold 3 197 121 109 33 64.37908 85.65217 69.13043 
Fold 4 211 97 133 19 61.33721 91.73913 66.95652 
Fold 5 186 120 110 44 62.83784 80.86957 66.52174 
Fold 6 203 118 112 27 64.44444 88.26087 69.78261 
Fold 7 181 132 98 49 64.87455 78.69565 68.04348 
Fold 8 200 121 109 30 64.72492 86.95652 69.78261 
Fold 9 199 142 88 31 69.33798 86.52174 74.13043 
Mean 194.5 126.4 103.6 35.5 65.41219 84.56522 69.76087 
SD 11.94362 15.10761 15.10761 11.94362 2.491912 5.192877 2.161814 
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Binary Tree Classification with Attribution adjustment with Selective Comorbidity 
 TP TN FP FN Precision Recall Accuracy 
Fold 0 223 172 58 7 79.35943 96.95652 85.86957 
Fold 1 223 172 58 7 79.35943 96.95652 85.86957 
Fold 2 208 195 35 22 85.59671 90.43478 87.6087 
Fold 3 217 179 51 13 80.97015 94.34783 86.08696 
Fold 4 216 175 55 14 79.7048 93.91304 85 
Fold 5 207 183 47 23 81.49606 90 84.78261 
Fold 6 222 178 52 8 81.0219 96.52174 86.95652 
Fold 7 210 193 37 20 85.02024 91.30435 87.6087 
Fold 8 219 185 45 11 82.95455 95.21739 87.82609 
Fold 9 216 173 57 14 79.12088 93.91304 84.56522 
Mean 216.1 180.5 49.5 13.9 81.46041 93.95652 86.21739 
SD 5.7 7.952987 7.952987 5.7 2.232298 2.478261 1.163399 
 
 
Binary Tree Classification without Attribution adjustment with Selective Comorbidity 
 TP TN FP FN Precision Recall Accuracy 
Fold 0 216 181 49 14 81.50943 93.91304 86.30435 
Fold 1 215 197 33 15 86.69355 93.47826 89.56522 
Fold 2 215 186 44 15 83.01158 93.47826 87.17391 
Fold 3 229 150 80 1 74.11003 99.56522 82.3913 
Fold 4 224 168 62 6 78.32168 97.3913 85.21739 
Fold 5 218 177 53 12 80.4428 94.78261 85.86957 
Fold 6 220 178 52 10 80.88235 95.65217 86.52174 
Fold 7 209 182 48 21 81.32296 90.86957 85 
Fold 8 213 190 40 17 84.18972 92.6087 87.6087 
Fold 9 218 176 54 12 80.14706 94.78261 85.65217 
Mean 217.7 178.5 51.5 12.3 81.06312 94.65217 86.13043 
SD 5.367495 12.16758 12.16758 5.367495 3.204031 2.333693 1.778893 
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Binary Tree Classification with Attribution adjustment with ICD code collapse 
 TP TN FP FN Precision Recall Accuracy 
Fold 0 163 201 29 67 84.89583 70.86957 79.13043 
Fold 1 196 162 68 34 74.24242 85.21739 77.82609 
Fold 2 186 174 56 44 76.8595 80.86957 78.26087 
Fold 3 225 227 3 5 98.68421 97.82609 98.26087 
Fold 4 224 227 3 6 98.67841 97.3913 98.04348 
Fold 5 225 227 3 5 98.68421 97.82609 98.26087 
Fold 6 224 229 1 6 99.55556 97.3913 98.47826 
Fold 7 228 224 6 2 97.4359 99.13043 98.26087 
Fold 8 227 222 8 3 96.59574 98.69565 97.6087 
Fold 9 199 162 68 31 74.53184 86.52174 78.47826 
Mean 209.7 205.5 24.5 20.3 90.01636 91.17391 90.26087 
SD 21.34502 27.11181 27.11181 21.34502 10.50018 9.280445 9.671739 
 
 
Binary Tree Classification without Attribution adjustment with ICD code collapse 
 TP TN FP FN Precision Recall Accuracy 
Fold 0 193 155 75 37 72.01493 83.91304 75.65217 
Fold 1 197 148 82 33 70.60932 85.65217 75 
Fold 2 221 119 111 9 66.56627 96.08696 73.91304 
Fold 3 185 169 61 45 75.20325 80.43478 76.95652 
Fold 4 201 138 92 29 68.60068 87.3913 73.69565 
Fold 5 196 144 86 34 69.50355 85.21739 73.91304 
Fold 6 187 167 63 43 74.8 81.30435 76.95652 
Fold 7 184 170 60 46 75.40984 80 76.95652 
Fold 8 192 152 78 38 71.11111 83.47826 74.78261 
Fold 9 181 176 54 49 77.02128 78.69565 77.6087 
Mean 193.7 153.8 76.2 36.3 72.08402 84.21739 75.54348 
SD 10.92749 16.6 16.6 10.92749 3.238949 4.751082 1.409695 
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Appendix J: Screenshot of the actual Software used to implement the 
framework 
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